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Abstract 
Scrapie, Creutzfeldt-Jakob disease and bovine spongiform encephalopathy belong to 
a group of diseases known as the transmissible degenerative encephalopathies. 
These diseases are characterised by astrocytic gliosis, neuronal vacuolation, 
deposition of amyloid plaques, long incubation periods and by their transmissibility 
to laboratory rodents. 
PrP has a central role in the pathogenesis of the transmissible degenerative 
encephalopathies. During disease PrP accumulates pathologically in and around cells 
of the brain. In uninfected animals PrP is a membrane bound sialoglycoprotein of 
molecular weight 33-35 kDa. PrP mRNA is found in most tissues, but at differing 
levels. The brain expresses PrP mRNA highly, whereas organs such as heart and 
kidney express PrP mRNA to a lesser extent. Liver and spleen express PrP at very 
low levels. The expression of PrP mRNA has also been shown to be regulated 
during mouse development, both postnatally and embryonically. PrP levels rise four-
fold from day 0 to day 20 and are then maintained at this level throughout adult life. 
Prenatally, PrP has been detected by in situ hybridisation at 13.5 days in the 
developing brain and spinal cord and by 16.5 days PrP transcripts could be detected 
also in specific non-neuronal populations. Nerve growth factor has been shown to 
influence the levels of PrP in vivo and in vitro. Injection into hamster brain increased 
PrP mRNA levels approximately nine-fold and PrP protein levels three-fold. 
The regulatory processes involved in controlling these types of expression are not 
known. 
This project sets out to examine the transcriptional regulation of the mouse Iip  gene 
by studying the promoter region and the first intron. 
This was done by isolating a 3.5 kb BamHI / KpnI fragment from a murine PrP 
cosmid clone. This subclone contained 1.2 kb of 5' region to exon 1. This exon was 
shown to be separated from exon 2 by a 2.3 kb intron. 
Sequence analysis of the 5' flanking region showed that it was highly G+C rich, 
contained no TATA box and had potential binding sites for many transcription factors 
including Spi, APi, AP2 and EGR1. 
In a transient transfection assay this 3.5 kb BamHI / Kpnl fragment was shown to 
act as a promoter by linking it to the bacterial reporter gene - chioramphenicol acetyl 
transferase and introducing it into neuro2a cells. Subsequent deletions both in the 5' 
flanking region and in the intron revealed positive regulatory elements in both. 
The transcriptional start sites of the PrP gene were mapped using the primer 
extension technique with an oligonucleotide whose target sequence resides in 
exon 2. 
These reporter gene constructs will be used to generate transgenic mice and to assess 
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Chapter 1 	Introduction 
1.1 Transmissible degenerative encephalopathies 
The transmissible degenerative encephalopathies (TDEs) are a group of naturally 
occurring and fatal, neurological, diseases of both humans and animals. 
Scrapie is the best studied of this group, its existence having being documented 
centuries ago, and occurs naturally in sheep and to a lesser extent in goats. The main 
mode of transmission in natural scrapie is thought to be maternal. However, 
horizontal transmission of natural scrapie also seems to occur (Dickinson et al., 
1974). Rodents, especially mice, are frequently used as experimental models of the 
disease. Bovine spongiform encephalopathy (BSE) first appeared in cattle in 1986 
(Wells et al., 1987) and epidemiological evidence later suggested that infection 
occurred by ingestion of contaminated food-stuffs (Wilesmith et al., 1991). This 
coincided with changes in the way which animal waste tissues were rendered. These 
changes meant that scrapie agent could now survive the rendering process and was 
therefore able to enter the food chain of animals which consumed it. In addition to 
cattle, scrapie-like diseases soon became manifest in exotic zoo animals such as 
nyala, gemsbok and kudu and these, too, were thought to be due to consumption of 
contaminated food-stuffs. Chronic wasting disease (CWD) affects mule deer and elk 
whereas transmissible mink encephalopathy, as the name suggests, affects mink. 
Both of these diseases are thought to stem from ingestion of scrapie infected tissues. 
In humans there are four diseases which can be classified into the TDEs. These are 
Creutzfeldt-Jakob disease (Cm), Oerstmann-Straussler-Scheinker syndrome (GSS), 
Kuru and the recently discovered fatal familial insomnia (FF1). CJD was first 
characterised at the turn of the century and since then has been shown to exist in 
three forms: sporadic, familial and iatrogenic. The majority of CJD cases are of a 
sporadic nature in that neither a genetic (familial) nor an accidental (iatrogenic) route 
of transmission can be found in such cases. The transmissibility of sporadic CJD is 
not understood. Unlike CJD, most cases of GSS are familial in nature, characterised 
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by an autosomal pattern of inheritance. The majority of patients with GSS have 
substitution mutations in the open reading frame of their PrP gene (for review see 
Hsiao and Prusiner, 1990). Kuru occurs only in the Fore tribe in Papua New Guinea 
but its prevalence is now declining since its route of transmission was established. 
Ritualistic cannibalism was traced as this route of transmission (Gajdusek, 1977). 
The TDEs are characterised by long incubation periods, transmissibility to laboratory 
animals, astrocytic gliosis and by neuropathology such as spongiform degeneration 
of neurones and deposition of amyloid plaques. The precise nature of this 
neuropathology can be quite variable and depends on the disease type, the species of 
animal and its genotype, and strain of agent (defined only in rodents). 
PrP protein has a critical role in the pathogenesis of these diseases. In uninfected 
animals PrP is found on the cell surface of many cell types, but especially neurones. 
During disease, however, PrP protein becomes altered in some undefined way. 
These alterations are poorly understood, but their consequences are that PrP 
aggregates pathologically in and around cells of the brain. 
In order to understand these diseases it is first necessary to understand at what level 
the regulation of PrP is affected. Several workers have suggested that there may be 
a post-translational (Borchelt et al., 1990) or conformational (McKinley et al., 1991) 
change in PrP during disease and that this causes infection-specific pathology to form 
and, indeed, is the basis of infectivity itself. Despite much effort, the exact nature 
of this change has not been determined (Stahl etal., 1993). There remains, however, 
the possibility that the regulation of PrP is affected, during disease, at a 
transcriptional or post-transcriptional level. These possibilities must initially be 
addressed by examining the regulation of PrP gene expression in uninfected animals. 
By doing this one can start to determine the role of such events during disease. 
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1.2 PrP Protein 
PrP (prion protein) is a cellular sialoglycoprotein (Bolton et al., 1985) which is 
attached to the outside of a variety of cells by a glycophosatidylinositol anchor (Stahl 
et al., 1987). PrP can exist as two different isoforms: the cellular form (PrP') which 
is found in healthy animals and the scrapie isoform (PrP) which is found only in 
diseased animals. PrP' is heterogenous in size and has a molecular weight ranging 
from 33-35 kDa (Turk et al., 1988; Bolton et al., 1987). PrPC is soluble and can be 
digested to completion with proteinase k (Meyer etal., 1986; Bendheim eral., 1988). 
PrP', on the other hand, is specific to the transmissible degenerative encephalopathies 
and has been found to be insoluble and partially resistant to proteinase k treatment, 
resulting in a resistant core of 27-30 kDa. This protease resistance is characteristic 
of the TDEs. 
Both isoforms of PrP have been shown to shown to undergo the same extensive post-
translational modifications; cleavage of the N-terminal signal peptide (Basler et al., 
1986; Hope et al., 1986; Turk et al., 1988), N-linked glycosylation at their predicted 
sites (Caughey et al., 1988) and addition of a glycophosphatidylinositol anchor at its 
C-terminus after cleavage of its terminal peptide (Turk et al., 1988., Stahl et al., 
1990). The difference between PrP' and PrP is not known, however similarities in 
size and charge suggest that this difference is slight and may reflect either a 
conformational or post-translational modification (Hope et al., 1986; Turk et al., 
1988). 
Based on DNA sequences, both cDNA and genomic, of PrP genes from various 
species the deduced amino-acid sequences have been shown to have a greater than 
85 % identity with each other (for review see Goldrnann, 1993). This homology of 
PrP proteins has been shown to occur in mouse (Locht et al., 1986., Westaway et al., 
1987), hamster (Basler et al., 1986), human (Kretsczmar et al., 1986) and sheep 
(Goldinann et al., 1990). This high degree of conservation suggests that PrP has an 
important function. This function, however, has not been determined, despite several 
speculations. 
During lymphocyte activation PrP protein increases in abundance on the surface of 
lymphocytes. Cashman et al (1990) showed that antibodies to PrP can block this 
activation. This led them to suggest that PrP, in lymphocytes at least, may play a 
role in signal transduction. Others have suggested that because a GFAP (glial 
fibrillary acidic protein) stimulating factor is produced from a cell line derived from 
a CJD infected brain that PrP may act in controlling astrocyte proliferation (Olescak 
et al., 1989). Due to its location on the external surface of cells, PrP has also been 
suggested to perform a similar function as the N-CAMs and Cadhedrins (Hope and 
Manson, 1991). That is, in directing and maintaining the architecture of the nervous 
system. In addition, PrP may play a role in embryogenesis (Manson et al., 1992 a). 
To determine what physiological role PrP plays and to understand the relationship 
which PrP has with the causative agent, several labs have generated mice in which 
the PrP genes have been ablated or "knocked-out" (Bueler et al., 1992; Manson et 
al., 1994). These are called PrP null mice. 
Bueler et a! (1992) generated PrP null mice by disrupting one allele of the PrP gene 
via a homologous recombination event. This involved replacing codons 4-187 of the 
PrP open reading frame with a neomycin phosphotransferase gene under the control 
of the HSY thymidine kinase promoter. Cells which contained the disrupted PrP 
gene were injected into 4 day old blastocyts and implanted into foster mothers. 
Heterozygotes were mated with each other to produce mice which were homozygous 
for the disrupted PrP gene. These PrP°  null mice showed normal development and 
had no abnormalities up to the age of seven months. Disruption of the PrP gene 
produced no gross abnormalities at both macroscopic and microscopic level in the 
brain and skeletal muscle (Bueler et al., 1992). These null mice showed no 
significant difference in the response of splenocytes, when compared to PrP mice, 
to activation by concanavalin A. In addition, PrP null mice showed no differences 
in learning ability, based on 3 simple learning tests and showed no breeding 
differences when compared to wild type mice. Recently, however, a phenotypic 
difference has been found between wild type mice and null mice (Collinge et al., 
1994). PrP null mice have an apparently weakened GABAA (y-aminobutyric acid 
type A) receptor-mediated fast inhibition response and also impaired long term 
potentiation. This defective synaptic inhibition was detected in the hippocampus. 
Collinge et al (1994) argue that during disease, PrP' loses its function (presumably 
by being converted to PrP) and that this loss of function contributes to early 
synaptic loss (Clinton et al., 1993) and to neuronal degeneration. 
1.3 	The scrapie agent: its properties and relationship to PrP 
One of the first indications that the causative agent of scrapie was different from 
other infectious organisms came from the work of Alper et al (1967, 1978) who used 
ionising and UN irradiation in inactivation of infectivity studies. These experiments 
indicated that the putative genome of the agent must be very small due to its high 
resistance to inactivation by irradiation. The interpretation of this data was called 
into question by Rowher (1984) who proposed that the genome of the agent was 
similar to that of a virus both in terms of its size and by its susceptibility to 
inactivation by irradiation. However, the original interpretation of the data by Alper 
et al was substantiated by more recent experiments which support this (Bellinger-
Kawahara et al., 1987, 1988). Other experiments have shown that scrapie infectivity 
is not affected by the action of nucleases (Prusiner, 1982). Furthermore, to date no 
one has managed to isolate a scrapie specific nucleic acid from infectious tissue 
fractions despite numerous attempts (Wietgrefe et al., 1985; Meyer et al., 1991; 
Kellings et al., 1992). 
Much evidence has now amassed which strongly suggest that the agent is composed 
of protein and if this protein is destroyed or modified then this has a deleterious 
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effect on infectivity. By using procedures which purified infectivity from scrapie 
infected hamster brain McKinley et at (1983) showed that PrP was the predominant 
protein in fractions purified for scrapie infectivity. Furthermore, the concentration 
of PrP was found to be directly proportional to the amount of infectivity and that the 
isoform of PrP was PrP based on it's resistance to proteinase k. In 1982, Prusiner 
demonstrated using fractions purified for infectivity that if the proteins found in these 
fractions were treated with proteinase k, phenol, SDS, or diethylpyrocarbonate then 
infectivity was greatly diminished. 
These lines of evidence lead to the proposal of the term "prion" to describe the 
infectious agent. This was introduced to distinguish it from viruses and viroids. 
Prions are defined as proteinaceous infectious particles which are resistant to 
inactivation by procedures which modify nucleic acids (Prusiner, 1982). Originally, 
prions were hypothesised to be either proteins which contained no genome, proteins 
which surrounded a nucleic acid (a virus) or proteins with which a small non coding, 
but perhaps regulatory, oligonucleotide was associated. 
If any of these models are correct they must incorporate into them, and explain, the 
existence of distinct strains of scrapie. The existence of such strains is based entirely 
on the length of incubation period and neuropathological differences which they 
cause when injected into inbred lines of mice (Outram, 1976; Dickinson and Fraser, 
1977). Like viruses, these scrapie strains can be mutated giving rise to other strains 
which have a different incubation period and which show different neuropathology 
in the same line of mouse. These changes are heritable and predictable and suggest 
that the scrapie agent contains its own independent genome (Bruce and Dickinson, 
1987). 
With a large degree of certainty all that can be said concerning the biochemical 
constitution of the agent is that it is composed or associated, at least in part, with the 
abnormal isoform of PrP. 
1.4 Genetics of disease susceptibility 
1.4.1 The Sinc and Sip genes 
The incubation period can be defined as the time from intracerebral injection, of 
infected material, to onset of clinical symptoms. In mice, this incubation period can 
vary between 4 months and 2 years and is dependent on the strain of scrapie injected 
and on host genetic factors (Bruce et al., 1991). The Sinc gene (scrapie incubation 
period) is the major gene which controls incubation period in mice (Dickinson et al., 
1968) and there are two alleles of this gene: s7 and p7. In sheep the major gene 
which controls scrapie incubation period is the Sip gene and this too has two alleles: 
sA and pA. Evidence is now growing that Sinc (or Sip) is closely linked to PrP and 
in fact that the two may be congruent. This has been shown in mice (Carlson et al., 
1986., Hunter et al., 1987) and in sheep (Hunter et al., 1989) by using restriction 
fragment length polymorphisms (RFLP). By nucleotide sequencing Westaway et a! 
(1987) have shown that a strain of mouse (NZW) which is s7 homozygous for Sinc 
differs from a mouse strain (I/Ln) which is p7 homozygous at predicted codons 108 
and 189 of the PrP protein. This nucleotide transition, at predicted codon 108, would 
result in a leucine (NZW) to phenylalanine change (1/Ln). At codon 189 a change 
from valine (l/Ln) to threonine (NZW) was predicted. This therefore suggests that 
PrP and Sinc are the same gene but absolute proof is still lacking. If the genes are 
congruent it may be that these changes in the primary amino acid sequence of the 
PrP protein are responsible for the effects of incubation difference between mice with 
different Sinc genotypes. 
Others have found that different genes may be involved in the disease process. Work 
with congeniè mice which differ only in their major histocompatibiity complex (H-2) 
suggested that another gene called Pid- 1 (prion incubation determinant) plays a role 
in controlling incubation period (Kingsbury et al., 1983). Nd-i has been mapped 
close to the D region of the H-2 complex on mouse chromosome 17, but neither its 
function nor whether it actually represents one or more genes is known. 
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That Pid-1 maps to the D region of the murine H-2 region is interesting as class I 
MHC genes also map to this region and have been shown to increase their expression 
during the disease process. This increased expression has been shown by 
immunocytochemistry to be localised in neurones - the primary seat of destruction 
during disease (Duguid and Trzepacz, 1993). Beta 2 microglobulin is associated with 
the class I MHC gene product, to form the class I complex, and has also been shown 
to have increased expression during scrapie in hamsters (Duguid and Dinaver, 1990). 
Furthermore class II MHC genes were also shown to increase expression during 
disease (Duguid and Trzepacz, 1993). While these events may suggest that there is 
an attempted immune response to infection, there is no evidence of a detectable 
hurnoral or inflammatory response by the host (Gajdusek, 1977). 
1.4.2 Mutations in the PrP gene which are linked to CJD and GSS 
In animals such as mouse (Westaway et al., 1987), hamster (Lowenstein eral., 1990) 
and sheep (Goldmann et al., 1990) differences in the nucleotide sequence, and 
deduced amino-acid sequence, of PrP have been shown to correlate with differences 
in scrapie incubation period. 
In humans, familial CJD and GSS (Masters et al., 1981) are linked to mutations in 
the open reading frame of the PrP gene (also known as the PRNP gene). There are 
however forms of these diseases, especially CJD, which have no apparent mutation 
in the open reading frame of the PrP gene and these are the sporadic and iatrogenic 
cases. 
a) Gerstmann Strausslgr Scheinker syndrome 
Most cases of GSS are familial, although some sporadic cases have been reported 
(for review see Hsiao and Prusiner, 1990). Out of the familial forms of GSS there 




GSS with neurofibrillary tangles 
Despite the heritability of familial GSS, as characterised by an autosomal pattern of 
inheritance, it is also infectious as indeed are all other members of the transmissible 
degenerative encephalopathies. 
GSS usually presents itself in the fourth decade of life and the average duration of 
the disease is five years, after which death ensues. GSS has a characteristically 
massive deposition of PrP amyloid and its incidence has been estimated at 1-10 per 
hundred million (see Hsiao and Prusiner, 1990). 
The first and best characterised example of a mutation in the human PrP which 
linked to ataxic GSS was reported in 1989 by Hsiao and colleagues. They found that 
three individuals (two pedigrees) with GSS had a mutation at codon 102 of the PrP 
protein which changed a proline residue to a leucine residue. This mutation was not 
found in eight unaffected relatives or in one hundred unrelated normal individuals 
from the same ethnic background. Also, this mutation was not found in fifteen other 
individuals who had another form of transmissible degenerative encephalopathy. This 
suggested that although the 102 mutation may cause GSS, or at least play a role in 
the pathogenesis of disease, it was not responsible for any other disease within the 
TDE group (see section 1.6 for further analysis of the codon 102 mutation). 
Subsequent analysis, by another group, showed that although the GSS 102 leucine 
—proline mutation is the most common mutation associated with GSS, it is not the 
only mutation. A codon 117 alanine —vaIine mutation can occur instead (Doh-ura et 
al., 1989). This mutation is associated with dementing GSS. 
The third form of GSS is unique in that all affected individuals have widespread 
Alzheimer-like neurofibrillary tangle (nft) deposition. These plaques immunolabel 
with and-PrP antibodies but not with anti j3-amyloid antibodies (Roberts etal., 1986). 
GSS with neurofibrillary tangle deposition has been best characterised in two 
families; from Indiana and Sweden. Each of the affected members of the families 
had a mutation in the open reading frame of the PrP gene. The Indiana family had 
a mutation at codon 198 which changed a phenylalanine residue to a serine. The 
Swedish family, on the other hand, had a different mutation at codon 217 which 
substituted an arginine residue for a glutarnine (Diouhy et al., 1992; Hsiao et al., 
1992). 
Table 1. Mutations associated with GSS 
GSS form Mutation 
Ataxic 102 proline - leucine 
Dementing 117 alanine - valine 




phenylalanine - serine 
glutamine --4 arginine 
b) Creutzfeldt-Jakpb disease 
In comparison to GSS, CJD occurs with a relatively higher frequency affecting 
approximately 1 in a million people. 5 - 10 % of these cases are familial and are 
characterised by an autosomal dominant pattern of inheritance. The average age of 
death in patients with CJD is 51 years and the duration is usually shorter than GSS, 
lasting about 1 year. CJD is characterised by subacute dementia and widespread 
spongiform degeneration of neurones (Masters et al., 1981). 
10 
Many studies have now linked several mutations in the human PrP gene to CJD. 
These mutations are both point and insertion mutations and a number of these will be 
described below. 
The first point mutation in the PrP gene to be linked to CJI) was reported by Goldfarb 
et at in 1990 (a). A mutation in codon 200 of the PrP which substituted a lysine 
residue for a glutamine was described initially for two clusters of CJD in Slovakia 
(Goldfarb et at., 1990 a). The same mutation was subsequently found in individuals 
of different ethnic origin who were affected with CJD (Goldfarb et al., 1990 b). A 
codon 178 mutation has also been reported which causes an asparagine to aspartic 
acid change (Brown et al., 1992). As well as linking to CJD, this mutation has been 
linked to a recently discovered disease called fatal familial insomnia, FF1, (Medori 
et al., 1992). This disease is characterised by sleep disturbances, ataxia and memory 
impairment. Neurone loss in FF1 is highly localised to the mediodorsal and anterior 
ventral nuclei of the thalamus (Manetto et al., 1992). 
In addition to point mutations, numerous insertion mutations have been described 
which link to CJD. All these insertion mutations are found in the same region of the 
PrP gene, corresponding to between codons 51 and 91 of the human PrP gene. In 
unaffected individuals there are 5 repeated octapeptides in this region. In some 
individuals affected with CJD the number of these repeats is increased from 5 to 10, 
11, 12, 13 and 14. All individuals with such insertions contract CJD but there is 
evidence that the number of repeats is related to age of disease onset and to the 
duration of disease (Goldfarb et al., 1991; Owen et al., 1991). 
It may be that these mutations in the human PrP gene increase the probability of PrP 
spontaneously forming an infectious conformation, if such a conformation exists. This 
would be de novo generation of infectivity. Alternatively, it may be that these 
mutations predispose an individual to infection by an agent which is ubiquitous. In 
either case, the different PrP proteins produced by such mutations may influence the 
pathology and clinical outcome of disease. 
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Table 2. 	Mutations associated with CJD 
Point 200 glutamine - 	lysine 
178 asparagine -f aspartic acid 
Octapeptide 10 
insertion (total number) 11 
12 
Between codons 51-91 13 
14 
--. 
1.5 	The PrP gene, its structure and expression 
1.5.1 	Conservation and structure 
The PrP gene (also referred to as Pm- .p in mice and PRNP in humans) has a structure 
of one or two 5' non coding exons which are separated from the open reading frame 
exon by a large intron (>10 kb). This arrangement is well conserved between species 
such as mouse (Westaway et al., 1987, 1994c), hamster (Basler et al., 1986), human 
(Puckett et al., 1991) and sheep (Goldmann et al., 1990). The PrP gene in these 
species appears to be single copy (Westaway and Prusiner, 1986; Oesch et al., 1985; 
Liao et al., 1986 and Goldmann et al., 1990) and the chromosomal location for mice 
and humans has been mapped to chromosome 2 and to the homologous chromosome 
20 respectively (Sparkes et al., 1986). 
12. 
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Figure 1. 
Structure of rodent PrP gene as known in 1990. This figure is based on data by Basler el al., (1982) 
and Westaway etal., (1987). The basic gene structure is conserved between mouse and hamster. The 
entire open reading frame is contained within a single exon, dubbed exon 2. One 5' untranslated exon 
was shown to exist on the hamster PrP gene whereas at least one 5' untranslated exon was found on 
the mouse PrP gene. This exon was dubbed exon 1. The 5' exon was separated from exon 2 by a 
large intron, the size of which was at least 10 kb. 
In addition to the structural similarities of the PrP gene between species there is also 
a high conservation at the nucleotide sequence level. Goldmann eral., (1990) showed 
that the protein coding region of PrP mRNA is 80-90% homologous between sheep, 
mouse and hamster. 
Based on Southern hybridisation Westaway and Prusiner (1986) have shown that 
sequences related to the hamster PrP gene may be present in lower organisms such 
as Drosophila melanogaster, C.elegans and S.cerevisiae. 
However no homologous gene has been isolated in non-mammalian species. 
13 
1.5.2 	5' non-coding exon (s) and promoter regions 
As mentioned previously, at the start of this project only the gene structures for both 
hamster and mouse PrP genes were known. In the case of the mouse gene the 51  
region of the gene was not well characterised. During the course of this project, 
however, it became clear that mouse, unlike hamster, had two 5' exons (Westaway et 
a!, 1991, 1994 c). Later, the structure of the human PrP gene was elucidated and this 
too was found to have only one 5' exon (Puckett et al., 1991). The significance of 
these differences and the function of the 5' exon (s) is not known. 
The length of PrP exon one in humans is 136 bp and transcription is initiated at one 
site (Puckett et al., 1991). In hamsters transcription has been shown to be initiated at 
multiple sites which result in exon 1 having a variable length of 56-82 bp (Basler et 
al., 1986). 
Preliminary work by Westaway et al (1987) has shown that the murine PrP gene also 
has multiple transcriptional start sites. That the PrP gene can initiate transcription at 
multiple start sites is not unusual, indeed many genes of diverse function also do this: 
dihydrofolate reductase gene (Mitchell et al., 1986), D1A doparnine receptor gene 
(Minowa et al., 1992), growth hormone-releasing hormone gene (Gonzalez-Crespo 
and Boronat, 1991) and glycogen phosphorylase (Herrick et al., 1993), to name but 
a few. The existence of multiple transcriptional start sites in these genes, and most 
others with multiple transcriptional start sites, can be attributable to their lack of a 
"TATA" box which has been shown to be involved in the accurate initiation of 
transcription (for review see Smale and Baltimore, 1989). Sequence analysis of the 
promoter regions of hamster (Basler et al., 1986) and human (Puckett et al., 1991) 
PrP genes has shown that they also do not contain a TATA box. Whether the use of 
differential start sites within the PrP gene serve any functional significance is not 
known, although there is evidence that alternative start sites in the alpha amylase gene 
serve a regulatory function. When expressed in the pancreas one site is utilised but 
when expressed in the salivary gland a different start site is used (Young et al., 1981). 
11- 
Our knowledge of the promoter regions of PrP genes in different species is limited. 
As yet, this knowledge is based almost entirely on sequence data. The preliminary 
work focused on the hamster gene (Basler et al., 1986) and then the human PrP gene 
(Puckett etal., 1991). This year, however, sequence data from the 5' flanking region 
of sheep (Westaway et al., 1994 b) and mouse PrP genes has been published 
(Westaway et al., 1994 c). In human, only 71 bp of the 5' flanking region has been 
sequenced and no functional analysis of this region was carried out. Despite this, the 
sequence data has shown that this region has no "TATA" box, is very GC rich (83%) 
and has several potential binding sites for the transcription factor Spi. Larger regions 
of hamster, mouse (this study) and sheep 5' flanking regions have been sequenced 
and by comparison with the human PrP promoter we can see that these features are 
also conserved in these regions. In addition to the sequence data, Basler et a! (1986) 
showed that a subclone which contained approximately 5 kb of hamster PrP 5' 
flanking region can function as a promoter. This was done in an in vitro transcription 
assay and by comparison, the adenovirus late promoter was shown to be 
approximately 10 fold stronger. 
1.5.3 	Introns: possible functions 
From recently published data (Westaway et al., 1994 c) it is now known that the 
murine PrP gene has three exons which are separated from each other by two introns. 
While the size of intron 1 has been shown to be approximately the same in different 
strains of mice, the size of intron 2 is dependent on the strain of mouse (Westaway 
et al., 1994 c), specifically on the PrP allele (either PrPa  or ppb) These alleles 
differ from each other by two amino acids at codons 108 and 189 (Westaway et al., 
1987) and these differences are consistently found in mice of different (see section 
1.6) Sinc genotypes (s7 or p7). Mice which harbour the PrP*  allele (Sinc s7) have 
been found to have an intron 2 size of approximately 17.3 kb whereas mice which 
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harbour the PrPb allele (Sine p7) have a deletion in this intron of about 6.7 kb 
(Westaway et al., 1994 c). 
The effect of intron sequences in the regulation of other genes is well documented. 
In some cases introns were shown to have a positive or stimulatory effect on gene 
expression such as those found in the dihydrofolate reductase gene (Schmidt et al., 
1990) and thymidine kinase gene (Rotheneder et al., 1991). In contrast, introns have 
also been shown to have a negative or inhibitory effect on gene expression e.g introns 
in the c-fos gene (Lamb et al., 1990) and in the alpha 1(I) collagen gene (Bornstein 
and McKay, 1988). 
Whether the intron (s) of the PrP gene have a role in the control of gene expression 
is not known as it has not been adequately addressed. There is , however, one study 
(Scott et al., 1989) which provides evidence, albeit indirect, that the intron of the 
hamster PrP gene may have an important effect on PrP gene expression. In this 
study, transgenic mice were generated using an intronless minigene construct. The 
minigene contained 1.5 kb of hamster PrP promoter, the open reading frame and the 
polyadenylation signal for the PrP gene. The mice which were transgenic for this 
construct failed to express hamster PrP protein in their brains. Mice which were 
transgenic for a genomic cosmid clone of the hamster PrP gene did produce both 
hamster PrP mRNA and protein in their brains. One interpretation of this data may 
be that the intron of the hamster PrP gene is crucial in directing high level gene 
expression. This could be achieved by the presence of a strong enhancer in the 
intron. It is impossible, however, to say with a degree of certainty that the minigene 
construct failed to express in mouse brain because it lacked intron sequences. There 
may be other explanations for this, such as transgene integration into a 
transcriptionally repressed site or absence of correct 5' flanking sequences. However, 
an investigation into the role of intron sequences on PrP gene expression would seem 
worthwhile. 
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1.5.4 The open reading frame exon: codes for PrP protein and 3' UTR 
In all species yet examined the entire open reading frame of the PrP gene resides on 
one exon and is not interrupted by introns (Oesch et al., 1985; Westaway et al., 
1987; Puckett et al, 1991). In hamster and mouse the ORF exon is approximately 
2000 bp in length (Basler et al., 1986; Westaway et al., 1987) whereas sheep have 
a much larger ORF exon of approximately 4000 bp (Goldmann et al., 1990). The 
actual open reading frame of PrP between these species are very similar in size (-760 
bp), but the remainder of the exon is composed of 3' untranslated sequence. There is 
a 10 bp untranslated region between the 5' splice site and the translational initiation 
codon ATG and this is well conserved between mouse (Westaway et al., 1987), 
hamster (Basler et al., 1986) and sheep (Goldmann et al., 1990). An interesting 
feature about the ORF exon is that the 5' end is organised into repeats. In rodents 
there are two small repeats (18 bp) which are followed by five 27 bp repeats. In 
humans, variation in the number of these repeats has been shown to correlate strongly 
with some cases of familial CJD (Goldfarb et al., 1991; Owen et al., 1991) 
See figures 2, 3 and 4 for comparisons of PrP open reading frames of mouse, hamster 
and human. From such comparisons, the presence of the repeated regions can clearly 
be seen (see figure legend for details) 
The 3' untranslated region of the ORF exon is not well characterised, but from 
sequence data one can see that it contains some highly conserved areas between 
hamster, mouse, sheep and human (Goldmann et al., 1990). The 3' UTR may contain 
some regulatory regions involved in, for example, message stability or RNA 
processing. An example of this is found in the 3' UTR of mouse protamine 2 mRNA. 
An 18 kDa protein when bound specifically to the 3' UTR is known to cause 
translational repression (Kwomdel and Hecht, 1993). 
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These figures represent graphical comparisons between two sequences and are generated by a programme called 
DOTPLOT (Maizel and Lenk, 1981). This programme constructs dot plots at points of homology between 
two sequences. In the case of mouse, hamster and human PrP open reading frames this homology is so high 
that these individual dots merge to give an almost unbroken straight line. Repeated regions can also be 
visualised using DOTPLOT and these can be seen in each figure as a series of short, unbroken lines which 
- 	-. - 	 - 	form a characteristic square shape around the central line. 
Figure 2 represents the comparison between mouse (Westaway ci al. ,1987) and hamster ORFs. 
- 	
Figure 3 represents the comparison between mouse and human (Puckett ci al., 1991) ORFs. 
- 	 Figure 4 represents the comparison between human and hamster (Basler ci al., 1986) ORFs. 
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1.5.5 	Expression of PrP mRNA in different tissues 
There have been a number of studies, using different detection methods, which have 
determined in which tissues PrP is transcribed. The three main detection methods 
used were RNA slot blots, Northern blot and in situ hybridisation. 
Initial work centred on the detection of hamster mRNA in a variety of tissues using 
Northern hybridisation and RNA slot blots. Using Northern hybridisation, Oesch et 
al., (1985) showed that single species of PrP transcripts are found in the brain, heart 
and lung and that they all appear to be the same size. Brain expressed PrP more 
highly than the other two tissues. By using the slot blot procedure PrP transcripts 
were found in brain, pancreas, heart, lung, kidney, testes and to a lesser extent in 
spleen. Caughey et al., (1988) also found PrP transcripts in a variety of tissues and 
cell lines and from Northern blots estimated that spleen contained about 0.8 % the 
amount of PrP transcripts when compared to brain. This result was confirmed by 
Brown et al., (1990) using in situ hybridisation. This revealed that PrP was barely 
detectable in liver and undetectable in spleen. That mRNA is barely detectable in 
spleen is of interest as spleen has been shown to harbour a high titre of scrapie agent 
in infected animals (Eklund et al., 1967). By using antisense RNA probes for in situ 
hybridisation, Manson et al., (1992 b) detected PrP mRNA in the majority, perhaps 
all, neurones of the brain. Different types of neurones, however, were shown to have 
different levels of PrP within them. In the same study PrP protein, as detected by 
immunocytochemistry, was found to be expressed in some, but not all, neurones of 
the brain. This therefore suggests that regulation of PrP gene expression may be 
controlled, at least in part, at a post-transcriptional level. 
In all these studies there has been no detectable difference in the amount of PrP 
mRNA between diseased and undiseased animals. This is in contrast to the levels of 
PrP protein which have been reported to rise between 10-100 fold during the disease 
course (Bruce et al., 1989). 
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+ + + denotes strong expression 
+ denotes weak expression 
1.5.6 Developmental expression of PrP mRNA 
McKinley et al., (1987) were the first to examine whether PrP gene expression is 
developmentally regulated, in hamsters. They found using Northern blotting, that PrP 
transcripts were only detectable post-natally, rising from day 1 to day 20. At day 20 
these levels became stabilised and were maintained throughout adult life. In rats PrP 
mRNA could be detected just before birth (embryonic day 20). These transcripts 
increased 3 fold to adult day 70 and this developmental change was shown to be due to 
a 3 fold increase in the transcription rate as measured by nuclear run off assays 
(Lieberburg, 1987). 
In mouse, Lazarini et al., (1991) showed that PrP was developmentally regulated at a 
post-natal level. PrP mRNA could be detected at birth, by Northern blot, and then 
increased 4 fold to day 20 where it was maintained at this level throughout adult life. In 
one study, Manson et al., (1992 a) showed that PrP mRNA can be detected prenatally in 
mice. In situ hybridisation analysis detected PrP transcripts in the developing embryonic 
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brain and spinal cord by 13.5 days but none were detected at day 6.5 or day 9.5. In 
addition PrP transcripts were also found in the peripheral nervous system by thy 16.5 and 
also in specific non-neuronal populations. 
In addition to developmental regulation, and the regulation which controls the level of PrP 
gene expression in different tissues, PrP has also been shown to be regulated by the 
action of nerve growth factor (NGF). In rat neuroblastoma cell line PC12, NGF was 
shown to increase the levels of PrP mRNA. This increase was detectable by 2 days but 
maximal increase was observed after 7 days (Wion et al., 1988). Interestingly beta 
amyloid precursor protein (APP) mRNA, which like PrP forms amyloid plaques during 
disease (Masters et al., 1985), was also shown to be affected by the action of NGF, 
although not in the same way. Mobley et al., (1988) provided in vivo evidence that 
injection of NGF can regulate both PrP and APP mRNA in neonatal hamsters. 
The DNA sequences and transcription factors involved in the regulation of PrP gene 
expression are unknown. However, it appears likely that PrP can be regulated at a 
transcriptional, post-transcriptional and possibly (during disease) at a post-translational 
level. 
1.6 	Transgenetic experiments 
The development and analysis of transgenic mice has proved invaluable for studying 
many facets of the transmissible degenerative encephalopathies. These facets include the 
species barrier, relationship of PrP to the causative agent, the effect of mutations in the 
PrP gene and in the control of scrapie incubation period. A summary of several of these 
transgenic experiments are described below. 
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In 1989 the first PrP transgenic mouse lines were developed. The mice harboured copies 
of the Syrian hamster PrP gene and were designated as being tg (Ha PrP) mice. Three 
transgenic lines were produced and contained varying copy numbers of the hamster 
transgene. Tg 69 and 71 had 4-8 copies of the hamster PrP gene while tg 81 harboured 
30-50 copies. On inoculation with hamster specific scrapie agent (sc237) the tg (Ha PrP) 
mice all developed disease. Tg 81 was found to have the shortest incubation period - - 
75 days, whereas the tg lines with less transgene copies had scrapie incubation periods 
of - 170 days. Non-transgenic mice did not develop disease 500 days after inoculation. 
The tg (Ha PrP) mice had PrP present in their brains, as determined by proteinase k 
resistance. In addition, the pathology was characteristic of hamster scrapie (Scott et al., 
1989). These results suggested that the PrP gene can modulate scrapie susceptibility 
(species barrier), incubation times and neuropathology. In addition, this experiment 
showed that the transgene copy number also can play an important role in the outcome 
of disease. 
OSS 102 transgenic mice 
As mentioned in a previous section, some patients who are affected by GSS have a 
mutation at codon 102 of the PrP gene which causes a proline to lysine change. In an 
attempt to develop an experimental model of GSS, transgenic mice were generated by 
Hsiao and co-workers (1990) which harboured an analogous mutation (mouse codon 101) 
on the PrP gene. The transgene copy numbers varied from approximately 10 - 64 copies. 
These mice were found to develop spontaneous neurodegeneration at an average age of 
166 days. They presented with clinical signs such as ataxia, lethargy and rigidity and 
gradually deteriorated until death. At a pathological level, vacuolar degeneration and 
astrocytic gliosis were seen. However, no amyloid plaques were detected. PrP was 
present in the brains of the transgenic mice but at very low levels. 
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One of the main problems in the interpretation of this experiment is the effect of high 
transgene copy numbers. For example, this experiment does not properly address whether 
spontaneous disease is caused by the 101 mutation or by increased PrP copy numbers. 
The transgenic experiments of Scott et al., (1989) clearly indicate that the transgene copy 
number can influence certain aspects of disease (see above). It seems likely that this 
contributed to the pathogenesis of spontaneous neurologic disease, as reported by Hsiao 
et al., (1990) as the mean age of disease onset correlated inversely with transgene copy 
number. 
Although technically more difficult, generation of transgenic mice by homologous 
recombination would act as a control for copy number effects as only one copy of a gene 
would be altered at a given time. 
During the course of this study two developments heightened the need to understand the 
regulation of the PrP gene. These developments were a) the production of PrP 
overexpressing mice which developed neurodegeneration and b) the production of PrP 
null mice, which were subsequently shown to be resistant to scrapie. 
These studies are discussed below. 
Overexpressing PrP mice 
A recent study by Westaway et al., (1994 a) has provided evidence that high copy 
numbers of wild type (wt) PrP transgenes are pathogenic, resulting in degeneration of 
skeletal muscle, peripheral nerves and CNS. 
A number of different transgenic lines were used in this study and differed from each 
other in terms of transgene copy number, transgenic status (i.e hemizygous or 
homozygous), and by the PrP transgene which they carried. Some mice were transgenic 
for the sheep PrP gene (e.g tg[sheep PrP°] ), the Syrian hamster PrP gene (e.g tg[sHa 
PrP f] ) and also for different alleles of the mouse PrP gene (PrP-B) which confer long 
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incubation periods on mice with most, but not all, strains of scrapie (e.g tg[mo PrP-B°  
] ) as described by Westaway et al., (1987, 1991). The transgene copy number of these 
mice was estimated to vary from 3-120. 
The animals with 31 copies, or more, of the PrP transgene all developed, spontaneous 
neurologic disease. The clinical symptoms included tremor, kyphosis, gait abnormalities 
and in tg(mo PrP-B° ) mice, hind leg paralysis. Onset of disease usually occurred in 
older mice (- 560 day in tg[mo PrP-B"] mice and> 600 days in tg[sheep PrP°] ). 
However, onset of disease was detected as early as 220 days in the 120 copy number sHa 
PrP homozygous mouse. 
All of these mice had vacuolation in the CNS and presented with necrolizing myopathy 
and peripheral neuropathy. Myopathy was most striking in the quadriceps, although it 
was found in all types of skeletal muscle including intercostal muscles and diaphragm. 
The vacuolation was localised to the stratum lacunosum, molecular layer of the 
hippocampus, midbrain tegmentum and to the superior colliculus. 
In the tg (mo PrP-B ') line, which contained 31 transgene copies, PrP mRNA was found 
to be overexpressed by - 7 fold, while PrPC  was overexpressed by - 8 fold in the brain. 
No protease resistant PrP was found in the mice, in either the brain or quadriceps muscle. 
This study showed that elevated PrP expression, caused by transgene dosage, is 
pathogenic and produces a progressive neurologic disease. 
PrP null mice 
To address the normal function of PrP and the role it plays in the transmissible 
degenerative encephalopathies PrP null mice have been generated. PrP homozygous null 
mice (PrPOU ) have been created in two labs, using two different targeting strategies 
(Bueler et al., 1992; Manson et al., 1994). Although both strategies resulted in mice 
expressing no PrP protein, Bueler and co-workers found that their null mice produced a 
neomycinphosphotransferasefprp transcript. The null mice of Manson and co-workers 
did not produce any PrP related mRNA sequences. Whether this difference will manifest 
itself at a phenotypic or disease related level is not known at this stage. 
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Both laboratories have, however, found that both heterozygote and homozygote null mice 
show no obvious phenotype. They show normal development up to the age of 7 months 
and are fertile. Apart from the very recently described synaptic differences, described 
in section 1.2 (Collinge et al., 1994), the null mice are apparently normal. 
That a more obvious phenotype is not apparent is perhaps surprising considering that the 
PrP gene is expressed in different embryonic (Manson et al., 1992) and adult tissues 
(Oesch et al., 1985) and is highly conserved in all mammals as yet studied (Goldmann 
et al., 1990). The generation of knock-out mice for other genes producing no obvious 
abnormality is not without precedent, however. Ablation of the p53 gene resulted in mice 
which showed normal development and reproduction, when a lethal phenotype was 
expected (Donehower et al., 1992). 
Preliminary experiments have been conducted in which PrP null mice (both heterozygotes 
and homozygotes) have been challenged with scrapie agent. PrP" have been shown to 
be completely protected against scrapie for at least 2 years while all wild type controls 
(PrP) died within 6 months. Heterozygotes (PrP" ) were shown to be partially 
protected from scrapie; having incubation periods of around 10 months (Bueler et al., 
1993). This study reinforces the idea that the levels of PrP' and the incubation period are 
inversely correlated. It also strongly suggests that the presence of PrP is necessary for 
disease. 
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1.7 Aims of this thesis 
The aims of the work described in this thesis are as follows: 
To construct a cosmid genomic library using mouse DNA. From this library a PrP 
clone will be selected and analysed in detail. 
Analysis of a PrP cosmid clone would consist of determining a simple restriction map 
and then identifying the 5' untranslated exons and the 5' flanking region. 
This 5' region of the PrP gene would be nucleotide sequenced and its homology to 
other published sequences determined. In addition, this sequence would be scanned for 
potential transcription factor binding sites. These may indicate the presence of regulatory 
elements. 
Having identified the 5' flanking region through sequence homology, the next stage 
would be to analyse the promoter by linking it to a reporter gene and transfecting into a 
suitable cell line. Deletions will then be made in the promoter region with the aim of 
identifying regulatory elements which are important for the expression of the PrP gene. 
Finally, the transcriptional start sites, of the PrP gene, will be determined by primer 
extension and mapped onto the promoter. 
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Chapter 2 	General materials and methods 
2.1 	Chemicals and enzymes 
All chemicals and enzymes were purchased from Sigma, Gibco-BRL, Boeringer-
Mannheim, Promega and Pharmacia and stored according to the manufacturers 
instructions. Packaging mixes and cosmid vector were purchased from Stratagene. 
Distilled water (dH20) was used routinely. However, for tissue culture and RNA 
analysis water was purified from a Millipore milli-QUF system. 
2.2 	Strains of E.coli used in this study. 
Table 4. 
Strain Genotype 
NM554 recA13, araD 139, L(ara-leu)7696 
A(lac) 17A, gal a, gal k, hsdr, 
rpsl(strr), mcr A, mcr B 
CMK 603 thr, leu, thi, supE, recBC, TJR, 
T5R, k-, M+, 1acZAM15, lacY, 
F'lacql, lacZM15 pro+ 
DH5a F'/endAl, hsdRl7(rk-mk+), supE44, 
thi-1, recAl, gyrA(Nalr), relAl, 
A(1acZYA -argF)U169, 
(480dlacA(lacZ)MJ5 
Strain N1M554 was used for the cosmid cloning, whereas strain CMK 603 and DFI5a 
were used for routine transformations. 
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The recipes for the solutions found in this chapter and in subsequent chapters can be 
located in the appendices. Most of these solutions were autoclaved before use to aid 
in the prevention of nuclease contamination and were stored in small batches. 
	
2.3 	Growth media and conditions used for culturing bacteria 
Bacteria were plated on L-agar and incubated upside down, at 37°C, overnight. 
For liquid culture a single bacterial colony was inoculated into the appropriate 
volume of L-broth, usually 3-5 ml and incubated with shaking at 37°C for 6- 16 hrs. 
When appropriate, antibiotics ampicillin and kanamycin were added to the medium 
at 100 jig ml' and 50 jig m11 respectively. 
2.4 	Techniques of DNA manipulation 
2.4.1 Small scale preparations of plasmid DNA 
These small scale preparations of plasmid DNA are more commonly known as mini-
preps. Two different types of mini-preps were used. Both are based around the 
original method of Birmboim and Doly (1979). The first one is known as the 
alkaline lysis method and was generally used for screening transformants. The 
second method (magic mini-prep - Promega) has an additional step which ensures 
much purer DNA and this method was generally used for preparing template for use 
in double stranded DNA sequencing. 
i) Alkaline lysis 
3 ml of L-broth (plus antibiotic) was inoculated with a single bacterial colony and 
incubated at 37°C, with shaking, for at least 6 hrs but usually overnight. 
1.5 ml of the culture was spun down in a microfuge for 30 sec at 13000 rpm and 
the supernatant discarded. 
The pellet was vortexed in 100 p.1 of solution I. 
To this was added 200 p.1 of freshly made solution H. 
150 p.1 of solution III was then added and mixed by vigourous vortexing. After 
being stored on ice for 5 mins the solution was spun for 5 mins at 13000 rpm in a 
microfuge and the DNA containing supernatant was removed into a fresh tube. 
The DNA was ethanol precipitated and resuspended in 50 p.1 of T.E. 
ii) Magic mini-prep (Promega) 
A bacterial pellet was prepared as above. 
The pellet was resuspended by vortexing with 200 p.1 of cell resuspension 
solution. 
To this was added 200 p.1 of cell lysis solution (identical to solution H) and this 
was mixed by inverting the tube several times. 
After lysing the bacteria, the solution was neutralised by adding 200 p.1 of 
neutralisation solution. This was mixed by inversion and spun down in a microfuge 
at 13000 rpm for 5 mins. 
1 ml of magic mini-prep purification resin was added to the supernatant and 
gently mixed. 
The DNA / resin mix was then pushed through a magic mini-column. This was 
prepared by removing the plunger from a disposable 2 ml syringe and attaching a 
luer-lock extension of the mini-column to the syringe barrel. After the DNA had 
been pushed through, the column was removed and the plunger withdrawn. The 
syringe barrel was then re-attached to the mini-column. 
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2 ml of wash solution was pipetted into the barrel and pushed through. The mini-
column was then dried by a brief spin in a microfuge at 13000 rpm. 
50 jil of H20 or T.E was then added to the mini-column and spun for 1 min at 
13000 rpm. The purified DNA was collected into an Eppendorf. 
2.4.2 Large scale preparations of plasmid DNA 
Two methods were used to isolate and purify plasmid DNA in large amounts. The 
first method was based on the Birmboim and Doly (1979) alkaline lysis method and 
is essentially a scaled up mini-prep. This method was used for most plasmid preps. 
The second method employs SDS and was specifically used to isolate cosmid clones, 
as it was more gentle. This is a standard method for isolating large plasmids 
(Sambrook et al., 1989). 
Both methods incorporate the use of cesium chloride gradient centrifugation and the 
difference lies in the methods by which the bacteria are lysed. 
a) Bacterial lysis 
Alkaline lysis method 
A bacterial pellet was obtained from a 500 ml overnight culture by centrifugation 
at 7000 x g for 15 mins at 4°C 
This pellet was resuspended in 18 ml of ice-cold solution I. 2 ml of a 10 mg ml' 
lysozyme solution (in 10 mM Tris-HC1 pH 8) was added and gently mixed. 
To this was added 40 ml of fresh solution II in order to lyse the cells. 
20 ml of ice-cold solution ffi was then added and mixed well. This was left on 
ice for at least 10 mins. This was centrifuged at 7000 x g for 15 mins at 4°C. 
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The supernatant was filtered through a layer of cheese cloth to remove any 
residual bacterial debris and mixed with 0.6 vol isopropanol. This was left for 10 
mins. The nucleic acids were recovered by centrifugation at 7000 x g for 15 mins 
at room temperature. 
The pellet was allowed to dry for about 15 mins. 
ii) SDS method 
The bacterial pellet from a 500 ml overnight culture was resuspended in 10 ml 
of an ice-cold solution of 10 % sucrose in 50 mM Tris-HCI pH 8. 
2 ml of a 10 mg ml' lysozyme solution in 10 mM Tris-HC1 pH 8 was added and 
mixed and then transferred to a 30 ml screw-cap centrifuge tube. 
4 ml of 0.5 M EDTA pH 8 was mixed into the suspension and placed on ice for 
10 mins. 4 ml of 10 % SDS solution was then added and mixed immediately by 
gentle inversion. 
6 ml of 5 M NaCI was then added and again gently mixed. This was stored on 
ice for 1 hr. 
This was then centrifuged at 65000 x g for 30 mins at 4°C and the supernatant 
transferred to a fresh tube where it was phenol:chloroform extracted. 
The aqueous phase was then ethanol precipitated and the DNA recovered by 
centrifugation at 7000 x g for 20 mins at 4°C. 
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2.4.2 b) CsCI ethidium bromide gradient centrifugation 
The nucleic acid pellet was dissolved in CsC1 (13 ml; ig ml-) solution. 1 ml of a 
10 mg rn!1 ethidium bromide solution was added and mixed well. The ethidium 
bromide/protein scum which forms was removed by centrifugation at 5000 x g for 
5 mins at room temperature. The clear red supernatant was then transferred to a 
Beckman "quick seal" tube and sealed. 
The sealed tubes were then centrifuged at 350 000 x g for 16 hrs at 20°C in a 
NVT65 near vertical rotor or at 100 000 x g for 48 hrs in a 70.1 Ti rotor, also at 
20°C. 
After centrifugation two bands were present in the middle of the tube. The lower 
band containing the supercoiled plasmid DNA was removed, by side puncture, using 
a 19 gauge needle attached to a 2 ml syringe. Another needle was inserted into the 
top of the tube to equalise the pressure. 
2.4.2 C) Rebanding plasmid DNA 
Plasmid DNA was subjected to a second round of centrifugation when it was to be 
used for transfections into mammalian tissue culture cells. This removed any residual 
chromosomal DNA or RNA and any nicked or linear plasmid which may affect 
transfection efficiency. This process involved removing the plasmid band and 
transferring it directly to a fresh tube. The tube was then topped up with the CsC1 
solution (1 g nit) and spun again in exactly the same fashion as previously 
described. 
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2.4.2 d) Removal of ethidium bromide from purified plasmid DNA 
After ultra-centrifugation, the ethidium bromide / CsC1 was removed from the 
plasmid DNA solution by adding an equal volume of T.E saturated butan-2-ol. After 
inverting the closed tube several times the two phases were allowed to separate. The 
ethidium bromide partitioned into the upper butan-2-ol phase and was discarded. The 
process was repeated until the bottom phase lost its colour. 
2.4.2 e) Removal of CsCI from purified plasmid DNA 
CsC1 was removed from the DNA solution by dialysis against 5 x 1L of either T.E 
(pH 8) or MilliQ H20. This was carried out at 4°C over a period of 24 hrs. 
2.4.2 f) Spectrophotometric determination of DNA concentration 
The optical density at 260nm (OD,) was measured in a quartz cuvette in a 
spectrophotometer. An OD of 1 corresponds to 50 jtg m11. The length of the light 
path was 40 mm. 
2.4.3 	Digestion and agarose gel electrophoresis of DNA 
DNA was digested using 1 unit of enzyme per microgram of DNA in the presence 
of the appropriate restriction enzyme buffer. When necessary the total volume was 
made up with dH20. The reaction was incubated at 37°C, except for enzymes whose 
optimal temperature was not 37°C e.g Smal. In both cases, however, the incubation 
was for I - 3 hrs. 
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0.3 - 1.5 % agarose gels were used, depending on the size of the DNA fragments 
which were to be separated. In all cases 1 x TAE solution was used as the running 
buffer and was also used in the composition of the gel. 
1 tl of gel loading buffer was added to, usually, 10tl DNA before being loaded into 
the gel. 1 p.g of HindIll digested Lambda DNA was used as size standards. Gels 
were electrophoresed at 15-100 V for between 1-16 hrs depending on the experiment. 
After electrophoresis the gel was soaked in 400 ml of a 0.5 tg ml' solution of 
ethidiurn bromide for 10-60 mins. The ethidium bromide was then decanted and 
replaced with 400 ml of dH20. This was washed at room temperature with shaking 
for 15 mins to destain the gel. The DNA was viewed using a U.V transiluminator 
and photographed using Polaroid 667 film. 
2.4.4 Estimation of restriction fragment size 
HindIll digested Lambda DNA were used as size standards in every gel. 
The migration distance of the X DNA markers were measured and plotted against the 
log10  of their molecular weight. From this standard curve the migration distance of 
a restriction fragment was converted to its apparent molecular weight. 
2.4.5 Isolation and recovery of restriction fragments from 
agarose gels 
Two techniques were used for the recovery of restriction fragments from agarose 
gels: 
Centrifugation through blotting paper. 
Low melting point agarose gels. 
Centrifugation through chromatography paper 
This technique involves cutting Out a band visualised in an ethidium bromide stained 
agarose gel and centrifuging this through blotting paper (Weichenham, 1991). Two 
1.5 ml Eppendorfs had their lids removed and one was placed inside the other. The 
bottom of the upper tube was punctured with using a 19 gauge needle. A small 
square (2 cm x 2 cm) of chromatography paper e.g Whatman 3MM, was wrapped 
around the inside of the upper tube to form a tight fitting cup. Into this cup was 
placed the gel piece containing the restriction fragment of interest. The assembly was 
then centrifuged at 13000 x g for 1 min using an adaptor fitted into the JA-20 rotor. 
After centrifugation the DNA was forced through the blotting paper into the lower 
tube, along with the electrophoresis buffer. The dehydrated agarose remains in the 
blotting paper. The DNA was then ethanol precipitated and resuspended in a suitable 
volume of T.E or H20. This was the method most commonly employed to isolate 
restriction fragments. 
Low melting point agarose 
Low melting point (LMP) agarose gels were poured and run under the same 
conditions as ordinary gels except that the voltage was always low (25 V) to prevent 
the gel melting. The band of interest was cut out using a sterile scalpel blade and 
placed in a 15 ml tube. 5 vols of 20 mM Tris-HC1 (pH 8), 1 mM EDTA (pH 8) 
were mixed per 1 vol of agarose and incubated at 65°C until the agarose melted. The 
mixture was then phenol extracted, phenol:chloroform extracted and then finally 
chloroform extracted. The phases were separated between each extraction by 
centrifugation at 1000 x g for 10 mins at room temperature. The aqueous phase was 
ethanol precipitated and the DNA recovered by centrifugation at 10 000 x g for 30 
mins at 4°C. 
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2.4.6 Phenol:chloroform extraction of nucleic acids 
Proteins were removed from DNA solutions by carrying out a phenol: chloroform 
extraction. An equal volume of phenol was added to the nucleic acids solution and 
vortexed for 10 secs. This was then spun at top speed in a microcentrifuge for two 
mins to separate the phases. The aqueous phase was then transferred to a fresh tube 
and an equal volume of chloroform was added and vortexed for 10 sees. Again the 
solution was centrifuged at top speed in a microcentrifuge and the nucleic acid 
containing aqueous phase was removed for ethanol precipitation. 
2.4.7 Ethanol precipitation of nucleic acids 
2-4 vols of absolute ethanol and 0.1 vol of 3 M sodium acetate was added to the 
DNA. This was vortexed and stored at -20°C for 30 mins. The DNA was recovered 
by centrifugation at 13 000 rpm in a microfuge for 10 mins, followed by washing the 
pellet in 70% ethanol. 
2.4.8 DNA modifications 
a) Filling in 3' termini 
Up to 5 tg of restriction enzyme digested DNA was used. 1 .t1 of a fresh 1 mM 
solution of all four dNTPs (dATP, dGTP, dCTP, dTTP) was added along with 1 jfl 
(6 units) of the Kienow fragment of DNA polymerase I. This was vortexed briefly 
and incubated at room temperature for 30 mins. To inactivate the enzyme(s) the tube 
was heated at 75°C for 10 mins. 
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b) Removal of protruding 3' termini 
Kienow fragment of DNA polymerase I has a 3'-5'  exonuclease activity which can 
be used to remove protruding 3' termini, but T4 DNA polymerase is much more 
efficient at this process and hence was used. Again up to 5 pg of DNA was 
restriction digested and to this was added 1 j.tl of a 2 mM dNTP solution. 1 unit of 
T4 DNA polymerase was added per ig of DNA, mixed and incubated for 15 mins 
at 12° C. The enzymes were inactivated by heating at 75° C for 10 nuns. 
C) Dephosphorylation of 5' phosphate groups 
To prevent self ligation of vector molecules during cloning, the 5' phosphate groups 
were usually removed from linear DNA before sticky ended ligation. Calf intestinal 
alkaline phosphatase (CIP) was the enzyme used for all dephosphorylation reactions. 
The appropriate amount of DNA was restriction digested then phenol:chloroform 
extracted and ethanol precipitated. The recovered DNA was dissolved in 90 tl 10 
mM Tris-Cl (pH 8.3). 10 p.1 of the 10 x dephosphorylation buffer was then added. 
For protruding termini 1 p.! of CIP was added and the reaction was incubated for 30 
mins at 37°C. For recessed termini 1 p.1 of enzyme was added and incubated at 37°C 
for 30 mins followed by 45 inins at 55°C with another addition of enzyme. The CIP 
was then inactivated by heating at 75°C for 10 mins and removed from the reaction 
by a phenol:chloroform extraction and ethanol precipitation. 
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2.4.9 Ligation reactions 
Sticky-end ligations 
Restriction fragments were gel purified, see section 2.4.5, and the amount of DNA 
recovered was estimated by comparison of band intensity with X Hind III markers 
when run on the same ethidium bromide stained gel. At least a three fold molar 
excess of insert was ligated to the CEP treated vector in the presence of 1 p.1 T4 DNA 
ligase (1 unit) and 2 p.1 of 5 x ligation buffer. The DNA concentration of the ligation 
reaction varied but was usually around 1p.g m11. The volume was made to 10 p.1 with 
dH20 and mixed. This was then incubated overnight at 160C. 
Blunt-end ligations 
Fragments were purified and quantified as described in sections 2.4.5 and 2.4.9 a. 
A higher insert to vector molar ratio was used in blunt-end ligations (>15 fold). 1 p.l 
of high concentration T4 DNA ligase (6 units), 2 p.1 of 5 x T4 ligation buffer and H20 
to 10 p.1 were added, mixed and incubated overnight at 16°C. The ligation reactions 
were then transformed into E.epli. 
2.4.10 	Transformation of E.coli with plasmid DNA 
1) Various strains of E.coli were used for the transformation procedure (see table 4). 
E.coli strains CMK and DH5a were regularly used but NM554 was also used. 
Transformations were carried out using the calcium chloride method of Cohen a al., 
(1972). A single fresh colony was used to inoculate 100 ml of L-broth and this was 
incubated at 37°C with vigourous shaking until the cells were growing in 
approximately mid-exponential phase. This was estimated by determining the OD 
at 600 nm. Optimal OD6,. for CMK was empirically determined to be 0.2 - 0.3 
RM 
whereas the optimal OD for NM554 and DH5a was 0.4 - 0.6. 
Once the optimal OD was reached the culture was split into two 50 ml tubes and 
spun at 1000 x g for 10 mins at 4°C. These pellets were resuspended in 10 ml of 
0.1 M ice-cold Cad 2  and spun again for 10 mins. This time the pellets were 
resuspended in 2 ml ice-cold 0.1 M CaC12 and stored on ice. These competent 
bacteria were either used immediately or stored on ice overnight at 4°C. 
Between 0.1 - 50 ng of DNA or ligation mix was mixed with 200 j.il of competent 
cells and stored on ice for 30 mins to allow the DNA to precipitate onto the cell 
surface. By heat-shocking for 90 sec at 42°C and then storing on ice again the DNA 
can enter the bacterial cell. 800 p.1 of L-broth was added and the cells were shaken 
gently for 45 - 60 mins at 37°C. This allows the bacteria to express the antibiotic 
resistance gene before selection on ampicillin agar plates. After incubation at 37°C 
the culture was transferred to Eppendorf tubes and the bacteria recovered by 
centrifugation at 13000 rpm in a microfuge for 30 secs. 800 91 of supernatant was 
removed and the pellet was resuspended in the remaining 200 p.1 and plated out onto 
a L-agar plate containing the appropriate antibiotic. Plates were incubated overnight 
at 37°C. 
Transformation efficiencies could be calculated from the number of Iransformants 
derived from using a given amount of DNA. For example, 0.01 ng and 0.1 ng would 
be in a transformation and the number of colonies present on the plate the next day 
could be counted. Transformation efficiencies are usually expressed in number of 
transformants per microgram of DNA. With this method, transformation efficiencies 
exceeded 1x106 transformants p.g' of DNA. 
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2.4.11 Radioactively labelling DNA with 32P 
a) Random primer extension 
This method was used for labelling restriction fragments of double stranded DNA for 
use as probes (Feinberg and Vogeistein, 1983). 
1) Preparation of DNA 
DNA was restriction digested and run on a low melting point agarose gel. The 
desired band was cut out and the gel slice weighed in a microfuge tube. To it was 
added 3 ml of H20 per gram of agarose and this was boiled for 10 mins. The DNA 
/ agarose was aliquoted out into 30 - 50 ng amounts and stored at -20°C until 
needed. 
Preparation of oligonucleotide labelling buffer (OLB) 
This buffer was a mixture of three separate solutions : A, B and C which were mixed 
together at a ratio of 100:200:150 respectively. 
Once made OLB was stored in 10 il aliquots at -20°C. 
Labelling reaction 
30 - 50 ng of the DNA to be labelled was denatured by boiling for 10 mins then 
placed at 37°C for a few mins. To it was added 10 lii OLB, 11.11  Klenow fragment, 
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5 tl (50 tCi) [a-32P] dCTP at 3000 Ci mrnol '. The volume was adjusted to 50 p.! 
with 1120, briefly mixed then incubated overnight at room temperature. 
200 p.1 of herring sperm DNA (50 p.g rn1 1) was added to the labelling solution then 
it was phenol extracted and ethanol precipitated. The DNA was redissolved in 100 
p.! of T.E and the radioactivity was measured by Cerenkov counting in a scintillation 
counter. Specific activities exceeding 4 x 108  cpm/p.g were usually obtained. 
2.4.11 b) Oligonucleotide labelling by phosphorylation 
The following were mixed together: 100 rig of oligonucleotide, 2.5 p.! 10 x kinase 
buffer, 5 p.! (50 p.Ci) [y-32P] ATP at 3000Ci mmol', lp.l (10 units) of T4 
polynucleotide kinase, H20 to 25 p.1. The reaction was mixed then incubated at 37°C 
for 1 hr. After labelling, 200 p.1 of herring sperm DNA (50 p.g m11) was added and 
the DNA was then phenol: chloroform extracted and ethanol precipitated twice in the 
presence of 2 M ammonium acetate. This removed most of the unincorporated label. 
2.4.12 Southern blotting 
DNA fragments from an agarose gel were transferred either to Hybond-N 
(Amersham) or Genescreen (DuPont) filters, both of which are positively charged and 
are nylon based. The same blotting apparatus was used for both filters. The original 
method for this transfer was devised by Southern (1975). 
For Southern transfer with Hybond-N the gel, after electrophoresis, was soaked in 
500 ml 0.25 M HC1 for 2 x 12 mins with gentle shaking. The gel was then briefly 
rinsed in dH20 and then soaked in 0.4M NaOH, 0.6 M NaCI for 2 x 12 mins. This 
solution is also used as the transfer buffer. 
For Southern transfer with Genescreen the gel, after electrophoresis, was soaked in 
Genescreen transfer buffer with gentle shaking for 30 mins. 
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A glass plate was balanced on the sides of a sandwich box. A length of Whatman 
3MM paper (e.g 15 cm x 40 cm) was draped over the glass plate and into the box. 
The box was then half filled with transfer buffer and the paper was allowed to 
become wet. On to this the gel was placed and air bubbles which formed were 
gently removed. A piece of membrane (Hybond or Genescreen), cut to the same size 
as the gel was soaked in H20 for at least 30 mins then in transfer buffer for 10 mins. 
This membrane was then placed on top of the gel and again air bubbles were gently 
removed. Three pieces of Whatman 3MM paper (cut to size of the gel) were placed 
on top of the membrane. On to this was then added a thick wad (10 cm) of blotting 
paper which was again cut to the size of the gel. A glass plate was then placed on 
top of the paper and then a weight (500 g) was placed on to the glass plate. This 
was left at room temperature overnight. 
Washing and fixing of membran 
After transfer Hybond membranes were washed in 200 ml 2 x SSC for about 5 mins 
and then allowed to dry at room temperature for at least an hour. The DNA was 
then fixed to the membrane by wrapping it in Saran wrap and placing it in a Hybaid 
crosslinker. It was then exposed to 0.4 J/cni2 of UN light and the filter was 
removed. Genescreen membranes were simply allowed to dry at room temperature 
after transfer. 
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2.4.13 Hybridisation and post hybridisation washes 
a) Hybond N 
i) Using random labelled probes 
Hybond N filters were prehybridised at 65°C for at least 4 hrs, usually overnight, in 
about 50 ml of prehybridisation solution. Prehybridisatiocn of membranes ocurred 
in sealed plastic bags. 
For hybridisation the membrane was transferred to another bag. The probe and 5 
mg of herring sperm DNA were denatured by boiling for 10 mins and added 
immediately to 10 ml of prehybridisation solution at 65°C. This was then added to 
the plastic bag containing the membrane and sealed. The bag was incubated 
overnight at 65°C with shaking. 
Washing 
After hybridisation the membrane was washed with the following solutions. 
1st wash - 2 x SSC, 0.1 % SDS, 30 mins at room temperature 
2nd wash - 0.1 x SSC, 	"to 	 11 
3rd wash - 	to 
	
" 
It 30 mins at 37°C 
4th wash - 	It 
	
" 	
it 30 mins at 65°C 
Each membrane was washed in about 200 ml of the wash solution. 
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ii) Using oligonucleotides 
Oligonucleotide hybridisations were performed exclusively on Hybond N membranes. 
The membrane was prehybridised in 30 ml of oligonucleotide prehybridisation 
solution at 65°C overnight in a shaking water bath. 
After the membrane was prehybridised, the probe was added to 10 ml of fresh 
prehybridisation solution and the membrane sealed into a new bag. Hybridisation 
took place overnight at 42°C. 
Washing 
After hybridisation the membrane was washed in the following solutions: 
1st wash - 6 x SSC, 0.1 % SDS, 30 mins at 42°C 
2nd wash - 2 x SSC, 
3rd wash - 0.1 x SSC, 
2.4.13 b) Genescreen 
Prehybridisation for Genescreen was done for at least 30 mins in about 50 ml of 
Genescreen prehybridisation solution. This occurred in a shaking water bath at 65°C. 
For hybridisation the boiled probe was added to 10 ml of prehybridisation solution 
and added to a sealed plastic bag along with the memebrane. This was incubated 
overnight at 65°C with shaking. 
Washing 
After hybridisation the membrane was washed in the following solutions: 
1st wash - 2 x SSC, 15 mins at room temperature 
2nd wash - 0.1 x SSC, 1 % SDS, 15 mins at 65°C 
3rd wash - " 	of 	 it 
2.4.14 	Colony blotting 
This method was based on the procedure used by Grunstein and 1-logness (1975). It 
involved growing bacteria on the surface of the circular membrane (Hybond-N) 
which was laid onto the agar plates. Master plates were made by pre-wetting a fresh 
membrane on an agar plate and then placing on a piece of sterile 3MM paper. The 
membrane with the bacterial colonies was then pressed against the fresh membrane 
and aligned with needle marks. The membranes were then placed on fresh L agar/ 
amp plates and grown for at least six hours. Master plates were then wrapped in 
parafllm and stored at 4°C. 
After bacterial growth, the membrane was removed with sterile forceps and placed 
colony side up onto 3 sheets of Whatnian 3MM paper which was soaked with 
denaturing solution, and left for 7 mins. 
The membrane was then placed onto fresh 3MM paper which was soaked with 
neutralising solution and left for 3 mins. This was then repeated with fresh 
neutralising solution. The membrane was then washed in 2 x SSC and the 
bacterial debris gently removed with a gloved hand. Membranes were then 
allowed to dry completely then the DNA was fixed to the membrane as previously 
described. 
Hybridisation and washing procedures were carried out as for Hybond. 
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2.4.15 	Developing autoradiographs 
Autoradiographs were developed in a dark room by washing the x-ray film for 1 
min in x-ray developer (Agfa-Gevaert) in a tray. The developing reaction was 
stopped by washing the film for 30 secs in a 3 % glacial acetic acid solution. The 
film was then fixed in X-ray fixing solution (Agfa-Gevaert) for 2 mins. Finally, 
the film was washed in cold running water for at least 10 mins and then dried in a 
drying cabinet. 
2.4.16 	DNA sequencing 
The chain termination method of DNA sequencing was used throughout and was 
based on the original method of Sanger and Coulson (1977). 
a) Double stranded sequencing 
i) Preparation of template 
A single fresh colony of bacteria transformed with the plasmid of interest was 
used to inoculate 3 ml of L broth containing the appropriate antibiotic. This was 
grown at 37°C with vigourous shaking for at least six hrs. The bacteria were 
pelleted by centrifugation for 1 min in a microfuge at top speed. 
Double stranded DNA was prepared as described for the magic mini-prep method. 
Alternatively DNA from a CsC1 preparation was used. 
Denaturation of double stranded DNA 
3-5 p.g of DNA was denatured by adding 0.1 vol of 2 M NaOH, 2 mM EDTA and 
incubating at 37°C for 30 mins. 3 vols of ice cold ethanol and 0.1 vol of 3 M 
sodium acetate was added, mixed and stored at -70°C for 15 mins or for 30 mins 
at -20°C. The DNA was recovered by centrifugation in a microfuge for 10 mins 
at top speed. 
Annealing of primer to template 
The denatured DNA was resuspended in 7 p.1 H20, 2 p.1 Sequenase (United States 
Biochemical Corporation) reaction buffer and 1 p.1 primer (1 pmol p.1'). This was 
mixed then heated to 65°C for 5 mins. The heating block containing the tube was 
then removed and allowed to cool to below 35°C. The annealed template was then 
briefly spun and stored on ice. 
Labelling reaction 
Still on ice, the following components were added to the annealed template-
primer; 1 p.! 0.1 M DTT, 2 p.11:15 diluted labelling mix, 0.5 p.! [a-35S] dATP 
(10 p.Ci p.!') and 2 p.11:8 diluted Sequenase. 1 p.1 of Mn buffer was added when 
sequence close to the primer was needed. This was mixed and left at room 
temperature for 3-5 mins. 
iv) Termination reaction 
The reaction was terminated by transferring 3.5 p.l of the labelling reaction into 
2.5 p.1 of each of the ddNTP solutions (ddGTP, ddTrP, ddATP, ddCTP), mixing 
and incubating at 37°C for 3-5 mins. 4 Al of stop solution, was added to each 
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tube. Samples were heated at 80°C for 5 mins before being loaded onto the gel. 
Alternatively, they were stored at - 20°C until needed. 
2.4.16 b) Single stranded DNA sequencing 
Preparation of an infected culture 
A single fresh colony containing the phagemid pT7T3 18 or 19u, was used to 
inoculate 3 ml of L broth containing ampicillin. Helper phage M13 K07 was 
added to a final concentration of 2 x 10 pfu/ml and incubated for 1.5 hrs at 37°C 
with vigourous shaking. Kanamycin was added to a final concentration of 70 tg 
m1 1 and the incubation was continued for 14 -18 hrs at 37°C, again with shaking. 
Preparation of single stranded template 
1.5 ml of the infected culture was centrifuged in a microfuge at top speed for 5 
mins. 1.3 ml of supernatant was transferred to a fresh tube and to it was added 
200 p1 of 20 % polyethylene glycol in 2.5 M NaCl. The tube was mixed by 
inverting several times followed by gentle vortexing. This was left to stand at 
room temperature for 30 mins. The precipitated bacteriophage were recovered by 
centrifugation for 5 mins in a microfuge at top speed. All of the supernatant was 
discarded without disturbing the pellet. 100 j.il of T.E was used to resuspend the 
pellet and then this was phenol I chloroform extracted, then chloroform extracted. 
After being centrifuged in a microcentrifuge for 2 mins at top speed the DNA, 
from the aqueous layer, was ethanol precipitated and the pellet dissolved in 50 p1 
5 p1 (-ljtg) of this was usually used for a sequencing reaction. 
iii) Annealing of template to primer 
5 p.1 of DNA, 2 p.1 H20, 2 p.1 sequenase reaction buffer and 1 p.1 of primer (lpmol 
were mixed and annealed in the same fashion as for double stranded DNA. 
Single stranded DNA was then sequenced as described for double stranded DNA 
2.4.16 c) Polyacrylamide sequencing gels 
6 % acrylamide solution was made by mixing 5.7 g acrylamide, 0.3 g bis-
acrylamide, 48 g urea, 1.1 g Tris, 0.55 g orthoboric acid and 600 p.1 0.5M EDTA. 
This was made up to 100 ml with dH20 and mixed until it dissolved. 
30 ml of this solution was used for a normal size gel (35 cm). 0.5 ml of 10 % 
ammonium persulphate was added and polymerisation was initiated by the 
addition of 25 p.1 TEMED (N,N,N',N' - Tetramethylethylene - diamine). For the 
large gels (65 cm) the volumes described above were doubled. 
The solution was poured between the glass plates and allowed to set for at least 
Mr. These gels were usually pre-warmed for at least 30 min at 1800 volts before 
the addition of the sample. 1 x TBE was used as the buffer and samples were 
usually run at 1500 volts for the appropriate length of time. 
After electrophoresis the gel was soaked in 10 % glacial acetic acid for 30 nuns to 
remove the urea then transferred to a sheet of Whatman 3MM paper. The gel was 
then dried for 30 mins at 80°C under vacuum. 
2.5 	Growth of mammalian tissue culture cells 
Neuro2a cells (murine neuroblastoma) 
These cells (from ICN-FLOW) were grown in Dulbecco's modified Eagle medium 
(DM-EM) which was supplemented with 10 % foetal calf serum. Penicillin and 
streptomycin (100 .ig ml-') were also added to this medium as a precautionary 
factor against bacterial infection. Cells were incubated at 37°C in an atmosphere 
of 6 %CO2  ,in air, until 80 % confluency was reached. The cells were then 
removed from the plate by scraping, either with a cell scraper or a cell lifter, and 
split 1:8. This essentially involves a 1:8 dilution of cells with fresh media. 
Freshly split cells were then returned to the incubator. For transfections, the cells 
were plated out in 60 mm2 dishes (6 ml) at 1-2 x 105 cells ml' as counted in a 
haernocytometer. Transfections were performed the next day. 
2.6 Storing of tissue culture cells 
When cells were approaching confluency they were removed from the plates as 
described above. The cells were recovered by centrifugation for 3 nuns at 1000 x 
g 4°C. The cell pellet was resuspended in 10 ml of freezing mix per 75 cm2 
flask and centrifuged again. The supernatant was decanted and replaced with 5 ml 
of fresh freezing mix. The cells were resuspended and aliquoted out into 0.5 ml 
amounts in Nunc screw top freezing vials. These were stored at -70°C overnight 
before being transferred into liquid nitrogen. 
For thawing, vials were removed from the liquid nitrogen and quickly placed into 
a 37°C water bath. Once thawed, the cells the cells were decanted into 5 ml of 
fresh media at 37°C and collected by centrifugation for 10 mins at 1000 x g. The 
cells were resuspended in 10 ml of fresh media and plated out into a 25 cm2 flask. 
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Chapter 3 	Construction and screening of a cos mid genomic 
library 
3.1 Introduction 
Analyses of PrP genes from Syrian hamster (Basler et al., 1986), human (Puckett et 
a!, 1991) and mouse (Westaway etal., 1987) have shown that they all have a similar 
gene structure. A single exon which contains the entire open reading frame is 
separated from 1 or 2 upstream exon (s) by intron (s) of at least 10 kb in length. 
Depending on the species there are 1 or 2 non-coding upstream exons. Mouse and 
sheep have 2 upstream exons (Westaway etal., 1991, 1994 b), whereas hamster and 
human have only been shown to have 1 (Basler et al., 1986; Puckett et al., 1991). 
The biological functions of these upstream exons are not known but they may play 
a regulatory role. 
Work on other genes has shown that regulatory elements can be found throughout the 
gene: both in 5' and 3' flanking regions and also in introns. 5' and 3' flanking regions 
can be defined as non-coding genomic sequences which are found 5' to the first exon 
and 3' to the last exon, respectively. There are many examples of regulatory 
elements in 5' flanking regions of genes. Transcriptional promoters are usually found 
in the 5' flanking regions of genes. Izumi et al., (1992) have analysed the promoter 
region of the Alzheimer's disease amyloid precursor protein gene. They found that 
both positive and negative regulatory elements are present in the promoter region and 
reside within several base pairs of each other. Others have shown that tissue specific 
expression can be due to elements in the 5' flanking region. For example, in the 
human neurofilament light chain promoter a 210 bp conserved region has been shown 
to be required for neuronal specific expression (Yazdanbakhsh et al., 1993). Work 
on the human a-globin has demonstrated that sequences 30-50 kb upstream of the 
first exon contain critical regulatory elements (Higgs et al., 1990). In addition to 5' 
flanking regulatory elements there are also some examples of regulatory elements in 
introns e.g in the first intron of the a-I(1) collagen gene (Bornstein and McKay, 
51 
1988) and in 3' regions e.g silencer and enhancer elements of the duck a-globin gene 
(Targa et al., 1993). 
The regions of the murine PrP gene which may be important for the regulation of 
gene expression are not known. To address this, one must obtain a genomic clone 
of the PrP gene. Such a clone would preferably contain 5' flanking sequences, the 
non-coding exons, and the introns of the PrP gene. 
There are a variety of vectors which may be used in the construction of genomic 
libraries: plasmids, lambda, P1, yeast artificial chromosome (YACs) and cosmids. 
Each of these vectors can accommodate different insert sizes. YACs have the 
capacity for propagating the largest inserts; - 400 kb (Burke eral., 1984) whereas the 
maximal insert size for most plasmids is approximately 15 kb. The maximal insert 
sizes for A. and cosmid vectors are approximately 23 and 45 kb respectively. The 
objective of this project was to obtain a single clone of the entire mouse PrP gene, 
together with its flanking sequences. Obtaining a single clone, as opposed to several 
overlapping clones, would facilitate subsequent experiments such as mapping and 
characterising the promoter region as well as in the generation of mice carrying 
functional PrP transgenes and deletions of such transgenes. Such transgenic mice 
could be used to study developmental and tissue specific expression of the PrP gene. 
As mentioned previously, such regulatory regions may lie many kilobases away and 
therefore it is crucial to obtain a single clone which contains maximal 5' and 3' 
flanking sequences. 
Westaway et al., (1987) had previously shown, by nucleotide sequencing and 
Southern blotting, that the exon containing the open reading frame in the mouse PrP 
gene was approximately 2 kb and that this exon was separated from an upstream 
exon by at least 11.5 kb of intron sequence. At the time this study was initiated only 
one untranslated 5' exon had been identified (Westaway et al., 1987). 
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To clone PrP by cosmid cloning therefore presented the best approach as one had a 
better chance of obtaining the full length gene in one clone. The cosmid vector used 
was pWE 15 (Wahl et al., 1987) and like other cosmid vectors it can accept and 
propagate fragments in the size range of 35-45 kb. Cosmids are essentially hybrids 
between plasmid and lambda vectors. They are designed around the fact that the 
enzymes which package viral DNA into the phage head, during normal viral 
replication, recognise specialised sites called cos sites. These cos sites are separated 
from each other by 37-52 kb of viral DNA. Cosmids utilise these cos sites so that 
35-45 kb of insert DNA can be ligated to the vector and efficiently packaged in vitro 
into phage heads. These particles can now be used to infect E.coli but they do not 
produce plaques as the normal virus would, this is because most of the viral DNA 
has been replaced with insert DNA. Instead, antibiotic resistant bacterial colonies are 
produced. These can then be screened by hybridisation to determine the clone of 
interest (see fig 5). 
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Schematic representation of the steps involved in the construction and screening of a cosmid genomic 
library. High molecular weight mouse DNA (129/01a) was isolated and partially digested with 
Sau3AL The DNA was size fractionated on a sucrose gradient to give DNA in the 35-45 kb range. 
The size selected DNA was then ligated to the dephosphorylated pWE 15 cosmid vector to produce 
concatamers. These concatamers were then packaged into phage heads by in vitro packaging. The 
recombinant phage particles then infected E.coli and ampicillin resistant colonies were produced. This 
resulted in the production of a genomic library which was then screened for a PrP cosmid clone. 
	
3.2 	Preparation of vector DNA 
20 j.tg of pWEI5 cosmid vector (Stratagene) was digested to completion with BamHI. 
The DNA was then dephosphorylated to prevent self ligation. This was followed by 
a phenol:chloroform extraction and an ethanol precipitation. The DNA was 
redissolved in 20 jil T.E (pH 8). 
3.3 	Isolation of high molecular weight DNA 
A 162 mm' flask containing murine embryonic stem cells (ES), grown to confluency, 
was used as the source of DNA. These cells were derived from a 129/01a mouse. 
PrP null mice had previously been generated with these cells by homologous 
recombination (Manson et al., 1994) and therefore it seemed prudent to generate 
future transgenic mice from the same genetic background. 129/01a mice are Sinc 
s7 homozygous. Sinc is the major gene which controls the incubation period of 
scrapie in mice (see section 1.4.1) and mice which are s7 homozygotes generally 
have shorter incubation periods, with most scrapie strains, than their p7 homozygous 
counterparts (Bruce et al., 1991). This mouse genotype was therefore also chosen 
as it is the genotype in which disease generally manifests itself more rapidly. 
To the flask was added 10 ml of a solution containing TEN 9, proteinase K (500 p.g 
ml-') and 1 % SDS. This was left shaking overnight at 37°C. 10 ml of phenol was 
then added and left gently shaking at room temperature for 1 hr. This solution was 
then decanted into a 50 ml centrifuge tube and spun for 10 mins at 1000 x g. The 
aqueous phase was then phenol extracted and then chloroform extracted. The 
aqueous phase was then dialysed against 4 L of T.E (pH 8) overnight at 4°C. The 
DNA concentration was determined and an aliquot was examined by 0.3 % agarose 
gel electrophoresis (on top of 1 % support gel). By comparison to Gibco BRL high 
molecular weight markers, the purified DNA was estimated to be in the 150-200 kb 
range. 
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3.4 	Partial digestion of high molecular weight DNA using Sau3AI 
The high molecular weight DNA was handled with cut off pipette tips (all sizes) to 
prevent shearing. Conditions were established which allowed partial digestion of the 
high molecular weight DNA with Sau3AI to generate fragments of DNA in the 
appropriate size range for insertion into the cosmid vector (35-45 kb). BamHT is the 
unique cloning site of the pWE 15 cosmid vector. However, Sau3AI was chosen 
to digest the genomic DNA as it digests DNA more frequently than BamFU. This 
is because it has a 4 bp recognition site. It also generates compatible ends with 
BamHI digested DNA. The following conditions resulted in digested DNA in the 
correct size range. 4 p.g of DNA was gently mixed with 10 p.1 the appropriate 
restriction enzyme buffer and 86 p.1 H.O. This was allowed to stand at 4°C for 
several hours to ensure that a homogenous DNA solution was formed before the 
restriction enzyme was added. 1 p.1 of Sau3AI (0.05 units p.l 1) was added to the pre-
warmed DNA solution and incubated at 37°C for 30 mins. The restriction enzyme 
was inactivated by heating the mixture to 75°C for 15 mins. This reaction was scaled 
up to give 260 p.g of digested DNA in total. The samples were pooled, 
phenol:chloroform extracted and ethanol precipitated. The DNA was resuspended in 
200 p.! T.E pH 8. 10 p.1 of this was then run on a 0.3 % agarose gel to ensure DNA 
was of the correct size. 
3.5 	Size fractionation of DNA using sucrose/salt gradient centrifugation 
a) Preparation of gradient 
A 10-40 % continuous gradient was prepared in a SW-28.1 centrifuge tube using the 
following solutions: 	40 % sucrose, 1 x T.E, 1M NaCl 
30 % sucrose, 1 x T.E, 1M NaCl 
20 % sucrose, 1 x T.E, 1M NaCl 
10 % sucrose, 1 x T.E, IM NaCl 
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2.5 ml of the 40 % solution was added to the tube. On top of this 2.5 ml of the 30 
% solution was gently added. The same was done with both the 20 % and the 10 % 
solutions. The gradient was then prepared by centrifuging at 90 000 x g for 3 hrs at 
12°C. 
3.5 b) Loading DNA sample and centrifugation 
Approximately 260 pg of partially digested DNA in a 200 pi volume of T.E was 
gently layered onto the gradient. The sample was then centrifuged at 90 000 x g for 
18 hrs at 12°C. 
c) 	Collection and electrophoresis of fractions 
500 tl fractions were collected from the bottom of the tube after centrifugation. 
35 tl of each fraction was run on a 0.3 % agarose gel overnight at 15 V. High 
molecular weight markers were used for size comparison. Samples 4, 5, 6, 7 ,8, and 
9 were pooled as they contained the DNA in the correct size range. The sucrose 
concentration was then reduced to below 10 % by diluting the pooled fractions five 
fold in H20. The DNA solution was then ethanol precipitated and then DNA 
recovered by centrifugation at 8000 x g for 30 mins at 4°C. The DNA was 
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3.6 Ligation and packaging of DNA 
Ligation of vector to size selected DNA 
DNA was ligated the addition of approximately 1.5 .tg size fractionated DNA, 3 tg of 
dephosphylated BamHI digested pWE 15,4 0 5 x ligation buffer, 1 plT4 DNA ligase, made 
up to 20 tl with H20. This  was incubated overnight at 16°C. 
in vitro packaging of DNA 
Gigapack II gold packaging extracts (Stratagene) were used. 
A freeze/thaw extract and a sonic extract were removed from the freezer and the 
freeze/thaw mix was quickly thawed. Four microlitres of the ligated DNA was then 
mixed in and placed on ice. Fifteen microlitres of the sonic extract was added to the 
freeze/thaw extract containing the DNA and mixed with a pipette tip. The tube was 
then briefly spun to ensure that the contents were at the bottom of the tube. 
Incubation for 2 hrs at room temperature then took place. After this 500 t1 of the 
phage dilution/SM buffer was added. Twenty microlitres of chloroform was added 
and the solution was gently mixed. Debris was removed after a brief spin and the 
supernatant was stored at 4°C. 
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C) Determining the titre of the cosmid library 
A single fresh colony of E,coli NM554, grown at 37°C overnight on L agar was used 
to inoculate 25 ml of L broth containing 0.2 % maltose. This was incubated at 37°C 
overnight with shaking. The bacteria were pelleted by centrifugation at 1000 x g for 
10 mins. The pellet was resuspended in 12.5 ml of 10 mM MgSO4. More solution 
was gradually added until the OD6 	was adjusted to approximately 0.5. The 
packaged DNA was diluted 1:10 and 1:50 in SM buffer. Twenty five microliires of 
each dilution was mixed with 25 p.1 of the diluted E.coli NM554 and incubated at 
room temperature for 30 mins. 200 p.1 of L broth was then added and incubated with 
intermittent shaking at 37°C for 1 hr. The bacteria were pelleted by centrifugation 
in a microfuge at 11600 x g for 30 secs and resuspended in 50 p.1 of fresh L broth. 
Each dilution was spread out onto L agar plates containing ampicillin (50 p.g ml') 
and incubated overnight at 37°C. 
The colonies were then counted and the titer calculated to be 2.2 x 105 transformants 
p.g' of size fractionated DNA. The titre is between the expected values of 5 x iø 
and 5 x 10 transformants p.g' of size fractionated DNA (Sambrook et al., 1989). 
There was approximately 1.5 p.g of size fractionated DNA in the ligation reaction. 
This meant that on packaging and plating of the entire ligation mix there should be 
approximately 3.3 x 105 colonies. After calculating the titre the rest of the ligation 
was packaged in a similar manner (4 p.1 per packaging mix). 
The number of colonies which one must screen in order to have a good chance of 
obtaining a specific clone is dependent on the average insert size and the total size 
of the genome from which the library is made. If one assumes that the average 
insert size was 40 kb, that the size of the mouse genome is 3 x 106  kb and that the 
number of colonies screened was 3.3 x i0 then according to the formula of Clarke 
and Carbon (1978) there was a> 95 % probability of obtaining a positive clone. 
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3.7 Plating, replica plating and storing of the cosmid library 
The packaged DNA (at - 30000 colonies equivalent) was mixed with an equal 
volume of E.cpli NM554 at OD6 , = 0.5. This was incubated at 37°C for 30 mins. 
Four volumes of L broth were added to each of the tubes and incubated for 1 hr at 
37°C with intermittent shaking. The culture was centrifuged at 1000 x g for 10 mins 
and then resuspended in 1.5 ml L broth. The culture was then spread onto 132 mm2 
circular Hybond-N filters which were placed on top of 150 mm' L agar/amp plates. 
Ten plates were produced in total and were incubated overnight at 37°C. According 
to the cosmid titre there should have been at least 300,000 colonies produced. 
A replica of the library was made by pre-wetting a fresh Hybond N membrane on 
a L agar/ampicillin plate then placing on a piece of sterile 3MM paper. The 
membrane with the bacterial colonies growing on it's suface was then pressed on to 
the fresh membrane. The filters were then aligned with three needle marks, replaced 
Onto the L agar/amp plates and re-incubated at 37°C for at least 4 hrs. This was done 
for all the filters of the library. The master filters were then stored at -70°C by 
placing on L agar/amp plates containing 25 % glycerol and wrapping in parafilm. 
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3.8 	Screening of the cos mid library 
Filters were prepared for prehybridisation as described in section 2.4.14. 
Prehybridisation and hybridisation also took place using the conditions described in 
section 2.4.13. 
The filters were screened for a PrP positive cosmid clone by using a 3.6 kb XbaI 
fragment which covered the entire length of exon 3. This probe was called probe 
X and was derived from pUC N 18. 
C N18 
Probe X 
BamHI P 	X P 	P 	X P 	P BamHI 




pUC N18 is a 8.8 kb genomic clone of a NZW moose PrP gene (provided by D. Westaway). This 
clone encompasses exon 3 and surrounding region. The entire open reading frame is indicated by a 
large open box. The narrower open box designates the untranslated regions of exon 3. The single 
straight line at the 5' end of the insert represents part of the large intron whereas the same line at the 
3' end represents 3' flanking sequences. Restriction sites: P, PstI; E, EcoR!; K, Kprd and X. XbaL 
The 3.6 kb XbaJ fragment was radioactively labelled by random primer extension to 
approximately 1 x 108 cpm ig 1 as described in section 2.4.11 a. Prehybridisation 
and hybridisation of the replica membrane were carried out overnight at 65°C in 10 
ml of prehybridisation solution. Membranes were exposed to X-OMAT X-ray film 
overnight at -70°C. 
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3.9 Results and discussion 
Several hybridisation signals were detected on the autoradiograph. The area on the 
master plate from which the hybridisation signal was emanating was determined by 
aligning it to the hybridised filter. Since there was a high density of colonies on the 
master plate it was necessary to scrape off a region of about 5 mm in diameter 
surrounding the hybridisation signal using a bacteriological loop. This region was 
estimated to contain about 20 - 40 colonies This was inoculated into 100 p.1 of L-
broth containing ampicillin. 




Autoradiograph of primary screen of cosmid library. 
Probe X (fig 7) was used to probe the library. After hybridisation the library was autoradiographed 
at - 70°C overnight. The encircled hybridisation signal is a putative positive, whereas the stronger 
hybridisation signals surrounding it are alignments made with radioactive ink. This filter represents 
1/10th of the total library. 
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The bacteria were diluted 1:1000 in L broth and 100 p.l of this was replated onto a 
Hybond N filter which was laid on top of a L agar plate containing ampicillin. This 




Autoradiograph of secondary screening of putative positive clones. 
Again probe X was used in the screening process, and after hybridisation the membranes were 
autoradiographed overnight at -70°C. Many more hybridisation signals were evident at this stage and 
are evident at the top left of the photograph. Some of these were picked for another stage of 
screening. Alignment marks, made with radioactive ink, are seen at the extreme left and right of the 
figure. 
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Individual colonies which represented the strongest hybridisation signals were picked. 
Using a toothpick these were streaked onto a 82 mm gridded Hyborid N filter and 
placed for overnight incubation at 37°C on an L agar plate containing ampiciffin. 
The hybridisation procedure was repeated again. 
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Tertiary screening of the cosmid library. 
This was the last in the screening stages. Colonies from the secondary screening stage which gave 
the strongest hybridisation signals were plated onto a gridded Hybond N membrane and again 
prepared for colony hybridisation. Probe X was used and after hybridisation the membrane was 
autoradiographed overnight at - 70°C. Colonies are numbered from left to right. 50 colonies were 
screened and 11 of these gave strong hybridisation signals. These were numbers 1, 4, 5, 7, 11, 18, 
23, 24, 26, 27, and 30. 
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The colonies which gave the strongest hybridisation signals were grown up in liquid 
culture for small scale plasmid preparation. These clones were then subjected to 
restriction enzyme digestion. Out of the 11 clones selected 7 gave the same 
restriction pattern when digested with BamHI. 3 clones gave separate and different 
restriction patterns. No DNA could be isolated from one colony. This gel was 
blotted onto Hybond-N and again probed with probe X (see fig. 7). 
Figure 11 a. 
a) Gel electrophoresis after DNA from putative positives was restriction digested with BamHl. 
0.8 % agarose gel electrophoresis analysis of the 11 BamHl digested putative positive clones. The 
gel was run at 50 V for 4 hrs and then stained with ethidium bromide. M designates markers and 
these are Hindifi digested Lambda DNA. The sizes of these markers range from 23.13 kb to 0.125 
kb (only some are arrowed). Seven of these clones appear to be identical and the other 3 are 
different. Lane one failed to contain DNA. 
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Figure 11 b. 
b) Southern analysis of the above gel (fig 11 a) when hybridised with probe X. 
The membrane was hybridised at 65°C and then washed for 30 mins in i) 2 x SSC, 0.1 % SDS at 
RI!'. ii) 0.1 x SSC, 0.1 % SDS at RI!'. iii) 0.1 x SSC, 0.1 % SDS at 37°C. iv) 0.1 x SSC, 0.1 % 
SDS at 65°C. The filter was then exposed at -70°C for 2 days. Five hybridisation signals were 
detected. These are seen in lanes 2, 3, 4, 8 and 9. The bands in lanes 4, 8 and 9 are the same size 
(- 22 kb). The band in lanes 2 and 3 were estimated to be approximately 18 and 20 kb respectively. 
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Three of the hybridisation signals came from clones with the same restriction digest 
pattern (lanes 4, 8 and 9). With these clones the probe hybridised to the same (-22 
kb) band. Why the other clones with the same restriction patterns did not result in 
any hybridisation signal is not clear. Two other clones also gave hybridisation 
signals (lanes 2 and 3) from smaller sized BamHI fragments of approximately 18 and 
20 kb respectively. That three separate clones (lanes 2, 3 and 7 + 8) with distinct 
restriction patterns all produced hybridisation signals, and that these were all different 
sizes, suggested that a PrP clone had not been isolated. 
Furthermore, none of the hybridised fragments were 8.8 kb in length. Westaway et 
al., (1987) had previously shown that the exon containing the open reading frame 
was contained within a 8.8 kb BamHI restriction fragment. It is noteworthy that in 
these experiments Westaway and his colleagues (1987) used the NZW and JuN 
mouse strains. In the experiments described above, the cosmid library was derived 
from a 129/Ola strain. Others have shown that the 129/01a mouse strain also has 
an 8.8 kb BamHI fragment (J. Manson, pers comm) which contains the PrP open 
reading frame. This allows one, therefore, to discount the possibility that a PrP 
specific 8.8 kb BamHI fragment was not detected during the hybridisation stages due 
to differences between mouse strains. 
This was confirmed and the specificity of probe X for this 8.8 kb BamHI PrP 
fragment was checked by genomic Southern hybridisation. This revealed that the 3.6 
kb Xbal probe hybridised only to an 8.8 kb restriction fragment when digested with 
BamI-il. This suggested that while the 3.6 kb XbaI probe is specific for PrP, there 
was still an anomaly regarding cross hybridisation to different clones. 
Another replica of the cosmid library was made (see 3.7) and this was screened 
again. The 3.6 kb XbaJ restriction fragment, from exon 3 of the mouse PrP gene, 
was freshly isolated from pUC N 18 and again used to probe the library (see figure 
7), in the same fashion as previously described. This second screening of the cosmid 
library again resulted in putative positive hybridisation signals. After more extensive 
screenings (secondary, tertiary and Southern blots of small scale plasmid 
preparations) these, however were not found to be clones of PrP. While the reasons 
for failing to obtain a PrP cosmid clone were being investigated (see below) an 
attempt at constructing a second cosmid library was undertaken. This attempt, 
however, failed due to persistent problems in obtaining high molecular weight DNA 
(> 150 kb) from the embryonic stem cells (see 3.3). From 0.3 % agarose gel 
electrophoresis, the isolated genomic DNA was approximately between 50 - 100 kb 
and was therefore too small. 
Subsequent Southern blot analysis using the digested pWE 15 vector (containing no 
insert) and the same probe X proved that the probe was cross reacting with the 
cosmid vector (see fig 12). 
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Figure 12. 
Cross hybridisation of the 3.6 kb XbaI PrP probe to pWE 15 cosmid vector. 
pWE 15 was digested with Hindifi and BamHI and blotted onto Hybond-N. This blot was then 
probed with probe X at 65°C and washed in i) 2 x SSC, 0.1 % SDS, at R/T ii) 0.1 x SSC, 0.1 % 
SDS, at R/T iii) 0.1 x SSC, 0.1 % SDS, at 37°C iv) 0.lx SSC, 0.1 % SDS, at 65°C. All washes 
were for 30 mins. Hindill digestion produced two bands; 3.3 kb and 4.9 kb, while BamHil digestion 
produced a 8.2 kb linear. The PrP 3.6 kb XbaJ probe hybridised to the 8.2 kb pWE 15 linear band 
and to the 4.9 kb pWE 15 HindIll band, while not hybridising to the 3.3 kb band, after a 3 day 
exposure at -70°C. 
70 
It therefore seems likely that the 3.6 kb XbaI fragment was not thoroughly isolated 
from the pUC 18 vector (2.9 kb) during low melting point gel electrophoresis and 
that some of the vector was subsequently labelled during the random priming step. 
pWE 15 and pUC 18 share extensive stretches of sequence e.g the ampicillin 
resistance gene and therefore this may have formed the basis of the cross 
hybridisation. 
It can be concluded therefore that cross hybridisation between the 3.6 kb XbaI probe 
and pWE 15 vector presented a problem during the screening stage. This could have 
been avoided if perhaps a shorter probe was used e.g 900 bp KpnJ/EcoRI fragment 
(see fig. 7) as this would have allowed better separation from the vector. 
Alternatively, the 3.6 kb XbaJ fragment could have been cloned into M13 thus 
preventing any cross hybridisation problems. 
That the probe hybridises to vector sequences (see fig. 12) implies that all 
recombinants in the library should produce a hybridisation signal as all recombinants 
contain the vector. This did not happen and the reasons why this is so are not clear. 
However, in a study in 1987, Gibson et al., showed that the insert itself can cause 
modulation of vector gene expression if it is transcriptionally active. In such 
circumstances the copy number of the cosmid can be affected, leading to under 
representation of a particular cosmid clones. 
With hindsight it would have been worthwhile to include a positive control during 
the screening stage. This would have indicated if the probe preparation and the 
hybridisation conditions were working well. Such a control could have been a probe 
which would have hybridised to another gene e.g f-globin. In addition, a negative 
control should also have been incorporated into the experiment. This could have 
been an E.coli gene such as ompC. 
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Westaway et al., (1987) have also experienced difficulties when screening both 
hamster and human genomic libraries for PrP clones. This occurred even when a 
genome equivalent of recombinants was screened. However, the biochemical nature 
of this problem was not identified. In the same study, construction and screening of 
mouse genomic libraries was undertaken. 
Successful screening of these libraries was found to be highly dependent on the 
vector / host system used. 
Other workers in our lab have also attempted to use the pWE 15 / NM554 system 
to clone PrP genes from other species e.g sheep. These attempts have also met with 
failure in that although clones hybridised, they were subsequently found to have 
undergone a recombination event. Such an event, therefore, cannot be excluded from 
the experiments described above and indeed might explain why the expected 8.8 kb 
BamHI fragment was not found. 
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Chapter 4 	Isolation, restriction mapping and sequence 
analysis of the 5' region of the PrP gene. 
4.1 Introduction 
A cosmid clone (designated cos 61/Ln J-4) of the murine PrP gene (provided by D. 
Westaway; see Westaway et al., 1991) was obtained from an I/Ln mouse genomic 
library. IJLn mice are Sinc p7 homozygous. The scrapie incubation periods of such 
mice are generally longer than Si nc s7 homozygotes when injected with the most 
commonly used strains of scrapie (Bruce et al., 1991). This means that the s7 
homozygous genotype is more commonly associated with disease and as such it 
would be the preferred genotype in which to study PrP gene regulation. 
At the beginning of this project there was very little information regarding the 
structure of the PrP gene (see figure 1, chapter 1). What information there was came 
from two papers by Basler et al., (1986) and Westaway et al., (1987) which described 
the hamster and mouse PrP genes, respectively. In the 1987 paper it was shown that 
there was at least one 5' untranslated exon in the mouse PrP gene. This exon was 
estimated to be greater than 11.5 kb upstream from the open reading frame exon. 
The existence of introns and measurement of their approximate size was based on 
several lines of evidence. Southern blots, using oligonucleotides and restriction 
fragments from various regions of PrP cDNA clones were used to probes genomic 
blots and blots of genomic clones. The size of the hybridising fragments was then 
measured. In addition Si nuclease mapping, primer extension and nucleotide 
sequence data also confirmed the exon / intron structure in mouse and hamster 
(Basler et al., 1986; Westaway et al., 1987). 
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After the failure of the cosmid library (see chapter 3) to yield a positive clone, a PrP 
clone, derived from a Sine p7 mouse, became available from D. Westaway (see 
Westaway et al., 1991 and figure 13). From the accompanying BamHI restriction 
map came the first indication that the PrP gene had two 5' untranslated exons. As 
a preliminary to identifying regulatory sequences within the PrP gene it was 
necessary to confirm this exon structure. 
The main aims of this chapter are basically three-fold: i) To isolate a subclone, from 
the cosmid clone, which contains both 5' exons and the putative promoter region. ii) 
To determine a detailed restriction map of such a subclone. iii) To analyse the 5' 
flanking region and confirm the exon / intron borders by nucleotide sequencing. 
The cosmid clone, itself, contains an insert of 40.8 kb and is flanked by NotI 
restriction sites.. The insert is cloned into a cosmid vector called pcos6.EMBL 
(Ehrich et al., 1987). The clone encompasses approximately 6.5 kb of 5' and 18 kb 
of 3' flanking sequences. Within these flanking sequences all three PrP exons are 
present. Exon 3 contains the entire open reading frame and is found within a 8.8 kb 
BamFIT fragment (Westaway et al., 1991). 
The cosmid clone of the mouse PrP gene and the subclones made from it were used 
throughout this thesis. The data presented subsequently, in this chapter, was at the 
time novel and had not been shown previously. 
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Figure 13. 
Organisation and structure of murine PrP cosmid clone. 
Exons are numbered 1. 2 and 3. Exons 1 and 2 are 5 untranslated exons. 
Exon 3 contains the entire open reading frame. Exon 3 also contains 
10 bp of 5' untranslated region and approximately 1.1 kb of 
3' untranslated region. Distances between BamHl sites are given in kb. 
4.2 Isolation of subclones from the 5' region 
To analyse the 5' region of the PrP gene it was necessary to obtain subclones from 
the cosmid clone. 
The vector used for the initial subcloning was pT7T3 18U (Pharmacia). This vector 
is a phagemid and hence single stranded DNA can be produced by infecting a 
transformed culture with the helper phage M13 K07. The multiple cloning site of 
pT7T3 18 U is flanked by the T3 and T7 promoters. The nomenclature of the 
following subclones was based firstly on the vector (pT18 = pT7T3 18 U), then on 
the insert (e.g PrP gene fragments) and then finally on the size of the insert (e.g 3.5 
= 3.5 kb). 
a) pT18 PrP 9 	 b 12Tl8 PrP 3.5 (subclone of pT18 PrP 9) 
a) i) pT18 PrP 9 
This plasmid comprises a 9 kb KpnI fragment from the cosmid clone which is cloned 
into the KpnI site of pT7T3 18U .  The 9 kb KpnI fragment stretches from the KpnI 
site in the middle of exon 2 of the PrP gene to a KpnI site in the vector (see figure 
13). Locht et at., (1986) had previously shown that a KpnI site was located in the 
5' non-coding leader sequence of a mouse cDNA clone. At this stage the existence 
of 5' non-coding exons in the mouse PrP gene was not known. However, it now 
seems very likely that this KpnI site corresponds to the KpnI site in exon 2. This 
was confirmed by digesting the cosmid clone with KpnI and using the 5.3 kb BamHJ 
fragment, at the extreme 5' end of the insert (see figure 13), to probe a Southern blot. 
This probe hybridised only to a 9 kb restriction fragment. In addition, apart from the 
5' exons the only other non-coding region upstream of the open reading frame in 
exon 3 is a stretch of 10 bp which directly proceeds the open reading frame. This 
region does not contain a KpnI site (Westaway et al., 1987). Therefore this KpnI site 
must be in one of the upstream exons. 
7, 
The 9 kb KpnI fragment was cloned into the KpnI site of pT7T3 18U in both 
orientations. These clones are called p118 PrP 9a and pT18 PrP 9b. 
KpnI BamHI 	BamHt 	KpnI 
40 primer 	00 
EcoRt, Sad 	 _.- 	Smal, BamHI, XbaI, Sall, 
Psil, Sphl, HindIH 
p118 PrP 9a 
- 1 k 
Figure 14. 
Partial restriction map and orientation of 9 k insert in pT18 PrP 9a. p118 Pr? 9b is in the opposite 
orientation than shown above. Pr? exons are designated by open squares and are numbered 1 and 2. 
Some resiriction sites are shown, as is the position of the target sequence to which the - 40 primer 
binds. 
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4.2 a) ii) Nucleotide sequence of region upstream of KpnI site 
in exon 2 
Single stranded DNA was prepared from p118 PrP 9b (see figure 14). This was 
sequenced using the -40 universal primer (5'-GF11-1 CCCAGTCACGAG-3') as 
described in section 2.4.16. The sequencing was carried out to prove that exon 2 was 
present in the subclone. This could be done by determining its homology to mouse 
PrP cDNA (Locht et al., 1986). 
All sequence analysis described in this thesis was carried out on a VAX785 computer 
and the University of Wisconsin genetics computer group (uwgcg) sequence analysis 
software package was used throughout (Devereux et al., 1984). 
1 gctgccctat ttcatgttca aatacgctcc atttgcgtga ctctttagta 
51 ttggtttgat gatttgcata ttagattaga ttgtatttca gttgtcagct 
101 tatttatcaa ttctagtttt ctctttttgt tgttttaaag gactcctggt 
151 atatttcaga actgaaccat ttcaaccgag ctgaagcatt ctgccttcct 
201 agtgatcccg ggtaccc 
Figure 15. 
Nucleotide sequence of the region upstream of the KpnT site in exon 2 of the mouse PrP gene. 
Nucleotides numbered 1-159 represent intron sequence while nucleotides 160-217 represent PrP exon 
2 sequence. This is based on homology to splice site consensus signals and to PrP cDNA which are 
detailed later in this chapter. 
W. 
101 tat ttatcaattctagttttctctttttgttgttttaaaggactcctg 150 
................................................ aa2 
151atatttcagaact 	 200 
I 1111111111111 liii! 
aaccatttcaaccfafctfaa7cattctgccttcct 
I 111111111 I I I 
3 ttccttcagaactgaaccatttcaaccgagctgaagcattctgccttcct52 
201 agtgatcccgggtaccc .............................. 217 
1111 	I II 	I 
53 agtggtaccagtccaatttaggagagccaagcagactatcagFtcatc99 
Figure 16. 
Homology of region upstream of the KpnI site in exon 2 to mouse PrP cDNA. There is a 85 % 
homology between the sequence shown in figure 14 and the published mouse PrP cDNA (Locht et a!, 
1986). PrP cDNA sequence is shown on the bottom lines and PrP intron I and exon 2 sequence is 
shown on the upper lines. The vertical lines between the two sequences represent areas of homology 
and gaps represent areas of mismatch. There is 100 % homology between nucleotides 155-204 of the 
genomic sequence (figure 14) and the corresponding region of the cDNA sequence. This is assumed 
to be PrP exon 2. The cDNA sequence of Loclit et al.., (1986) is not full-length and does not include 
exon 1 (Westaway et al., 1994 c). 
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4.2 b 0 PT 18 PrP 3.5 
Having shown, by sequence homology to mouse PrP cDNA, that pT18 PrP 9 
contained exon 2 of the PrP gene, the opposite end of the insert should contain 5' 
flanking region (see fig. 14). 
This study aimed to examine the regulatory elements of the PrP promoter and the 
DNA sequences which constitute these elements. This was to be done, initially, by 
nucleotide sequencing. This strategy could be facilitated by subcloning a smaller 
fragment rather than working directly on the 9 kb insert of pT18 PrP 9 (fig. 14). 
A 3.5 kb BamHI fragment was isolated from pT18 PrP 9a and cloned into the 
BarnHI site of pT7T3 18U to produce pT18 PrP 3.5a and b. This 3.5 kb fragment 
stretches from the BamHI directly upstream of exon 1 to the BamHI site in the 
polylinker of the vector. 
1 	 2 
BamHI 	 BamHI 
EcoRl, Sad, Kpnl, Smal 	. --Id .. 	 _- 	Xbal. Sail, Psti, Sphi, HindUl 
- -- 
pTl8 PrP 3.5a 
1 k 
Figure 17. 
Physical map of pT18 Pr? 3.5 a. This clone, contained approximately 1.2 kb of 5' flanking region, 
exon 1, and approximately hail of exon 2. Pr? exons are numbered I and 2. pTI8 Pr? 3.5 was made 
by cloning a 3.5 kb BamHI restriction fragment (from pTlS Pr? 9) into the BamHI site of pT7T3 
ISU. The position of the restriction sites in the polylinker of the vector are given. 
ON 
4.2 b ii) Restriction mapping of pT18 PrP 3.5 
A restriction map was determined for pT18 PrP 3.5. This was done in order to aid 
in the sequencing of the 5' flanking region and in the subsequent deletion analysis 
of this region and of the first intron (see chapter 5). 
Restriction sites were determined for EcoRl, HindlU, HinclI and Stul. These 
enzymes were chosen as they were not expected to restrict the DNA too frequently. 
Also, these sites are present in the multiple cloning site of the vector and as a result 
may aid in any recloning process. Both single and double digests of all four 
enzymes were carried out and the sizes of the resultant bands determined (see section 
2.4.3 and 2.4.4). Enzymes which only cut in the polylinker were also used in double 
digests e.g Smal. Where possible (i.e in the 5' region) the restriction sites were 





BamHI Hincil Hincil 	EcoRl Hindlil Stul 
Li fl 	1 	
4jKpnI 
Stul 
40 -*' —b. 
667w 	884w 	 1 kb 
334w 781w 
Figure 18. 
Restriction map of pT18 Pr? 33a. Position of restriction sites are shown. Pr? exons are designated 
by open boxes and are numbered 1 and 2. In addition to the restriction map, the lower part of the 
figure shows the oligonucleotides which were used as primers for sequencing the 5' flanking region 
of the gene. The approximate length of sequence from each primer is indicated by arrows. See figure 
19 for sequence of each oligonucleotide. 
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4.2 b iii) Nucleotide sequence of PrP 5' flanking region 
By restriction mapping pT18 PrP 3.5 it was found that there were no suitable 
restriction sites which could be used to make internal deletions in the 5' flanking 
region (see figure 18). That is, there were no unique restriction sites (i.e which 
restrict the insert only once) separated from each other by - 200-300 bp in the 5' 
flanking region. If there were, one could have utilised them to create a construct 
which had deletions progressing from the 5' end of the flanking region to exon 1. 
Instead a series of oligonucleotides were synthesised and used as sequencing primers. 
For each primer, the sequenced samples were run on a denaturing 6 % 
polyacrylamide gel for 1.5 hrs (+ Mn buffer), 2.5 hrs (- Mn buffer) and 4.5 hrs (-Mn 
buffer). Mn buffer is used for obtaining sequence close to the primer. This ensured 
that maximal sequence data was obtained (for this apparatus) from one primer. This 
strategy was used to produce over 1.2 kb of sequence data from one strand of pT18 
PrP 3.5. The sequence stretched from the BamHJ site in the 5' flanking region to, 
and through, exon 1 and into the 5' end of the first intron. 
This 1.2 kb of sequence obtained from the 5' flanking region of the mouse PrP gene 
(see figure 20) was analysed for binding sites of known transcription factors (figures 
21 and 22), for the presence of a CpG island (figure 23) and also for its homology 
to PrP 5' flanking regions of other species (figures 24, 25, 26 and 27 ). 
EN 
Synthetic oligonuleotides used as primers for sequencing PrP 5' region. 
-40 	5'- GITITCCCAGTCAGGAC3' 
334w 	5'- TCAACTCAGGTCTACGC-3' 
667w 	5'- TGGGTGCGAGTCTACA-3' 
781w 	5'- ACGTGGCTTCCTCGCT-3' 
884w 	5'- CGCCATTGGTGAGCAT-3' 
Figure 19. 
Sequence of synthetic oligonucleotides which were used as primers for sequencing the 5' flanking 
region of the PrP gene. Figure 18 shows the position of these oligonucleotides in relation to the 5' 
flanking region. 
1 ThGGCTAAT?, CTGGATACAA ATA?rATCC AACCCMTC TTGTGTCTGT 
51 TMTGATCTT CAGTGTC'rcG CCCTCAGCAA GAG'ThCAGGA ThTTATGTTT 
101 TCCCTGTCAT TrATGACCTC TTCTTCTCA GTATTGGCG CAATTTATTT 
151 ACATGGC1'-TT GGAGTGTGTT ATATTGTAG ThTGCPCATC AGGGTGCMG 
201 TCAACCTATG TGTGCACGCC AGAGGTCAAT GTCATGTCTT GCCA.ATCACT 
251 GCCAGTGTCC TGCATCAACT CAGGTCTCAC GCTGGATGGA CTAGCCAGT 
301 GCCCCAGCTC CTAACCCTCC CCTGTTTTAA AAAGCTCTCA TTATGTTGCC 
351 CAGGTCGCC TTGAACTTA GAGTCTCCTG ACTGCAGGCC TCTCATCCAA 
401 GTCAGCACGC ATCTTGAACA AGAACATCAT TTCCTTTAAG CTGTTTCAGO 
451 CTGTGTTTGG TGGGAGCTGT TAAATGCAGT GCATTTrFCC TTTGGACACA 
501 AT1iAA?AGAA AAAAGTCATT AATGAGTTGG GTGTGGTGGG TGCGAGTCTA 
551 CAATCTAGAA CTCAGGACAT TGAGGGAGM GCTTGCTCTG AGTTTCAGGT 
601 CAGCDTAAAT TACTTAGThG GAACACCAGG CCAAATTGGG CTATGGGATT 
651 GTCTCCAAAG iTAAGAAA AAGGGAAGGA GAGAPGAA ?AGAAAAACA 
701 AAGGAAAGAA GGGGAAAAGA AGGAATCAGC AGAGAATAAT AAGTCAACAT 
751 GCPLATGCCA ATATACTTTC TAGGCCTCTA ATTCTTTTAT AGTTTGTGAG 
801 GGAAAATGTC GAAAATCTTC GTTACCItATT TCTTGTTACC AAAGTTCAAC 
851 GTGGCTTCCT CGCTCCGTTA GTAATTTCAT TTTCTCAACT ACCCATTATG 
901 TAACGGGAGC ATTGGGTACT GGATCAGTCT TCCATTAAIG ATGATTTTTT 
951 ATAGTTGCTG AGCGTCGTCA GGGAGTGCTG ACACTGGGGG CGGTTTAA)C 
1001 AGAThCAAGC ATTThAGCCA GTCCGGAGCG GTCACTCACC CCCCCCCACC 
1051 CCCACCCCCC CGCGACAGAC GCGCCCGCCA TTGGTGAGCA TCACGCCCCG 
1101 CCCCTctcc'r CCCGCCTAGC TCCCGCCTGC CCGCCGCCC CTTTCCACTC 
1151 CCGCCCCCCC CCGCGTTGTC GGATCACCAG ACCGATTCTG GGCGCTGCGT 
1201 CCGATCGGTG GCAC*TX1 GC GGGCTGCTGA AGCAGGCCTG GCGTTGCACT 
1251 CAGCTTCGTG GTAAG 
Figure 20. 
Nucleotide sequence of the 5' flanking region of the PrP gene. Nucleotide number 1 indicates the region 
of DNA closest to the BamHl site directly upstream of exon 1(see figure 13). Potential 3' splice Site is 
indicated with a slash and underlined and sequence 3' to this is intron. 
4.3 Transcription factor binding Sites in the 5' flanking region of the PrP gene 
The 1.2 kb of 5' flanking sequence from the mouse PrP gene was analysed for the 
presence of potential transcription factor binding sites. Over 2000 transcription factor 
binding sites were used in the search. [database: TFsites 1 .dat (Ghosh, 1990)]. 
Over 140 Sites for transcription factors were found within the 1.2 kb of 5' flanking 
region. Some of these sites are shown in figures 21 and 22. The potential binding 
sites are represented as vertical lines. The horizontal lines represent the 5' flanking 
sequence and nucleotides are numbered. Nucleotide number 1 represents the base 
nearest the Bam.HI site which is 1.2 kb 5' to exon 1. Nucleotide 1100 represents, 
approximately, the beginning of exon I (see chapter 6). The name of the 
transcription factor is given on the left hand side of each figure and the putative 
binding sequence is given on the right hand side. The number of times a binding site 
is found is also given on the right hand of each figure. Incompletely specified bases 
are shown in accordance with the nomenclature committee for the international union 
of biochemistry, 1985, (see abbreviations). 
Within the 1.2 kb of PrP 5' flanking sequence there are potential sites for 
transcription factors such as Spi (Dynan and Tjian, 1983), APi (Angel et al., 1987), 
AP2 (Mitchell et al., 1987; Imagawa et al., 1987) and EGR-1 (Lemaire et al., 1990; 
Cao et al., 1990). There are approximately 140 potential binding sites for 
transcription factors within this 1.2 kb DNA sequence. However, which of these 
have a role in PrP gene expression is not known at this stage. From figures 21 and 
22 it should be noted that the majority of transcription factor binding sites are located 
within, approximately, nucleotides 950-1150. These occur in the region where 
transcription initiation occurs and suggests that at least some of these transcription 
factors may play a role in the transcription of PrP (see chapter 6 and Westaway et 
al., 1994 c). 
It should also be noted that some transcription factors are represented more than once 
e.g Spi. This is because Spi has a loose binding specificity (Faisst and Meyer, 
1992) and as such this factor may recognise different sequences in different genes. 
row 
Figure 21. (see text for details) 
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Figure 22. (see text for details) 
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4.4 CpG island in the 5' flanking region of mouse PrP gene. 
In vertebrate DNA the frequency by which the dinucleotide CpG occurs is much 
lower than would be expected from the base composition (Josse et al., 1961). The 
relatively rare occurrence of CpG dinucleotides is probably explained by the failure 
of cellular DNA repair mechanisms to recognise deamination of 5methylcytosine to 
give thymine (Coulondre et al., 1978). This is significant considering that between 
60-90 % of all CpGs are methylated at the 5 position of the cytosine molecule (Bird, 
1986). Despite the rarity of CpGs, there are regions of the genome where CpGs 
occur at close to the expected frequency. These regions are known as CpG islands 
and are predominantly unmethylated (Gardiner-Garden and Frommer, 1987). 
The 5' flanking sequence (figure 20) obtained from the mouse PrP gene was analysed 
for the presence of CpG islands. This is the first such analysis for a PP gene from 
any species. Although the methylation status of PrP 5' flanking region was not 
investigated, CpG islands are sufficiently distinctive to be identified by computer 
analysis (Gardiner-Garden and Frommer, 1978). The analysis involves plotting the 
observed / expected CpGs (obs / exp CpGs) against the average G+C percentage. 
The obs/exp CpG ratio can be calculated as shown below 
Number of CpG 
Obs/Exp CpG 	 x N 
ratio 	 Number of C x number of G 
where N is the total number of nucleotides. A moving average value for the 
percentage C+G (% G+C) and for the obs/exp CpG was calculated for 100 bp 
windows of sequence at 1 bp intervals. 
A CpG rich region can be defined as a stretch of DNA with a moving % G+C over 
50 and a obs/exp CpG ratio greater than 0.6. CpG rich regions which were at least 




















CpG island occurrence in mouse PrP 5' flanking region. By using the 1.2 kb of 5' flanking sequence, a graph of the number of obs/exp 
CpGs was plotted against the % G+C. The broken line represents the % G+C and the solid line represents the obs/exp CpGs. Based 
on criteria of Gardiner-Garden and Frommer (1978), which is described in the text, a CpG island is located between nucleotides 970-
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The length of the CpG island found in the 5' flanking region of the murine PrP gene 
(and exon 1) is at least 210 bp in length, based on the sequence data which were 
presented in figure 20 of this chapter. It may be that the CpG island is larger than 
this and extends well into the gene, as is the case with most 5' CpG islands 
(Gardiner-Garden and Frommer, 1978). However, more sequence information from 
the first intron of the PrP gene would be needed to prove this. Indeed, in this same 
study they found that there were no examples whereby a CpG island lay entirely 
within the 5' untranslated flank of a gene. 
4.5 Homology of mouse PrP 5' flanking region to PrP 5' flanking regions 
of other species 
a) mouse to human • 
951 	 1000 
III 	III 	IllIllIlIf 	(III 
1 ..... ggccggccgcccgccgcgggggcacagagtgtgcgccg ....... 38 
1001 AGATACAAGCATTT?GCCAGTCCGGAGCGGTGACTCACCCCCCCCCACC 1050 
II 	111111 	1111111 
39 ......................gcgcgccggcgaattggtccccgccgcg 66 
1051 CCCACCCCCLGCGAGAGA *CGCGCGCGCCATTGGTGAGCATCACGCCCCG 1100 
III 	I IIIIIIIIIIIIII 	liii 	11111111 
67 acctc. cgcccgcgagcgccgcccgttccctt ........ccccgccccg 107 
1101 CCCCTCCCCTCCCGCCTAGCTCCCGCCTGCCCGCCCGCCCCTTTCCAc1'C 1150 
I 	I I 	H I 	I I 	I I 	III I 	till 	I I 	I HI 	II 
108 cgtccctccccgcctcggccccgcgcgtcgcctccagtcgc.tgccagtc 156 
1151 CCGGCCCCCCCCGCGTTGTCGGATcAGcAGAccGATTcTGcGcGcTGT 1200 
III 	lilt 	II 	III 	I lilt 
157 gctgacagccgcg ............. gcgccgcgagcttctcctctcctc 1.93 
1201 CCGATCGGTGGCAGGTAAGCGGGCTGCTGIJGCAGGCCTGGCGTTGCACT 1250 
IIIIIHIIIHIHI 	ii 
194 acga.ccgaggcaggtaaacgcccgggg ................... ...220 
Figure 24. 
Homology between human 5' flanking region (Puckett etal., 1991) and mouse 5' flanking region (this 
study). Mouse sequence is shown in uppercase while human sequence is shown in lowercase. These 
sequences show a 58 % homology to each other (using the gap programme: gap length = 3, length 
weight = 0.1). Regions of identity are shown as vertical lines between nucleotides. 
91 
b) mouse to hamster 
800 GCGAAAATGTCCAAATCT... TcGTTACCAATTrC 	CCAAAOTT 846 
1111t11111 	IIIIItIIIIIIIIIlIIIIIl 
1 .........tcgaaaatctccctctttagcaatttcttgctcctagagtt 41 
847 CA.A..CGTCGCTTCCTCGCTCCGTTAGTAA . . . TTTCAT'FTTCTCAAC . T 890 
I 	I 	Jill 	11111111 	liii 	I 	IllIllIlilIllIl 
42 tcagcaattgctttctcgctc cat taggcaacetttcattttctcacctt 91 
891 ACCCTTATGTkACGCGAGCATGGGTACTGCATCAGTCCATTPG 940 
IiIiIliIllIIiIillIlI 	11111 	11111 	iiIiiiiiiIiiiiii 
92 ccccattatgtaacgggagcaatgggttctggaccagtcttccattaaag 141 
941 ATGATTTTTTATAGTTGCTCAGCGTCGTCAGGGAGTGCTGACA.CTGGGG 989 
liii 	ilIllIlIllillillI 	iIlilIlliii,ijIIi 	111111 
142 atga.tttttatagtcggtgagcgccgtcagggagtgatgacacctgggg 190 
990 GCOGTTTAAACAGATACAAGCATTTAAGCCAGTCCGGAGCGGTGACTCAC 1039 
ilIlilIlilt 	1111111 	liii 	111111 	illIllIllItlil 
191 gcggtttaaaccg. tacaatcccttaaaccagtctggagcggtgactca. 238 
	
1040 CCCCCCCCACCCCCACCCCCCCGCGAGAGcC GCGCCA 	TGAGC 1089 
111111111 	I 	iilIlIiilIlll 
239 ..............tttccccagggagaagtg9cgcg9ccattggtgagc 274 
1090 ATCACGCCCCGCCCCTCGCCTCCCGCCTAGCTccC.GcCWCCCGcCcGCC 1139 
I 	(Ill 	ill 	Ii 	(liii 	liii 	11111 	11111 
275 acgacgcaagccccgccccacccagccccgccccgccctgctacccctcc 324 
1140 CCTTTCCACTCCCGGCCC. . . CCCCCGCGTTGTcGGATCP.GCAGACCGA. 1185 
II 	1111111 	11111111 	III 	lIlIlillIllIl 
325 tgactcactgccccgcccgctcccccgcggcgtccgagcagcagaccgag 374 
1186 .......TTCTGGGCGCTGCGTCCGATCGGTGGCAGOTAAGCGGGCTGCT 1228 
II 	II 	liii 	lII1IlililIlIillIililI 
375 aaggcacatcgagtccactcgtcgcgtc9gtggcaggtaagc. ggcttct 423 
1229 G7AGCAG0CCTGGCGTGCACTCAGCTTCGTGGTJG 1265 
424 	gaa .................................. 426 
Figure 25. 
Homology between hamster 5' flanking region (Basler el al., 1986) and mouse 5' flanking region (this 
study). Mouse sequence is shown in uppercase while hamster sequence is shown in lowercase. These 
sequences show a 78 % homology to each other (using the gap programme: gap length = 3, length 
weight = 0.1). Regions of identity are shown as vertical lines between nucleotides. 
ciz 
c) mouse to sheep 
850 CGTGGCTTcT4CTCcGTTAGTAATTTCATTTTCTC7JACTACCCArrAT 899 
1 	1111 	111 	11111 	11111111111 	111111 
1 aattgctttctcattccctaa. .tctttcattttct.......ccattac 41 
900 GThACGCGGCATTGGGThCTGCATCAGTCTTCCATTAJ3GATCATTTTT 949 
11111111 	liii 	III 	11111 	IlIlIllIllIll 
42 gtaacgagaagctggggctttggccgattttccctctaaagatga. tttt 90 
950 TATAGTTGCTGAGCGTcGTCAGGGAGTGCTGACAC'FtJG . GGCGCTTTAA 998 
(liii 	Ill 	IIIIIII1I 	III 	liii 	1111111 
91 tatcgtcaacaagcaatttcagggagtgatgagccagggaggcggtgttt 140 
999 ACAGATACAAGCATTTAACCCAGTCCGGAGOGGTGACTCACCCCCCCOCA 1048 
I 	IllIllIllIlIllIll 	I 	II 	III 	I 
141 agtgatgctagcgtttatgctagtctcaactcgtttttcccaggacttag 190 
1049 CCCCCCCCCCCCGCCAGA0AC ..... GCGCGcGCCATTCGTGAGCATCA 1093 
II 	I 	II 	III 	1111111 	1111111 
191 attcctgggtctgccggtaaaccccgggcgcccgcagcgggcgcgcctga 240 
1094 CGCCCCGCCCCTCGCCTCCCGCCTAGCTCCCGCCTGCCCGCCCGCCCCTI' 1143 
	
III 	I 11111 	II 	1111111 	111111 
241 gcgtgcgcgcgccgtcgcctccc.....cccccccgcagctcctcctctg 285 
1144 TCCCTCCCGGCCCCCCCCGCGTTGTCGCATCAGCGACcGATTCIyGC 1193 
I 	I 	II 	III 	11111 	I 	111111 	liii 
286 cacggcgactcaccagccctagttgcc. . agtcgct9acagccgcagagc 333 
1194 GCTGCGTCc ATCGGTGGCAGGTAAGCGG"CTGAAG C* AGGCCTGGCG 1243 
II 	II 	I 	III 	I 	III 
334 tgagagcgtcttctctcccag..aggcag..................... 360 
Figure 26 
Homology between sheep 5' flanking region (Westaway a al., 1994 b) and mouse 5' flanking region 
(this study). Mouse sequence is shown in uppercase while human sequence is shown in lowercase. 
These sequences show a 57 % homology to each other (using the gap programme: gap length = 3, 
length weight = 0.1). Regions of identity are shown as vertical lines between nucleotides. 
93 
d) mouse (published) to mouse (this study) 
855 cTCCTcGcrccGrmo. . TAATTTCATTTTCTCCTACCCAT12ATGTA 902 
iiiiiiiiitiiiitji 	i 	IIIIItIIIIIIIIJIIIIIJj:Jiiii 
1 c t t c ct cgCtCCgt t a99taa ct tt cat t tt c t c aact 	 50 
903 ACGCCCCATTGGGTACTGGATCAGTCTTCCATTGATGATTTTAT 952 
III IIIIIIlIIlII 11111111 liii JI 1IIIlIIIIIII 	1111111 
	
51 	 99 
953 AGT GCTGAGCGTOGTCA r 
,
GGAGTGCTGACACTGGGGGCGGTTTAAACAG 1002 
100 agttgctgagcgtcgtcagggagtgctgacactgggggcggtttaacg 149 
1003 	 1052 
11111111 III Jill! I IllilIllill 	111111 I 	11111 I 	I I I I 150 at ac aa9cat t t aa9ccagtcc99 ag cq9tgact 199 
1053 CACCCCCCCGCGACAGAC0. . cGCGCCATT0GTCAGCATCGC1y.cG 1100 
111111111111111111 I I I 	IIIIII III 	I I 111111111111 
200 cacccccccgcgagagacgcggcgcggccattggtgagcatcacgcc0g 249 
1101 	 1150 
illillil 	IIIIIIIJIIIIIIJIIJI 	IIIIIIIIIIIIIIIII 
250 cccctcgc. . ccagcctagctcccgcctgc. . .cccgcccctttccactc 294 
1151 CCGGCCCCCCCCGCGTTGTCGGATCAGCAGACCGATTCTGGGOGCTGOGT 1200 
liii 	I IIIJJIIIIIIIIIIIIJIIIIIIIIIIIIIIIIIIIIIIIII 
295 ccgg. ctcccccgcgttgtcggatcagcagaccgattctggggctgg 343 
1201 CCGATCGGTGGCAGGTGCCGGCTGCTCGCAGGCCTCGTTGCACT 1250 
I 	IIiIIl1IIIIIIIIIIiiIIiiii 	 I 
344 cgcatcggtggcaggtaagcgggctgct ......................371 
Figure 27 
Homology between mouse 5' flanking region (Westaway et al., 1994 c) and mouse 5' flanking region 
(this study). Mouse sequence produced in this study is shown in uppercase while the published 
sequence is shown in lowercase. These sequences show a 96.5 % homology to each other (using the 
gap programme: gap length = 3, length weight = 0.1). Regions of identity are shown as vertical lines 
between nucleotides. 
The 5' flanking regions of mouse and hamster PrP (Easier et al., 1986) genes are well 
conserved, showing a homology of 78 % (figure 25) over a 400 bp region of 5' 
flanking region. This level of homology between two closely related species is not 
unexpected and may represent similar regulatory processes between the two species. 
Westaway et al., (1994 c) have recently published the PrP 5' flanking sequence from 
a cosmid clone derived from a IJLnJ mouse. In the present study, subclones from the 
same cosmid clone were also sequenced. The sequence produced in this study is 
96.5 % homologous to the sequence produced by Westaway er al., (1994 c). Since 
both sequences were generated from the same strain of mouse and indeed from the 
same cosmid clone, one may have anticipated a higher level of identity between the 
two sequences. In this chapter the strategy employed to sequence the PrP 5' flanking 
region has been described in detail: briefly, the 5' flanking region was sequenced on 
one strand using five oligonucleotides to generate 1.26 kb of sequence. The 
sequencing strategy employed by Westaway et al., is, however, not given in detail 
and one cannot ascertain if one or both strands were sequenced. We do know, 
however, that double stranded DNA was used as the template for sequencing in that 
study. This form of sequencing is widely known to be less reproducible than single 
stranded sequencing; producing more variable band intensities and less readable 
sequence further from the primer (Sambrook et al., 1989). Such differences in 
sequencing strategy may account for the differences when the two sequences are 
compared (figure 27). This figure shows that most differences are minor, 
representing one or two nucleotide mismatches. There are, however, larger 
differences between the two sequences. For example, there is a mismatch of five 
nucleotides between nucleotide numbers 1075-1079 of my sequence and numbers 
222-226 of the Westaway et al., sequence (figure 27). 	On sequencing 
autoradiographs there appears to be no ambiguities in this area, as shown in figure 
28. 





Autoradiograph of sequence derived from PP 5' flanking region between nucleotides 1054-1089. 
Sequence was generated from single stranded DNA, derived from pT18 PrP 33, using 
oligonucleotide 781 (5' ACGTGGCTFCCTC(iCr 3'). Nucleotides CGCGC corresponding to 
nucleotides numbers 1075-1079 are clearly present, but are absent from the sequence of Westaway 
ci at.,. (1994 c), as illustrated in figure 27. 
The discrepancies between the two sequences, as depicted in figure 27 and 28, 
were probably due to inaccuracies in the reading of sequencing autoradiographs, 
especially at highly G C regions. These discrepancies may have arisen because of 
errors in either my work, Westaway's work, or both. 
From figures 26 and 27, one can see that homology between mouse and sheep and 
human PrP 5' flanking regions is more limited. Mouse and sheep are 57 % 
homologous whereas mouse and human are 58 % homologous. 
96 
4.6 Conservation of splice sites 
Potential spice sites have been determined for the 5' and the 3' splice sites of the 
first intron of the PrP gene. These are based on homology to the consensus 
sequences derived by Mount (1982). 
As mentioned previously, at the time this work was initiated there was no direct 
evidence that the mouse PrP gene had two 5' exons. However, through comparing 
sequence data in exon 1 and 2 with splice site consensus sequences this shows that 
this is the case and the recent study by Westaway et al., (1994 c) confirms this. 
5' flanking 	 intron 
region 1 	 2 
Splice consensus 
signal 	 C AG/GIA AGT 	 TNCAG/G 
A 	G 	 CT 
PrP exon 1 / intron 
border 	 CAG/GTAAGC 
PrP intror. I exon 2 
border 	 TTTCAGi'A 
Figure 29. 
Homology of PrP splice sites to donor and acceptor splice site consensus sequences (Mount, 1987). 
The underlined nucleotides of the splicing consensus signal are the first two (01) and the last two 
(AG) nucleotides of an intron and these are strictly conserved. The PrP splice sites are in good 
agreement with consensus splice sites, both of which show one mismatch. Exons are numbered and 
are represented as open boxes. 
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4.7 Determination of the 1st intron length 
The length of the BamHI insert of pT18 PrP 35 was measured at 3.5 kb. This was 
sequenced from the BamHI in the 5' flanking region through to exon 1 and into the 
intron. There were 1214 nucleotides from the BamHI site to the exon I / intron 
border. This border was identified by sequence homology; a splice site was found 
at nucleotide number 1214 (CAG/GTAAGC). Similarly, a splice site was found 
at the intron / exon 2 border at nucleotide number 140 of figure 11 (TTI'CAG/A). 
This showed that there were approximately 60 nucleotides of exon 2 present in 
pT18 PrP 3.5 
3.5 kb 
BamHl 	 1 	 intron 	 2 BamHI 
I p 
1.2 kb 	 60 bp 
Figure 30. 
Determination of int.ron I length based on sequence homology to splice consensus signals. The 
entire insert of pTI 8 PrP 33, derived from the 5' end of the PrP gene, is approximately 33 kb in 
length. From the 5' BamHI site to the exon I / intron border is 1214 bp. 60 bp of exon 2 are also 
present within the insert. Then remainder is 2.2 kb and this is assumed to be intron 1. 
4.8 Discussion 
To recapitulate, briefly, a subclone designated pT18 PrP 3.5 was analysed in detail 
by nucleotide sequencing. This clone contains exon 1, intron 1, approximately 60 
bp of exon 2 and 1.2 kb of 5' flanking sequence. 
The entire 1.2 kb of 5' flanking region was sequenced on one strand using 
sequential oligonucleotides as primers. Analysis of this sequence revealed several 
features. Firstly, there is quite a large variation in the G+C richness over the 1.2 
kb of sequence. For example, at the extreme 5' end (nucleotides 1-100) the 0-i-C 
content is only 38 %. However, nearer exon 1 (nucleotides 1101-1219) the 5' 
flanking region has a G+C composition of 75 %. In addition, the sequence data 
shows that there is no apparent TATA box located 20-30 bp upstream of exon 1 
(Breathnach and Chambon, 1981), nor is there a CAAT box which is usually 
present further upstream of the TATA box (Benoist and Chambon, 1980). 
Computer analysis of the 5' flanking region showed that a CpG island exists 
between nucleotides 970-1180. This CpG island may extend further into the gene 
(i.e intron 1 and exon 2) but in the absence of more extensive sequence data, this 
is impossible to ascertain. The existence of a CpG island in the 5' flanking region 
of the PrP gene may provide a mechanism whereby the expression of PrP could be 
regulated. For example, it is known that PrP mRNA is expressed more than 100 
times more highly in the brain than in the spleen (Caughey etal., 1988). Although 
the mechanisms controlling this differential expression have not been investigated, 
it may that methylation levels of the CpG island in different tissues vary. The CpCi 
island in the brain, for example, would be poorly methylated, allowing increased 
transcription levels. The CpG island of the spleen, on the other hand, would be 
extensively methylated, thus inhibiting transcription of PrP. When mouse genomic 
DNA from spleen and brain was restriction digested with MspI and Hpall, 
Southern blotted and probed with a 1.7 kb BamHI / EcoRI PrP fragment 
encompassing the 5' flanking region (see figure 18), differences could be detected 
in band size between brain and spleen. This data was not shown due to the poor 
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quality of the autoradiograph, but at least provides preliminary evidence that 
methylation differences exist in the PrP 5' flanking regions of spleen and brain. 
Again by computer analysis, it was possible to identify potential binding sites for 
transcription factors within the PrP 5' flanking region. The potential binding sites 
for over a hundred different transcription factors were identified in this way. 
The presence of such consensus sites does not, of course, prove that these 
transcription factors actually bind in such locations. To determine if proteins bind 
at such locations one could analyse the region by DNaseI footprinting, or at least 
initially by band shift assay. 
Finally, by sequence analysis, it was shown that the 5' flanking region of the 
murine PrP gene highly homologous (78 %) to the hamster PrP gene 5' flanking 
region (Basler et al., 1986'), over a 400 bp stretch. This degree of conservation did 
not, however, extend to sheep (57 %) and human (58 %). Whether these 
differences in homology represent differences in the mechanisms by which PrP 
expression is controlled in different species, is not known. It may just represent 
evolutionary divergence. Such comparisons, though, could be more revealing if 
longer stretches of 5' flanking region were available for other species. Conserved 
sequences within these regions, across a number of species, would give a better 
indication of their functional importance. However, to prove functional importance 
of specific DNA sequences it is necessary to mutate them, for example by deletion. 
The effect of such mutations on transcription can then be measured. 
The next chapter describes the construction of a number of deletions in the 5' 
flanking region and in the first iniron and measures their effect in transient 
transfection assays. 
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Chapter S 	Development of reporter gene constructs for the PrP 
gene and their analysis by transient transfection 
in neuro2a cells. 
5.1 Introduction 
Our knowledge of eukaryotic gene regulation has been greatly enhanced by the 
ability to introduce genes or fragments of genes into living systems: both transgenic 
mice and tissue culture cell lines. 
The development of reporter gene vectors has proved invaluable in such studies. 
Reporter genes code for proteins which are exogenous or are easily distinguishable 
from all other cellular proteins found, for example, in a particular cell line. Reporter 
genes are most commonly used for the analysis of putative promoter regions, 
although they may also be used to study enhancers and repressors. The basic 
strategy for analysing promoter regions is to clone such DNA upstream of the coding 
sequence of the reporter gene. As a result, the reporter gene is placed under the 
transcriptional control of the test DNA. The influence of the test DNA can be 
quantitatively measured by introduction of the recombinant plasmid into a suitable 
cell line and assaying for the reporter gene product. The main advantage for using 
reporter constructs to study gene regulation is that the reporter protein is not found 
in the test system. This allows reporter gene expression to be distinguished from 
expression of the gene which is being studied. At present there are about five 
commonly employed reporter genes. These are chioraniphenicol acetyl transferase 
(CAT), 3-galactosidase, luciferase, alkaline phosphatase and human growth hormone 
(for review see Alam and Cook, 1990). 
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There are a number of different methods whereby recombinant reporter gene vectors 
may be introduced into mammalian tissue culture cells. These include calcium 
phosphate precipitation (Graham and Van der Eb, 1973; Chen and Okayama, 1987), 
lipofection (Feigner et al., 1987), electroporatioo (Potter et al., 1984) and DEAE 
mediated transfection (McCutchan and Pagano, 1968). There are also more 
specialised transfection methods such as microprojectile mediated bombardment 
(Klein et at., 1988) and laser mediated transfection (Kurata et al., 1986). These 
methods, however, are less commonly used. 
This chapter aims to identify regulatory regions within the promoter and first intron 
of the PrP gene. This will be done by attaching various deleted fragments of the PrP 
gene to a reporter gene and then assaying for reporter activity after transient 
transfection of such constructs into neuro2.a cells. 
In this study, CAT was used as the reporter gene. CAT is an E.coli gene whose 
function is to confer resistance to the antibiotic chioramphenicol. It does this by 
transferring an acetyl group from acetyl co-enzyme A (coA) to chioramphenicol. 
CAT is not found in mammalian cells and it is easily assayed. The assay is linear 
over a large range of enzyme concentrations which means that it can be used for 
assaying promoters which have large variations in strength (Seed and Sheen, 1988). 
For these reasons CAT is the most widely used reporter gene. 
For transfections, the calcium phosphate method was routinely used. This technique 
relies upon calcium chloride forming a precipitate in the presence of a phosphate 
buffer and DNA. This DNA / precipitate complex is presented to the cells and taken 
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Figure 31. 	 (figure taken from Promega) 
pCAT basic (Promega) was the reporter vector used for PrP promoter analysis (Rosenthal, 1987). The 
vector is 4.364 kb in length and lacks both eukaryotic promoter and enhancer sequences. This allows 
Putative promoter fragments to be cloned into the multiple cloning site or putative enhancer/repressor 
sequences to be cloned into either the multiple cloning site or the Bam}ll site which is downstream 
from the CAT gene. pCAT basic also has a gene for arnpicillin resistance and a binding site for the 
reverse primer, located 5' to the multiple cloning site. The SY40 small T antigen is present 3' to the 
CAT coding region and contains an muon which enhances expression. 
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5.2 Construction of pCAT Li-P 3.5 
The entire 3.5 kb BamHT fragment from pT7T3 18 PrP 3.5 (section 4.2 b) was tested 
for promoter activity by firstly cloning into the Xbal site in the polylinker of pCAT 
basic. This was done by digesting pCAT basic with XbaI and then filling in the 
resulting 3' termini with kienow fragment to produce blunt ends (see section 2.4.8 a). 
The 3.5 kb BamHI fragment was excised from pT7T3 18 PrP 3.5 and was treated in 
the same fashion as above to produce a blunt ended fragment.. Both were ligated 
together to form pCAT PrP 3.5. 
The orientation of the insert was confirmed by restriction digests and by double 
stranded nucleotide sequencing using the reverse primer. The binding site for ihe 
reverse primer is located 15 bp upstream from the HindIH site in the polylinker of 
the vector. Depending on the orientation of the insert one would obtain either PrP 
exon 2 sequence (figure 15) or PrP 5' flanking sequence (figure 20) using this 
strategy. PrP 5' flanking sequence was shown to be present directly downstream of 
the polylinker. Therefore the insert was in the correct orientation with regard to 
promoting transcription of CAT. 
1 	 2 






pCAT PrP 33 is a 7.8 kb construct which contains a 33 kb PrP fragment cloned upstream of the 
CAT gene in pCAT basic. This 33 kb PrP fragment contains 1.2 kb of 5' flanking region, exon 1, 
2.3 kb intron, and about 60 bp of exon 2. Exoas are numbered and the reverse primer binding site 
is indicated. The CAT gene is directly downstream from PrP exon 2. 
1 kb 
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5.3 Construction of deletion mutants 
In order to define any regulatory elements which may exist within the promoter and 
intron, deletions were made in these regions. The rationale behind this is that if any 
regulatory elements were present within a deleted region then this would result in a 
different CAT value when compared to pCAT PrP 3.5. 
Two deletions were made in the 5' flanking region and another was made in the 
intron, producing four different PrP CAT constructs. How these constructs were 
made is described below. 
a) Using exonuclease III 
i) pCAT PrP 3.1 
Initially, it was intended that all deletions in the 5' flanking region would be made 
using exonuclease fill. This enzyme can digest DNA from a 5' protruding end or a 
blunt end, whereas 3' protruding ends are resistant to such digestion (Heinikoff, 
1984). Deletion construction based on the exonuclease method has the advantage that 
the deletions can be very specific. This is because exonuclease ifi will digest DNA 
at a predictable rate when incubated at a given temperature. 
Both SphI and Sail were shown to digest PCAT PrP 3.5 only once; in the multiple 
cloning site. SphI forms, exonuclease ifi resistant, 3' overhangs on digestion whereas 
Sail produces, exonuclease ifi susceptible, 5' overhangs. Therefore, when pCAT PrP 
3.5 was digested with Sail and SphT, exonuclease can digest in a unidirectional 
manner into the insert. The rate of exonuclease digestion can be controlled by the 
incubation temperature. Generally, the lower the incubation temperature the slower 
the rate of exonuclease digestion. After exonuclease ifi digestion the DNA can be 
treated with Si nuclease to remove single stranded tails left over from the 
exonuclease digestion. The digested DNA can then be made blunt, religated and 
transformed. 
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10 pg of pCAT PrP 3.5 was cut to completion with Sail and SphI. The digested 
DNA was phenol:chloroform extracted, ethanol precipitated and washed in 70 % 
ethanol. 
The DNA pellet was resuspended in 120 p1 of I x exonuclease Ill buffer. 20 p.1 
of this solution was prewarmed to 37°C and 5 p.1(325 units) of exonuclease HI added, 
mixed and returned to 37°C. At this temperature exonuclease HI should digest at 
-450 bp / mm. 
2.5 p1 samples were taken every 30 sec and mixed with 7.5 p.1 of a solution 
containing 9 p.1 Si 7.4 x Si buffer, 20 units S 1 nuclease, 57 p.1 H20. 
After collection all of the samples then were incubated at room temperature for 
30 mins. 
1 p.1 of Si stop buffer was added and mixed to each time point aliquot. The Si 
nuclease was heat inactivated at 70°C for 10 mins. 
Digestion was checked on a 0.8% agarose gel by loading 1p.l of each time point. 




Exonucicase ifi digestion of pCAT PrP 3.5. 
10 jtg of pCAT PiP 3.5 was digested with Sail and SphL 325 units of exonuclease III were added 
and incubated at 37°C for various time intervals. After heat inactivation at 70°C for 10 min the digest 
was incubated with 20 units of Si nuclease at room temperature. 
Lane 1-11: 200 ng of each time point (Lane i = 0 mm, lane 2 = I min etc) 
Lane 13 : Lambda HindIH markers 
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pCAT PrP 3.1 was derived from the Imin time point when incubated with 
exonuclease ifi at 37°C. 
 
800 bp 	1 	 2 
r e v'"\ - 
(cr 	 1 kb 
TCAGCAGGCATCTTGAACA 
Partial nucleotide sequence data from the 5' end of pCAT PrP 3.1 using the -40 primer. This was 
used to determine the exact amount which was deleted from pCAT PrP 35 to produce pCAT PrP 
3.1 (also see legend). 
Figure 34. 
Schematic representation of pCAT PrP 3.1. This clone contains a 3.1 kb insert. After 
exonuclease ifi digestion for 1 min at 37°C only - 800 bp of 5' flanking region remained. 
This was confirmed by double stranded sequencing (with Mn buffer) the clone using the 
reverse primer (see section 2.4.16 a). The partial sequence is shown. By comparing to the PrP 
5' flanking sequence one can see that 402 nucleotides have been removed from pCAT PrP 3.5. 
II 
It was not possible, however, to isolate the predicted deletion mutants from other 
time points. After the 1 min time point, all other time points seemed to undergo 
some type of recombination or rearrangement event which resulted in most of the 
insert being lost. This was shown by digesting such clones with BamHL This 
produced a linear fragment of approximately 4.5 kb. This meant that the clone 
only contained an insert of - 200 bp. By analysing aliquots of each deletion time 
point on a 0.8 % agarose gel (figure 33) it could be seen that the exonuclease ifi 
deletion reaction had worked, and at the predictable rate of about 450 bp min*' at 
37°C. However, when these aliquots were blunt-ended, religated and transformed 
into E.cpli CMK 603 they lost most of their insert, as shown when restriction 
digests were analysed by agarose gel electrophoresis. 
Several variations in the experiment were introduced in an attempt to resolve this 
problem. 
Firstly, the deleted bands were excised directly from the gel, after exonuclease UI 
treatment, and purified before re-ligation and transformation. The rationale behind 
this was that if any smaller DNA molecules were present after the deletion step 
then they might preferentially re-ligate, thereby interfering with the expected 
deletions. By excising the bands directly from the gel this possibility could be 
avoided. This, however, made no difference in that most clones only had an insert 
of - 200 bp. In addition, when the Si nuclease step was omitted and the above 
procedure was repeated the predicted deletions were still not obtained. This 
problem persisted when new Si nuclease, exonuclease UI, Sail and SphI were 
used and when a fresh CsCI preparation of pCAT PiP 3.5 was made. 
These data suggested that the event which caused the insert size to decrease to - 
200 bp probably occurred after introduction of exonuclease UI treated DNA into 
.Ecoli_CMK 603. 
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Transformations of the deletions was then carried Out in a different strain (NM 554) 
to determine if a different genotype made a difference. This strain has a recA 
mutation, which eliminates general recombination, but again this was found to 
make no difference. 
Therefore to circumvent this problem, further deletions were made by recloning 
various restriction fragments of pCAT PrP 3.5 into pCAT basic. 
5.3 Construction of deletion mutants (cont) 
b) Using Restriction digests 
(i) pCAT PrP 2.7 
pCAT PrP 2.7 contains a further deletion in the 5' flanking region of the PrP gene. 
This construct contains approximately 500 bp of sequence 5' to exon 1. pCAT PrP 
2.7 was constructed from pCAT PrP 3.1. After exonuclease digestion pCAT PrP 
3.1 had the HincIl site located at nucleotide number 202 removed (see figures 18 
and 20). This meant that a 2.7 kb HindflJSmaJ fragment could be easily isolated. 
This 2.7 kb Hind / SmaT fragment contains - 500 bp of 5' flanking region, all of 
the first intron and 60 bp of exon 2. This fragment was cloned into the blunt 
ended XbaT site of pCAT basic. Again the orientation was confirmed by double 
stranded nucleotide sequencing using the reverse primer. 
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pCAT PrP 2.7 
AACATGCAATGGCCAATATACTTTCT 
Partial nucleotide sequence from the 5' end of pCAT PrP 2.7 using -40 as a primer. This data was 
used to determine exactly how many nucleotides had been deleted from pCAT Pr? 3.1 to produce 
pCAT PrP 2.7 and also that the insert was in the correct orientation, with respect to transcription, 
after re-cloning. 
Figure 35 
Schematic representation of pCAT PrP 2.7. This clone has a 2.7 kb insert and was made from 
pCAT PrP 3.1, which had its 5' FlincH site destroyed by exonuclease deletion. This allowed a 2.7 
kb Rind / Smal fragment to be cloned into the blunt-ended XbaI site of pCAT basic. 
Orientation of insert was confirmed by double stranded nucleotide sequencing (with Mn 




5.3 Construction of deletion mutants (cont) 
b) Using restriction digests 
(ii) pCAT PrP 1.7 
pCAT PrP 1.7 has no deletions in the 5' flanking region but it does have a large 
deletion which removes 1.8 kb of the first intron. Approximately 500 bp of this 
intron remains. Whether any regulatory elements are found in the introns of the 
murine PrP gene is not known. However, there is some indirect evidence for the 
existence of such elements within the intron of the hamster PrP gene. Scott et al., 
(1989) constructed a minigene which contained hamster PrP promoter attached to 
the open reading frame of PrP. Transgenic mice which harboured this mini-gene 
were found not to produce hamster PrP. It might therefore be the case that 
adequate expression of PrP is dependent on intron sequences. In addition, 
regulatory elements have been found in the introns of other genes e.g c-fos gene 
(Lamb et al., 1990). pCAT PrP 1.7 was made by cloning a 1.7 kb Sail / EcoRl 
fragment from pCAT PrP 3.5 into the Sail site of pCAT basic. After the Sail 
termini of the fragment had been ligated in, the reaction was blunt-ended to allow 
the EcoRl termini to be ligated in. 
1.2 kb 	1 	500 bp 
.4 	 . 
Hindill, Sphl, Psil, SalI--., 
pCAT PrP 
1.7 	
- 1 k 
Figure 36. 
pCAT PrP 1.7 was made by isolating a 1.7 kb Sal! / EcoRl fragment from pCAT PrP 3.5. This 
was cloned into pCAT basic by an initial sticky end ligation of the Sail termini, followed by a 
blunt end ligation of the EcoRl termini to the Sail termini. This construct contains 1.2 kb of 5' 
flanking region and -500 bp of the first intron. No suitable restriction sites were found upstream 




5.4 Summary of PrP CAT constructs 
pCAT PrP 3.5 
pCAT PrP 3.1 
pCAT PrP 2.7 
pCAT PrP 1.7 
Figure 37. 
Fou r constructs were made which contained varying lengths of 5' flanking region and first intron 
of the Pr? gene. All were cloned upstream of the bacterial reporter gene CAT in the correct 
orientation to promote transcription of CAT. The CAT vector is pCAT Pr? basic. 
pCAT PP 33 contained a 3.5 kb insert which was composed of 1.2 kb 5' flanking region. exon 
1, 1st intron and 60 bp of exon 2. 
pCAT Pr? 3.1 is a derivative of pCAT Pr? 33 and was made by exonuclease HI deletion. This 
construct contained - 800 bp of 5' flanking sequence, exon 1, 1st intron and 60 bp of exon 2. 
pCAT Pr? 2.7 is a subclone of pCAT Pr? 3.1 and was made by cloning a 2.7 kb HincIlJSmal 
fragment into pCAT basic. This construct contained - 500 bp of 5' flanking sequence, exon 1, 1st 
intron and 60 bp of exon 2. 
pCAT Pr? 1.7 is a subclone of pCAT PrP 33 and was made by cloning a 1.7 kb SaIT/EcoRl 
fragment into pCAT basic. This construct contained 1.2 kb 5' flanking region, exon 1 and - 500 
bp of the 1st intron. 
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5.5 Calcium phosphate mediated transfection 
DNA constructs used for transfections were purified by two rounds of cesium 
chloride - ethidium bromide gradient centrifugation. This removed any residual 
RNA, open circular and nicked DNA which could have affected transfection 
efficiency. The DNA was exhaustively dialysed against tissue culture grade H.O. 
Transfections using the calcium phosphate method involved mixing the DNA with 
CaCl2, then vortexing into a phosphate buffer (FIEPES buffered saline) to form a 
fine precipitate. This was then presented to the cells and taken in by endocytosis. 
5 p.g of the plasmid pSV-3-ga1actosidase (Promega) was routinely added to the test 
DNA for every transfection. This plasmid contains the lacZ gene of Jc Ji which 
codes for the easily assayable 3-galactosidase enzyme. Transcription of the IacZ 
gene is driven by the SV40 promoter and enhancer. This plasmid was used as a 
co-transfectant in order to distinguish between differences in transcriptional 
activity from differences in transfection efficiency. To illustrate this, suppose two 
different constructs (plasmid A and plasmid B) were being compared for promoter 
strength and that an internal control was not used. If plasmid A gave an arbitrary 
promoter strength of 2 and plasmid B gave an arbitrary promoter strength of 4, 
then this could result in different interpretations. Firstly, it could mean that 
plasmid B has twice the promoter strength of plasmid A. On the other hand, it 
could mean that plasmid B had been transfected twice as efficiently. By including 
an internal control (pSV3galactosidase) such anomalies can be circumvented. 
Previous studies have shown that PrP is highly expressed in mouse ne.uroblastoma 
cell lines such as neuro2a and C1300 (Race et al., 1987, 1988; Butler et al., 
1988). It therefore seems sensible to test the PrP CAT constructs in such a cell 
line. Neuro2a cells were used. 
The day before transfection the cells were plated Out at 1-2 x 105 cells 
MI-1.  
The media (DMEM + 10 % fcs) was replaced with fresh media 3 hrs before the 
transfection. 
5 tg of test CAT construct was mixed with 5 tg of pSV-J3-galactosidase, 37 41 
of sterile 2M CaCl2  and the volume was adjusted to 300 j.il with sterile H.O. 
The DNAJCaCl2 was then added, dropwise, to 300 tl sterile I-[EPES buffer pH 
7.1 which was being vortexed during the addition. 
The precipitate was then allowed to form for 30 mins at room temperature. 
Just before addition to the cells, the solution was vortexed and then added to the 
cells in a dropwise fashion. After addition, the plate was gently swirled then 
replaced at 37°C, 6 % CO2 for 48 hrs. 
5.6 Preparation of cell extracts 
After 48 hrs the cells were removed with a cell scraper and decanted into a 15 ml 
tube along with the media. The cells were recovered by centrifugation at 1000 x 
g for 10 mins. The pellet was resuspended in imi PBS (Phosphate Buffered 
Saline) then split into 2 x 500 j.il aliquots: one for the CAT assay and the other for 
the lacZ assay. Both aliquots were spun at 5000 rpm in a microfuge for 5 mins. 
The pellets were then lysed for 5 nuns using 60 .t1 of a solution of 10mM Tris-
HC1 pH 8, 2mM MgCl2, 0.5 % Nonidet P40. The samples were then centrifuged 
in a microfuge for 2.5 mins at 13000 rpm and the supernatant collected. The lacZ 
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aliquots were usually stored at -70°C until the next day. The CAT assay aliquots 
were heated at 60°C for 7 mins, to destroy any endogenous deacetylases, then spun 
for 10 mins at 13000 rpm in a microfuge. The supernatant was used for the CAT 
assay. 
5.7 CAT assays 
This was done according to the method of Seed and Sheen (1988) and uses butyryl 
co-A rather than acetyl co-A. 
50 jt1 of cell extract was incubated in a 93 jil reaction volume containing mix A. 
Mix A was made by mixing the following: 
H 20 : 1M Tris-HCI pH 8 : "C chloramphenicol : 2.5mM butryl co-A 
5 vol 	ivol 	 2 vol 	 2 vol 
When 43 41 of mix A was added to 50 J21 of cell extract the tube was vortexed and 
incubated at 37°C for 4.5 hrs. 
After incubation the reaction mixture was extracted with 200 .t1 of mixed xylenes 
by vortexthg then centrifugation in a microfuge for 5 mins at 13000 rpm. The 
butrylated chloramphenicol partitions into the xylene (upper) phase and 180 j.tl was 
removed to a fresh tube where it was back extracted with 100 t1 of T.E. This 
back extraction involved vortexing and spinning for 4 mins in a microfuge at top 
speed. The back extraction was then repeated. This removed any residual un-
butrylated chloramphenicol. 150 tl of the top layer was then added to 2 ml of 
scintillation fluid in a vial and measured in a scintillation counter. Each construct 
was done in quadruplicate. 
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5.8 3-galactosidase assays 
pSV-0-galactosidase was used as an internal control with every transfection in 
order to standardise transfection efficiencies. The plasmid contains the E.coli lacZ 
gene (which codes for -galactosidase) driven by the SV40 promoter and enhancer. 
[3-galactosidase can be measured spectrophotometrically by utilising its ability to 
hydrolyse the chromogenic substrate ONPG (o-nitrophenyl--D-ga1actopyranoside). 
This method was an adaption of that of Rosenthal (1987). 
For each CAT assay, two f3-galactosidase were done and they were set up as 
follows: 25 tl cell extract, 3 tl 100 x Mg buffer, 50 jtl ONPG at 4 mg mV and 
222 fl 0.1M sodium phosphate buffer at pH 7.5. This was vortexed and incubated 
at 37°C until a yellow colour developed (1-2 hrs). 0- galactosidase assays were 
also done on a positive control which comprised 0.05 units of -ga1actosidase 
standard (Sigma). Negative controls were mock transfected cells. The reactions 
were stopped by heating at 75°C for 10 mins and measured in a spectrophotometer 
at 420 nm. The blank was 1 x Mg buffer, 0.6 mg m11 ONPG and 0.1M sodium 
phosphate. 
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5.9 	Norm alisation of CAT results 
To differentiate transfectjon from transcriptional differences, CAT assays were 
normalised or standardised against 3-galactosidase assays (a-gal). For each DNA 
construct, at least four separate transfections were performed. In addition to this, 
at least two different DNA preparations were tested. Normalisation basically 
involves dividing a CAT assay value (in cpm) with its corresponding J3-gal value 
(in OD 600 nm units). N.B the cell extract from transfected cells was used for 
both CAT assay and 3-gal assay. A mock transfection (no DNA) was also 
performed to control for endodgenous lysosomal -galactosidase activity. For 
every CAT assay performed, two p-gal assays were done and the average value 
of them determined. This was done as the 3-gal assays tended to give more 






Tables 5-10 represent data obtained in the normalisation procedures of pCAT PrP 3.5, 3.1, 2.7, 1.7, pCAT control and pCAT basic, respectively. 
The CAT assays were done in quadruplicate and individual results (expressed in counts per mm - cpm) are shown in column a. For each CAT 
assay two f3-galactosidase (beta-gal) assays were done and the average of these calculated. This is referred to as the mean beta-gal value and this 
is shown in column b. In addition, a fi-gal assay was performed for a mock (no DNA) transfection to allow for endodgenous 3-gal activity. This 
control value = 0.79, and when subtracted from the values in column b results in the column c values being produced. 
Normalised CAT assay values are produced by dividing CAT assay values (a) by adjusted beta-gal values (c). Then the average of these four normalised 
CAT assay values (d) is calculated and expressed ± the standard error of the mean (underneath each table). 
A summary of these data is shown in figure 38. 
Normalisation of pCAT PrP constructs 
Table 5 - Normalisation of pCAT PrP 3.5 
(a) CAT assay (cpm) b) Mean beta-gal (C) Mean beta-gal -control (d) Normoflsed CAT assay (a/c) 
160,816 1.566 0.776 207,237 
164.263 1.210 0.420 391,102 
173,902 1.450 0.660 263,487 
175,279 1.181 0.391 448,283 
Norma Used result for pCAT PrP 3.5 
327527 j 55673 
Table 6 - Normalisation of pCAT PrP 3.1 
(a) CAT assay (cpm) b) Mean beta-gal (c) Mean beta-gal- control (d) Normaflsed CAT assay (a/c) 
193,603 1.386 0.596 324,837 
151,819 1.179 0.389 390,280 
142,248 1.348 0.558 254,924 
152,037 1.292 0.502 302,862 
Normailsed result for pCAT PrP 3.1 
318225±28104 
Table 7 - Normalisation of pCAT PrP 2.7 
(a) CAT assay (cpm) b) Mean beta-gal (C) Mean beta-got -Control (d) Normoilsed CAT assay (a/c) 
81,669 1.579 0.789 103,509 
54,180 1.390 0.600 90.300 
62.829 1.335 0.545 115.284 
104,069 1.737 0.947 1091840 
Normailsed resutt for pCAT PrP 2.7 
104733 ±5379 
Table 8 - Normoilsatlon of pCAT PrP 1.7 
(a) CAT assay (cpm) b) Mean beta-gal (C) Mean beta-gal -control (d) Normolised CAT assay (a/c) 
45,181 1.260 0.470 96,129 
32,950 1.217 0.427 77,166 
22,180 1.092 0.302 73,443 
44,259 1 	1.300 1 	 0.510 1 	 86.782 
Norrnoltsed result for pCAT PrP 1.7 
83380 ±. 5094 
Normalisation of control constructs 
Table 9 - Normalisation of pCAT control (positive control) 
(a) CAT assay (cpm) b) Mean betogoi (C) Mean beta-gal -control (d) NormcHsed CAT assay (a/c) 
64.207 1.615 0.825 77,826 
51,458 1.524 0.734 70.106 
71,987 1.538 0.748 76,239 
51,924 1 	1.421 1 	 0.631 1 	 82.288 
Normoilsed result for pCAT control 
81614±6713 
Table 10 - Normalisation of pCAT basic (negative control) 
p) CAT assay (cpm) b) Mean beta-gal (C) Mean beta-gal -control (d) Normoused CAT assay (a/c) 
2.829 1.283 0.493 5,738 
2,587 1.136 0.346 7.476 
Normailsed result for pCAT basic 
6607±616 
AT activity 





pCAT PrP 3.1 	
II 	
_—flCAT 1 97 ± 8.8 
pCAT PrP 2.7 
32 ± 5.1 
pCAT PrP 1.7 
25 ± 8.8 
pCAT Control (+ve) SV40-1 	
25 ± 8.2 
pCAT Basic (-ye) 	
[CAT] 	 2 ± 9.3 
Figure 38. 
CAT activity of PrP deletion constructs and controls. Constructs containing varying lengths of PrP 
5' flanking and intron region were cloned upstream, and in the correct orientation with respect to 
transcription, of the CAT gene. The positive control encompassed the SV40 promoter and 
enhancer driving the CAT gene, whereas the negative control consisted of the promoterless plasmid 
pCAT basic. These constructs were transfected into neuro2a cells by calcium phosphate mediated 
transfection and after 48 hrs CAT activity was measured. Each construct was done in 
quadruplicate (except pCAT basic), with CAT activity being normalised to beta-galactosidase 
activity (see tables 5-10 for raw data). The highest normalised CAT assay value (pCAT PrP 3.5) 
was arbitrarily designated as having a promoter activity of 100 and all other constructs were 
expressed as a percentage of this. Each value is an average of four separate transfections ± the 
standard error of the mean (SE.M). 
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5.10 	Results and Discussion 
To identify the regulatory regions responsible for the expression of the mouse PrP 
gene several 5' deleted fragments of the PrP promoter, and a deletion in the intron, 
were fused upstream of the CAT reporter gene. The promoter activity of these 
constructs was then analysed by transfection into murine neuro2a cells and 
subsequent measurement of CAT activity. 
pCAT PrP 3.5 contained 1.2 kb of 5' flanking region, exon 1, all of the first intron 
and about 60 bp of exon 2 fused upstream of CAT (see figure 32). This construct 
had the highest promoter strength and, as such, was designated as having an 
arbitrary promoter strength of 100. All other values were expressed as a 
percentage of this value. pCAT PrP 3.1 (figure 34a), which contains 800 bp 5' 
flanking region, exon 1, the entire first intron and about 60 bp of exon 2, had 
approximately the same promoter strength as pCAT PrP 3.5 (see figure 38). 
pCAT PrP 2.7 is the same as pCAT Pr]? 3.1 except that it has only 500 bp of 
sequence 5' to the first exon. This deletion results in a greater than 3-fold 
reduction in CAT activity when compared to pCAT Pr]? 3.5 (figure 38). This 
suggests that the PrP promoter possesses a positive regulatory element which 
resides within the deleted region (- -500 to -800). pCAT PrP 1.7 has no deletions in 
the 5' flanking region but it does have a large deletion in the first intron. This 
construct contains 1.2 kb 5' flanking region and approximately 500 bp of intron 1. pCAT 
PrP 1.7 shows, approximately, a 4-fold reduction in CAT activity when compared to pCAT 
PrP 3.5 (see figure 38). This analysis has shown that there may be a positive 
regulatory element in the first intron of the PrP gene. The level of CAT activity from 
pCAT PrP 1.7 is comparable with that of the positive control (pCAT control) and is 
approximately 12.5-fold higher than the negative control (pCAT basic). In order to 
determine the net effect of the first intron on the expression of CAT, one would have 
to delete it entirely. As it is, pCAT Pr]? 1.7 contains - 500 bp of intron. 
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Probably the simplest way of deleting all of the first intron would be to amplify 
the promoter region by PCR and then redone it into pCAT basic. Such a construct 
would then be re-tested in a CAT assay after transfection. 
A more detailed analysis of the PrP promoter region could be gained by creating 
more deletions in the 5' flanking region. This could be done by using Sph 1,1 Sail 
digested pCAT PrP 2.7 as substrate for exonuclease III. This would produce 
unidirectional deletion within the 500 bp region which is 5' to exon 1. Most of 
the potential transcription factor binding sites are located in this 500 bp region. 
The effect of their deletion could therefore be ascertained. 
The positive control used in these transfection experiments was pCAT control. 
This construct contained the CAT gene which was driven by the SV40 promoter 
and enhancer sequences. This construct gave approximately 4-fold less CAT 
expression when compared to pCAT PrP 3.5 but approximately the same levels of 
expression as did both pCAT PrP 3.1 and pCAT PrP 2.7. Other workers have also 
found that the SV40 promoter is not particularly strong in neuronal cell lines. For 
example, Donis et al., (1993) compared the strength pf several different promoters 
when linked to CAT and transfected into PCI2 cells. Like neuro2a cells PC12 
cells are a neuronal cell line but are derived from rat rather than from mouse. In 
that study the SV40 promoter was shown to be weaker than the long terminal 
repeat of the Moloney murine leukaemia virus (MMLV), the Rous sarcoma virus 
(RSV) promoter, the beta-actin promoter and the simian cytomegalovirus (SCMV) 
promoter. Indeed, the SV40 promoter directed only five times the amount of CAT 
activity when compared to cells which were not transfected. Similar results were 
found with an immortalised neuronal cell line called HT4. 
For a negative control in this study, the promoterless pCAT basic plasmid was 
used. This control gives one an estimation of the 'background noise' of the basic 
plasmid. The relatively small CAT activity from pCAT basic (8% of pCAT 
control) is probably due to spurious promoter elements located in the vector. 
lZ5 
This assumption is supported by experimental evidence from the no DNA control 
(mock transfection) which gave an average cprn of 226 (n = 2) in the CAT assay 
(data not shown). This means that there is very little endodgenous CAT activity 
in the neuro2a cells. 
An important assumption which is often made in studies involving reporter gene 
constructs is that transcriptional activity is directly proportional to the activity of 
the reporter enzyme. This assumption is generally true (Alam and Cook, 1990), 
although it need not necessarily hold in every case. For example, pCAT PrP 1.7 
has 1.2 kb of 5' flanking region, exon I and about 500 bp of intron. This intron 
is only flanked by one splice site at the exon 1 I intron border and hence this 
could affect RNA stability or its ability to be processed correctly. This may affect 
the levels and possibly the activity of the CAT enzyme. Therefore a more direct 
approach which could have been used instead, or additionally as a control, would 
be to measure CAT mRNA directly rather than CAT enzyme activity. This could 
have been done by quantitative RT-PCR, primer extension or by ribonuclease 
protection. 
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Chapter 6 	Primer extension analysis of PrP mRNA 
6.1 Introduction 
Primer extension is a technique which can be used to determine the 5' termini of 
mRNA. This by definition determines where transcription starts and can be mapped 
precisely on the DNA if nucleotide sequence of this region is available. The 
principle of the technique is that a radioactively labelled primer, either a single 
stranded restriction fragment or an oligonucleotide, corresponding to the gene of 
interest is hybridised to RNA. Reverse transcriptase is then used to extend this 
annealed primer to produce a cDNA. This extended product is then analysed on a 
denaturing polyacrylamide gel with e.g M13 sequence as size markers. The 
extension reaction should terminate at the extreme 5' end of the RNA. 
The primer extension reaction is more sensitive and gives rise to less artefacts with 
poly (Ak) RNA rather than total RNA. Further artefacts can be prevented by 
designing primers which are as close to the 5' terminus of the RNA as possible 
(preferably within 100 nucleotides of the 5' terminus). 
Primer extension analyses have previously been performed on the PrP gene using 
human (Puckett et al., 1991), hamster (Basler et al., 1986) and mouse (Westaway 
et al., 1987) RNA. 
Puckett et al., (1991) analysed the human PrP gene by primer extension using a 30 
mer as a primer and poly (Ak) RNA and found that transcription initiated at one site. 
This was located approximately 136 bp upstream of the 5' splice site. In contrast, 
when Basler et al., analysed the hamster PrP gene by primer extension, using a 35 
mer as a primer and poly(A) RNA, multiple transcriptional start sites were identified. 
These were found between 55 and 80 nucleotides upstream of the 5' splice site. In 
1987 the promoter region of the murine PrP gene was uncloned. 
However, Westaway et al., (1987) found that murine PrP RNA had heterogenous 
5' termini when analysed by primer extension. In this case a 30 mer primer and total 
RNA were used. Due to the promoter region being uncloned, however, the multiple 
5' termini of the RNA could not be mapped to the promoter region of the gene. 
The group of experiments described below reproduce and expand those of Westaway 
et al., (1987), but also contain several important modifications. These include the use 
of a different oligonucleotide as a primer and of poly (Ak) RNA instead of total 
RNA, which often gives unacceptably high levels of premature terminations. Also 
the transcriptional start sites could be mapped directly to the promoter region as this 
has been cloned and its nucleotide sequence determined (see chapter 4). 
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Labelled oligonucleotide annealed 
to the mRNA 
5 ' 	 3' 
C) 	 AAAAAA 
54 
The labelled oligonucleotide 
(now acting as a primer) can be 
"extended' using dNTPs and Moloney 
murine reverse transcriptase. A 
full length extension Droduct will 
terminate at the 5' terminus of the 
mRNA. 
d) Extension products are then analysed by denaturing 
polyacrylamide gel electrophoresis 
Figure 39. 
Schematic representation of primer extension. 
Approximately 20000 cpm of exon 2 specific oligonucleotide (designated 03206) was annealed to 
five micrograms of brain mRNA derived from a VMIDk mouse (henceforth referred to as VM). This 
was performed by beating to 90°C for 10 rnins and then allowing to cool to room temperature. The 
primer was then extended to the 5' terminus of the mRNA by incubating at 37°C with Moloney 
murine reverse transcriptase and dNlPs for 1 3/4 hrs. The extension products were analysed by 
denaturing polacrylamide gel electrophoresis. M13 sequence was used as size markers. AsterLx 
denotes radioactive label and broken arrows represent the extension reaction. 
	
6.2 	Isolation of total RNA 
Total RNA was initially purified from a frozen brain (0.457 g) of a VM (Sinc p7) 
mouse and then later scaled up to produce larger amounts of RNA. The brain was 
ground in a small volume of liquid nitrogen using a mortar and pestle. The powder 
was added to 9 ml of RNAzo1 (Biogenesis Ltd) and then mixed by vigorous 
vortexing. 900 R' of chloroform was added to the homogenate and again vigorously 
vortexed. The homogenate was then incubated on ice for at least 5 mins and then 
spun at 12000 x g for 15 mins at 4°C. After centrifugation the suspension separated 
into two phases: the lower blue phase and the upper colourless phase. The upper 
phase was transferred to a fresh tube. An equal volume of isopropanol was added, 
mixed, and stored at 4°C for 15 mins. After this the tube was spun at 12000 x g for 
15 mins at 4°C to recover the RNA. The pellet was then washed in 70 % ethanol 
and spun at 7500 x g for 8 mins. The pellet was resuspended in 500 i.tl of DEPC 
treated H20 and stored at -20°C. Approximately 470 .Ig of total RNA was recovered 
from 1 brain. 
6.3 	Isolation of mRNA 
There are several methods which can be used for the isolation of mRNA, all of 
which utilise the poly(A) region which is found at the 3' region of most eukaryotic 
mRNAs. 
The system described here relies on magnetically separating mRNA from other RNA 
species. The polyAtract mRNA isolation system (Promega) was used. This system 
involves annealing a biotinylated oligo(dT) primer to the 3' poly(A) region of the 
mRNA. Streptavidin paramagnetic particles are then added to the annealed mix and 
these bind to the biotin. 
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On application of a magnetic force to the side of the tube, the strepavidin 
paramagnetic particles which are coupled to the oligo(dT)/biotin mRNA complex are 
pulled to the side of the tube. These are washed several times and the rnRNA is then 
eluted. 
Protocol 
1 mg of total RNA in a volume of 500 p.1 H20 was heated at 65°C for 10 mins. 
3 p.1 of the biotinylated-oligo(dT) probe and 13 p.! of 20 X SSC were then mixed into 
the RNA and allowed to cool to room temperature. Meanwhile, the streptavidin 
paramagnetic particles were resuspended by gently flicking the bottom of the tube 
and the captured onto the side of the tube using a magnet. The particles were 
washed three times in 0.5 X SSC (0.3 ml per wash) and collected each time using 
the magnet. The particles were resuspended in 0.1 ml of 0.5 X SSC. 
Then the entire annealing reaction was added to the washed streptavidin 
paramagnetic particles and incubated for 10 mm. The particles were then recaptured 
using the magnet and washed four times in 0.1 X SSC (0.3 ml per wash). 
To elute the mRNA, 100 p.1 of H20 was used to resuspend the captured particles. 
After recapturing the particles the eluate was transferred to a fresh tube. The elution 
procedure was repeated using 150 p.1 of H20. The two eluates were then pooled. 
Typically, 12 p.g of poly (Ak) was isolated from 470 p.g of total RNA, which was the 
equivalent of one mouse brain. This is consistent with approximately 1-2 % of total 
RNA being composed of mRNA (Sambrook et al., 1989). 
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6.4 Northern blot of PrP mRNA 
A Northern blot was carried out to check the integrity of the PrP mRNA. 
a) Electrophoresis of RNA 
A 100 ml gel was made with 72 ml H201  18 ml formaldehyde, 1 g agarose and 10 
ml of 10 x RNA running buffer. An equal volume of formamide sample buffer was 
added to 1 j.tg of brain mRNA and heated to 75°C for 5 mins and then quickly cooled 
on ice. 0.25 vol of Ficoll-dye-EDTA was added, mixed and then loaded Onto the gel 
immediately. The gel was run at 15 volts overnight. 
b) Northern transfer 
After electrophoresis the gel was washed in 500 ml of H20 for 10 mins to remove 
traces of the formaldehyde from the surface of the gel. The set up for the Northern 
blot was essentially the same as for a Southern blot, except that the transfer buffer 
for the Northern blot was 20 x SSC. The RNA was blotted onto Hybond-N overnight. 
After transfer the membrane was washed in 2 x SSC, dried and fixed by baking at 
80°C for 2 hrs. 
C) Prehybridisation of Northern blot 
The membrane was prehybridised in 50 ml of Hybond-N prehybridisation buffer at 
65°C overnight in a shaking water bath. 
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d) Hybridisation and washing of Northern blot 
A 2 kb Pstl fragment (see figure 40), encompassing the ORF of mouse PrP gene, was 
labelled with 32P by random priming (see section 2.4.11 a) and used to probe the 
Northern blot. The 2 kb Pst-I fragment was derived from exon 3 of the mouse PrP 
gene - see diagram below. The probe was boiled for 7 mins and then added to the 
hybridisation solution and incubated overnight at 65°C. 
The membrane was washed twice for 15 mins in 0.1 x SSC, 1 % SDS at 
65°C. A 2.4 kb band was evident from the resulting autoradiograph and little 
RNA degradation was detected (see figure 41). The primer extension 
experiments were then performed. 
pUG N18 
2 kb 
BamHI P X 	P 
	
X P 	P BamHI 




pUC N18 is a 8.8 kb genomic clone of a NZW mouse PrP gene (provided by D. Westaway). 
This clone encompasses exon 3 and surrounding region. The entire open reading frame is 
indicated with a large box. The narrower open box designates the untranslated regions of 
exon 3. The single straight line at the 5' end of the insert represents part of intron 2, whereas 
the same line at the Tend represents 3' flanking sequences. The 2 kb PstI fragment used as 




Northern blot of PrP mRNA from a VM mouse. 
One microgram of poly (Ak) brain RNA from a VM mouse was electrophoresed overnight 
on a I % agarose gel containing formaldehyde. After electrophoresis the gel was washed in 
H20 for 10 mins and blotted overnight onto Hybond N, using 20 x SSC as the transfer 
buffer. The membrane was then baked at 80°C for 2 hrs to fix the RNA to the membrane. 
A 2 kb PstI restriction fragment encompassing exon 3 (see figure 40) was radioactively 
labelled with31p, using random priming, and hybridised to the RNA at 65°C overnight in 
0.5M sodium phosphate, 7 % SDS. The membrane was then washed twice, for 10 mins, in 
0.1 x SSC, 1 % SDS at 65°C and autoradiographed overnight at -70°C. A single band of 
approximately 2.4 kb was evident. Gibco BRL RNA markers were used as size standards 
(not shown) and ranged from 0.24 to 9.5 kb. 
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6.5 	Primer extension 
a) 	Design of oligonucleotide primer and its location on mouse cDNA 
sequence 
By referring to the published mouse cDNA sequence (Locht et al., 1986) an 
oligonucleotide was designed which corresponded to the 5' terminus of the 
cDNA sequence. The position of this oligonucleotide (designated G3206) 
with respect to the cDNA sequence is shown below. Oligonucleotide G3206 
was designed to bind as close to the 5' terminus as possible, based on the 
information which was available at the time. This reduces the possibility of 
the reverse transcriptase either becoming dissociated from the RNA or 
stopping at a region of high secondary structure (Sambrook et al., 1989). The 
first 9 nucleotides of the cDNA sequence (Locht et al., 1986) were not found 
in the exon 2 sequence which is presented in chapter 4 (figure 15) and hence 
were ignored in the design of G3206. It seemed likely that this 9 bp region 
was a cloning artefact, and indeed it was not found in the recent sequence 
analysis of exon 2 by Westaway et al., (1994 c). 
G3206 
5' 1 AATTCCTTCA GAACTGAACC A'JTT.cAACCG AGCTGAAGCA 
41 11TCTGCCTFC CTAGTGGTAC CAGTCCAATT TAGGAGAGCC 
81 AAGCAGACTA TCAAGTCM GCGAACCTFG 3' 
Figure 42. 
Location of G3206 on PrP cDNA. 
The first 110 nucleotides (from 2.1 kb) of the mouse PrP cDNA sequence are shown. The 
ATG highlighted indicates the translational start codon found in exon 3. Oligonucleotide 
G3206 is derived from exon two sequence and corresponds to position 10 - 30 on the cDNA 
sequence. The target sequence for the primer is underlined. 
G3206 5'-CGGT7GAAATGGTFCAGTFCT-3' 
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6.5 b) Labelling of oligonucleotides 
100 ng of oligonucleotide was labelled with 32P dATP and polynucleotide kinase as 
described in Materials and Methods. After labelling, the DNA was phenol:chloroform 
extracted. Unincorporated label was removed by 2 ethanol precipitations in the 
presence of 2M ammonium acetate. 
C) Annealing of oligonucleotide to mRNA 
Approximately 1 - 2 x iO cpm (lpmol) of labelled oligonucleotide primer was mixed 
with 5 j.tg of poly (Ak) RNA in the presence of 50mM Tris HC1 pH 8.3, 75mM KCI, 
10mM DTT, 3mM MgC12 in a total volume of 10 p1. The oligonucleotide was 
allowed to anneal to the RNA by heating at 90°C for 10 mins then leaving to cool to 
room temperature. 
Extension reaction 
The annealed primer was extended by adding 0.5 p1 of each dNTP and 1 p1 of 
Moloney murine leukaemia virus reverse transcriptase and incubating at 37°C for 1 hr. 
Another I .tl of enzyme was added and the reaction was continued for another 45 mins. 
The cDNA product was then ethanol precipitated, washed in 70 % ethanol and then 
resuspended in 4 j.il of loading buffer. 
Polyacrylam ide gel electrophoresis 
Samples were heated to 90°C for 10 mins before being loaded onto a 6 % sequencing 
gel. M13 sequencing reactions were used as size markers. The gel was run at about 
1500 volts until the first dye migrated into the buffer. The gel was then treated in the 
same way as a sequencing gel (see section 2.4.16 c) except that it was exposed to x-
ray film overnight at -70°C, instead of overnight at room temperature. 
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6.6 Results 
a) Primer extension of mouse brain mRNA with oligonucleotide G2306 
	
Primer extension 	A C Ci T 
- 
114 bp 	4 
I 






p 4 = I 
Figure 43. 
Primer extension analysis of brain mRNA. 
There are at least 10 extension products visible on the gel (left hand side of photo). M13 sequence 
is shown on the right hand side of photo and is used as size markers. There total sizes of the extension 
products are 70, 71, 76, 77, 78, 80, 81, 83, 111 and 114 bp in length. Some of the extension products 
are marked with arrows and their sizes shown. By subtracting 21 bp to account for the primer then 
the actual extensions from the 3' end of the primer are 49, 50, 55, 56, 57, 59, 60, 62, 90 and 93. 
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6.7 Mapping transcriptional start sites on PrP promoter 
1122 CCCGCCTGCC CGCCCGCCCC 'ITII'CCACTCC CGGCCCCC 
V VV VVY 	 VY 1' 	1' 
1160 CCCGCGYFGT CGGATCAGCA GACCGATFCT GGGCGCTGC 
rr 	IT 
1199 GTCCGATCGGT GGCAG / OT AAGCGGGCTG AAGCAGGCC 
= Exon 1 I intron 1 =o- *
Figure re 44. 
Position of transcriptional start sites in mouse PrP promoter. 
Transcriptional start sites (v)  were deduced from a primer extension assay using an exon 2 specific 
oligonucleotide as a primer. Based on the sequence data of exon 2, presented in chapter 4 (figure 15), this 
primer was predicted to bind to a target sequence which is 17 bp from the intron I/ exon 2 splice junction. 
By taking this into account, and the 21 bp which constituted the oligonucleotide, the remainder of the total 
extension length must correspond to sequence 5' to the exon 1/ intron I splice site (represented with a slash 
and underlined). The complete sequence of the promoter is given in chapter 4 (figure 20). 
T represent start sites for transcription which were recently deduced by Westaway et at., (1994 c). 
6.8 	Discussion 
When a PrP exon 2 specific oligonucleotide is used in the primer extension assay 
multiple extension products are observed. At least ten different extension products 
were identified and these may correspond to transcriptional start sites within a 44 bp 
region of PrP 5' flanking sequence. These extension products have variable band 
intensities and this may reflect the frequency with which a particular site is utilised. 
From figure 43, one can see that the extension product of 71 bp (second band from 
bottom) is the most intense, closely followed by the product of 77 bp. Therefore these 
two sites, corresponding to nucleotide 1134 and 1140 of PrP 5' flanking region, 
probably represent major start sites for transcription in the brain. The remainder of 
the extension products are less intense and therefore will represent start sites which 
are less frequently used for initiating transcription. 
Initiation of transcription in the PrP gene of hamster (Basler et at., 1986) and sheep 
(Westaway et al., 1994 b) also occurs at multiple sites. This, however, is not the case 
in human PrP gene where transcription starts at one site (Puckett et al., 1991). The 
significance of this difference, if any, is not known at present. However, it appears 
that transcriptional initiation at multiple sites, or at one site, bears no correlation as to 
whether disease in that animal can actually occur. The effects of multiple 
transcriptional start sites may be more subtle, however, in that while they do not cause 
disease per Se, they may still influence how PrP gene is regulated. Assuming that the 
sequence CAG/GTAAAG (see figure 44) is the correct splice site consensus signal, 
then the length of exon 1 may vary from 33 bp to 75 bp, depending on which 
transcriptional start site is utilised. The inclusion, or exclusion, of this stretch of DNA 
into the PrP transcript may be of importance if this sequence performs a regulatory 
function. Work with other genes, such as thymidine kinase, has shown that 5' non-
coding sequences can have a negative effect on translational efficiency, of the 
corresponding mRNA, if such sequences have the capacity to form secondary 
structures (Pelletier and Sonenberg, 1985). 
139 
Genes such as c-myc (Piecheazyk et al., 1985), human histone H3 (Morris et al., 
1986) and ferritin (Goosen etal., 1990) also have regulatory elements residing in their 
5' untranslated regions (UTRs). Whether PrP gene has regulatory elements associated 
with its 5' UTR is not known, however it is possible that differential use of 
transcriptional start sites could affect the regulation of such elements. 
To determine if the putative splice sites (see above and figure 20) are correct one 
could have initially performed RT-PCR on PrP mRNA to produce a full-length cDNA. 
Then, one could sequence the 5' region of this eDNA and compare it to the sequence 
of exon l(see figure 44) and exon 2 (see figure 15), allowing for where splicing was 
expected to occur. 
The discrepancies (figure 45) between the mapping of transcriptional start sites, onto 
the promoter, in this study when compared to the study of Westaway et al., (1994 c) 
may be attributable to several factors. Firstly, in chapter 4 it was made clear that there 
were differences in the nucleotide sequence of PrP 5' flanking sequence and also a one 
nucleotide difference in the sequence of exon 2. This therefore would have introduced 
inaccuracies in the designation of where transcription starts on the PrP promoter. 
Another factor which may have produced differences between the two studies is that 
different mouse strains were used for the isolation of the RNA. In this study, \'M 
mice were used, whereas Westaway et al., (1987) used I/Ln mice. Despite these 
differences, there is good agreement between both studies and they confirm multiple 
transcriptional start occur within the mouse PrP gene and that most of them are located 
within, approximately, a 44 bp region (see figure 44). 
Due to the high secondary structure which would be expected within the G C rich PrP 
promoter, one must interpret the data presented in this chapter with caution. As well 
as mapping true 5' termini of mRNA the primer extension technique also maps sites 
where the reverse transcriptase pauses or stops, often due to high secondary structure. 
Therefore some of the extension products seen in figure 43 may be artefacts. This is 
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also a criticism of the work of Westaway et al., (1987) as similar potential problems 
would have existed. 
With hindsight, it may have been better to use a more thermostable enzyme rather than 
Moloney murine leukaemia virus reverse transcriptase which has an optimum 
polymerisation temperature of 37°C. An enzyme such as TET-z polymerase 
(Arnersham) has reverse transcriptase activity and can function at 70°C . At this 
temperature much of the predicted secondary structure associated with the PrP 
promoter would be eliminated and hence a more reliable primer extension result would 
be obtained. In addition, the primer extension results could have been confirmed with 
Si nuclease mapping. 
Chapter 7 	Summary and Discussion 
To understand if PrP gene regulation is altered in a diseased animal one must first 
address how the PrP gene is regulated in healthy animals. At present there is 
virtually nothing known about the DNA sequences and trans-acting factors which 
control the expression of PrP in different tissues and during development. It is also 
not known if the regulation of PrP gene expression is affected during disease. 
This study has made an initial investigation into PrP gene regulation, in uninfected 
mice, by analysing the promoter region and the first intron using several different 
techniques. Each individual results chapter has its own discussion section attached 
to it. This chapter aims to recapitulate the data obtained in this project and to 
suggest ideas for further experiments based on this data. 
7.1 Summary 
Firstly, a subclone was isolated from a mouse PrP cosmid clone, cos 6JILnJ-4, 
(Westaway et al., 1991). By nucleotide sequence analysis this subclone, pT18 PrP 
3.5, was shown to contain part of exon 2 of the PrP gene. This was based on its 
high homology to the published PrP cDNA sequence (Locht et al., 1986). Sequence 
analysis from the opposite (5) end of the subclone revealed that approximately 1.2 
kb of PrP 5' flanking sequence was present as was the first exon. This region 
showed high homology to the hamster PrP promoter but lower homology to the 
human and sheep PrP promoters. The presence of splice site consensus sequences 
bordering exon 1 and exon 2, confirm earlier work which suggested that the mouse 
PrP gene has two non-coding exons separated from each other by an intron of 
undisclosed size (Westaway et al., 1991). 
Secondly, studies were conducted on the promoter activity of various subclones of 
the PrP gene. A fragment containing 1.2 kb of the 5' flanking region, exon 1, intron 
and part of exon 2 was cloned upstream of the reporter gene CAT, in the reporter 
vector pCAT basic. 
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When transfected into neuro2a cells this construct (pCAT PrP 3.5) was found to 
direct high expression of CAT. This level of expression was greater than 3-fold 
higher than the positive control. The positive control contained the SV40 promoter 
and enhancer linked to the CAT gene. A deletion was made in pCAT PrP 3.5 which 
removed 400 bp at the 5' end so that 800 bp of 5' flanking region remained. This 
construct was called pCAT PrP 3.1 and its promoter strength was approximately the 
same as pCAT PrP 3.5. A further deletion in the 5' flanking region of the PrP gene 
removed 300 bp and this left 500 bp of promoter region. This construct, pCAT PrP 
2.7, showed a marked decrease (3-fold) in promoter activity when compared to pCAT 
PrP 3.5. This suggests that a positive regulatory element resides in the PrP promoter 
at position -500 to -800. To determine if the first intron plays a regulatory role, a 
large deletion was introduced into this region. pCAT PrP 1.7 contained the full 5' 
flanking region (1.2 kb) but only —500 bp of the first intron remained. This 
construct showed a 4-fold reduction in CAT activity when compared to pCAT PrP 
3.5. 
Thirdly, the transcriptional start sites were determined from the PrP gene using the 
primer extension technique. An oligonucleotide was synthesised, based on the 
published mouse cDNA sequence (Locht et al., 1986). This oligonucleotide was 
labelled at the 5' termini and annealed to mRNA derived from the brain of a \'M 
(Sinc p7) mouse. The annealed primer was then extended using MMLV reverse 
transcriptase and dNTPs. After this extension the reactions were ran on a 6% 
polyacrylamide sequencing gel and the length of the extended products calculated. 
M13 sequence was used as size markers. Using this technique multiple 
transcriptional start sites were identified within a 44 bp region of the PrP promoter. 
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7.2 Function of multiple transcription start sites and the possibility of RNA 
splicing. 
That transcription starts at multiple sites in the mouse PrP gene is probably 
attributable to its lack of a TATA box in the promoter region. The TATA box 
controls accurate initiation of transcription (see Smale and Baltimore, 1989, for 
review) and in genes which lack it, often housekeeping genes, multiple sites for 
transcriptional initiation are common (Mitchell et al., 1986; Herrick et al., 1993). As 
mentioned earlier, there is at least one instance whereby differential utilisation of 
transcription start sites provides a mechanism whereby gene expression can be 
regulated. This occurs in the cc-amylase gene; one start site is utilised when the gene 
is expressed in the pancreas and another is utilised when it is expressed in the 
salivary gland (Young et al., 1981). 
Whether the use of differential transcriptional start sites plays a role in the regulation 
of the PrP gene, perhaps under certain circumstances or in certain cell types, is not 
known. Depending on the transcriptional start site, exon 1 could be between 32 - 75 
bp in size. If regulatory sequences exist in exon 1, then their inclusion, or exclusion, 
could be dependent on which start point for transcription is utilised. 
There are examples of regulatory elements residing in the 5' untranslated regions of 
other genes. For example, an iron responsive element is located in the 5' leader 
sequence of the ferritin gene (Goosen et al., 1990). In some genes the rate of mRNA 
decay has been shown to be controlled by their 5' leader sequence such as those 
which are found in the human histone H3 mRNA (Morris et al., 1986) and in the c-
myc mRNA (Piechaczyk et al., 1985; Rabbits et al., 1986). The human c-myc gene 
consists of three exons. Exons 2 and 3 code for the protein, whereas exon 1 is 
noncoding. Two forms of the gene can exist; normal and truncated (i.e lacking exon 
1). Truncation can occur by a translocation event in a manner analogous to that in 
Burkitts lymphoma. Normal c-myc mRNA has been shown to have a half life of 
approximately 30 mins. In contrast, the truncated c-myc mRNA has a substantially 
increased half life, suggesting that exon 1 of c-myc is involved in mRNA stability 
(Rabbits et al., 1985). 
It is therefore conceivable that the upstream exons of PrP may also fulfil such a 
regulatory role and that this regulation may be adversely affected during disease. For 
example, suppose that there are two mRNA species; one disease specific (message 
1) and the other which is found in uninfected animals (message 2). Now, previous 
studies have shown (Oesch et al., 1985; Chesebro et al., 1985) that there are no 
detectable differences in PrP mRNA levels between infected and uninfected animals. 
This has only been determined, however, at one time point and as yet no-one has 
attempted to determine PrP mRNA differences between infected and uninfected 
animals over a time period. This means that if such stability differences do exist then 
they might not have been detected. Such mRNA stability differences could be 
mediated by either differential transcription start site usage or by alternatively spliced 
PrP forms. The repercussions of this are that if message 1 is more stable, it would 
have more opportunity to be translated in comparison to message 2. This hypothesis 
becomes more relevant when one considers the published data which shows that the 
levels of normal PrP protein inversely correlate with the length of incubation period 
(Prusiner et al., 1990). Indeed, recently it has been shown that overexpression of 
PrP, involving no scrapie challenge, can result in a neurodegenerative disease in mice 
(Westaway et al., 1994a). 
Mouse (Westaway et al., 1987, 1991) and sheep PrP genes (Westaway et al., 1994 
b) have two small exons which are located far upstream from the open reading frame 
exon. In contrast, hamster (Basler etal., 1987) and human (Puckett etal., 1991) PrP 
genes only have one 5' exon. The relevance of these differences on PrP gene 
expression is not known. In mouse and sheep, therefore, there exists the possibility 
that PrP gene expression may be under an additional level of control: RNA splicing. 
Gene regulation by means of RNA splicing of noncoding exons, in other genes, is 
well documented. Brain derived neurotrophic factor (BDNF) gene, for example, has 
four upstream noncoding exons which are separated from the open reading frame 
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exon by a large intron (> 16.5 kb). By alternative splicing events several different 
messages are transcribed which are expressed predominantly in certain tissues. 
Messenger RNAs which contain exon I, II and III have been found to be 
predominantly expressed in the brain, whereas exon IV containing transcripts were 
predominantly expressed in the heart and lung (Timmusk et al., 1993). In the case 
of murine PrP, however, it is not known if splicing plays a similar role. In a recent 
study, though, Westaway et al (1994 c) showed, by PCR analysis, that in uninfected 
neonatal and adult brain exon 2 appears to be present in most rnRNAs. As 
mentioned earlier, however, this analysis was not carried out in different tissues or 
in scrapie infected animals. Therefore in some circumstances RNA splicing may 
have a role in PrP gene expression. Perhaps a better way of addressing whether 
splicing of PrP occurs, would be to conduct in situ hybridisation analysis. 
In situ hybridisation is a method which can be used to detect mRNA molecules in 
Situ i.e in tissue sections. Firstly, one would determine if splicing of exon 2 occurs. 
Using sequence data, obtained in this study, for exon 1 and exon 2, specific 
oligonucleotides could be synthesised for each exon. As a control an oligonucleotide 
from exon 3 could also be used. These oligonucleotides would be radioactively 
labelled and used to probe tissue sections from various organs e.g brain, heart, 
kidney, spleen and liver. If RNA splicing does not occur one would expect that each 
probe would hybridise to the same tissue and to the same cell types within that tissue. 
If RNA splicing does occur then one would expect the exon 1 and 2 probes to 
hybridise to different cellular locations or to different cell types. Of course the same 
protein would be translated whether splicing occurred or not as the entire open 
reading frame is found in exon 3. However, the different messages transcribed may 
be regulated differently. 
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One assumption that would be made with such experiments is that exon 1 is always 
included in the transcribed message. From the primer extension results presented in 
chapter 6, this seems to be the case, at least, with PrP mRNA isolated from brain. 
It is worth bearing in mind however that there are examples in other genes were 
multiple promoters are found within one gene, leading to the production of different 
mRNA isoforms. Examples of such genes include alcohol dehydrogenase (Benyajati 
etal., 1983), a fos responsive gene called Fit-i (Bergers etal., 1994) and the myosin 
light chain gene 1/3 (Garfinkel and Davidson, 1987). The different mRNA isoforms 
transcribed from genes with multiple promoters are often differentially regulated. 
Studies by Benyajati et al (1983) have shown that alcohol dehydrogenase niRNA 
(from D.Melanogaster) differs in its 5' end during different developmental stages. 
Many studies have shown that PrP is developmentally regulated (Lieberburg et al., 
1987; McKinley et al., 1987; Lazarini et al., 1991 and Manson et al., 1992a) but the 
process controlling this regulation are, as yet, not understood. 
7.3 The use of transgenic mice to study PrP gene expression. 
The use of tissue culture cell lines in the analysis of gene expression is often 
invaluable. Many facets of gene expression can be studied in this way. These often 
include mapping promoter elements and other regulatory elements such as enhancers 
and repressors. This is usually done by determining the effects of deletions on such 
elements. Studies involving tissue-specific expression of genes can also be performed 
in tissue culture cell lines. Tissue specific elements have been found in the rat 
insulin gene (Edlund et al., 1985) and in the chicken 8-crystalline gene (Hayashi et 
al., 1985) in this way. Both of these studies, incidentally, showed that tissue specific 
expression was mediated by elements found in the 5' flanking regions of the 
respective genes. It may be that elements which control tissue specific expression 
of PrP are also located in the 5' flanking region. 
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Despite the widespread use of cell culture for analysis of gene expression, it is often 
used for preliminary investigations. Although much valuable data can be obtained 
from tissue culture work, it is impossible to analyse sequences responsible for the 
correct temporal and spatial gene expression in the living animal. To do this one 
would have to produce transgenic mice. These mice contain either new or altered 
genes and these genes are present in every cell of the mouse. The most common 
way of creating a transgenic mouse is by direct microinjection of DNA into one of 
the pronuclei of a fertilised egg (for review see Palmiter and Brinster, 1986). To 
examine the expression of PrP one could use the PrP CAT constructs which were 
described in chapter 5. Although CAT has been used as a reporter gene to generate 
transgenic animals in the past (Julien etal., 1990), both f3-galactosidase and luciferase 
are generally preferred for such studies. This is because these proteins can be 
detected in situ rather than having to produce cell extracts for reporter protein 
measurement (for review see Alam and Cook, 1990). This makes both 
developmental and tissue specific gene expression easier to study. The objective of 
such experiments would be to determine the DNA sequences which control 
developmental and tissue specific expression of PrP. Would, for example, pCAT PrP 
3.5 (described in chapter 5, but substituting CAT for lacZ) confer the normal pattern 
of PrP expression onto the reporter gene? For example, would lacZ be highly 
expressed in the brain, at intermediate levels in the heart and at low levels in the 
spleen (Oesch et al., 1985; Caughey et al., 1988)? Would lacZ be expressed at 
embryonic day 13.5 in the brain and spinal cord and then rise approximately 4-fold 
to adult day 20 (Manson et al., 1991; Lazarini et al., 1987)? If this was the case 
then one could conclude that all the sequences responsible for correct tissue specific 
and developmental expression were present within 1.2 kb of 53  flanking sequence and 
the first intron. If, however, abnormal expression of the reporter gene was observed 
then one would have to examine the role of the large intron (intron 2), 3' flanking 
region or more distal 5' flanking sequences. 
7.4 	PrP and Sinc: Relevance of flanking regions. 
In mice, the major gene which controls scrapie incubation period is called Sine (also 
known as Pm-i), of which there are two alleles: s7 and p7 (Dickinson et al., 1968). 
Tight genetic linkage has been demonstrated between PrP and Sine by crosses 
between s7 mice (NZW) and p7 mice (I/LnJ) as shown by Carlson et a! (1986). 
Evidence that PrP and Sine are congruent is given by restriction fragment length 
polymorphism (RFLP) analysis (Hunter et al., 1987) and by direct nucleotide 
sequence analysis of mice with different Sine genotypes (Westaway et al., 1987). 
Sequence analysis of s7 mice predicts that they have a leucine residue at codon 108 
and a threonine residue at codon 189. Sine p7 mice have phenylalanine and valine 
residues at these respective codons. 
Transgenetic studies have also been used in an attempt to define the relationship 
between PrP and Sine. Westaway et al., (1991) produced transgenic mice from a 
NZW background (Sine s7 or Pm-a) which contained cosmid transgenes from an 
IJLnJ mouse (Sine p7 or Pm-b). These transgenes were expected to confer a 
prolonged scrapie incubation period upon the transgenic mice when inoculated with 
scrapie agent. In fact, the opposite happened; mice carrying the Sine p7 allele 
actually had shorter scrapie incubation periods than their s7 (NZW) counterparts. 
This occurred in four separate lines. This result was unexpected and several 
suggestions were proposed to explain it, including elevated levels of PrP' expression 
causing reduced incubation periods or aberrant transgene expression. 
Alternatively, however it may be that the gene controlling incubation period lies 
adjacent to the PrP gene or is only partially represented Within the genomic clone. 
Therefore, it may be that Sine is very close to the PrP locus but that the two are not 
congruent. An examination of the flanking regions of the PrP gene may prove 
fruitful in proving if Sine is distinct and separate from PrP. One way of doing this 
could be by looking for transcripts in the flanking regions of the PrP gene. Having 
identified transcripts, one could clone the cDNA of the gene and analyse it more 
fully. 
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7.5 Sporadic CJD: How is it caused? 
Creutzfeldt-Jakob disease (CJD) can be divided into three basic forms: Jatrogenic, 
familial and sporadic. 
latrogenic cases of CJD are those which are caused by accidental transmission. 
These accidental transmissions usually occur during surgical procedures, especially 
those involving the brain or the eye. The contamination in these cases either 
originates from graft tissue taken from a CJD affected individual or from 
contaminated surgical instruments which had presumably been used on a CID patient 
and improperly decontaminated. Another example of iatrogenic CJD, involving no 
surgery, is given by individuals, usually children, who received human growth 
hormone treatments either subcutaneously or intramuscularly. Some of these patient 
subsequently developed CJD. A likely explanation for this is that pooled pituitary 
glands, from which the growth hormone was extracted, contained infectious agent. 
These pituitary glands had been inadvertently taken from Cii) affected individuals 
(see Brown, 1988, for review). 
Familial forms of CII) are those which are characterised by an autosomal form of 
inheritance (see Hsiao and Prusiner, 1990, for review). Familial forms of CJD are 
linked to mutations in the ORF of the PrP gene. A number of both point and 
insertion mutations have been described in this region (see section 1.4.2). 
By far, the majority of CJD cases ( > 80 %) are of a sporadic (or "spontaneous") 
nature. The title of "sporadic" is generally attributed to a CII) case if there is no 
evidence of iatrogenic transmission or if no mutation in the ORF of PrP can be 
identified. A crucial point, however, is that much of PrP molecular biology is 
concentrated on the open reading frame exon (exon 2 in humans) as this is the exon 
which codes entirely for the protein. As a result of this no-one has looked at the 5' 
flanking exon or other possible regulatory regions of the gene for the existence of 
mutations. The possibility exists, therefore, that the incidence of sporadic CJD can 
be explained by mutations in the upstream exon of the PrP gene or possibly in 
regulatory regions such as the promoter or the intron. As exon 1 of the human PrP 
gene (Puckett et al., 1991) is only - 136 bp in length it would be relatively simple 
to determine if CJD patients harboured mutations in this region, by comparing 
nucleotide sequence to unaffected individuals. Data presented in chapter 5 is the first 
evidence of regulatory elements being found in the 5' flanking region of a PrP gene 
in any species. Examination of the equivalent region of the human PrP gene for 
mutations could also be performed. In the absence of data relating to the existence 
of other regulatory elements occurring elsewhere in the gene, it would be difficult to 
determine if mutations in such regions are linked to sporadic CJD. 
Sporadic CJD may be explained, however, in other ways such as by a rare infection 
of a ubiquitous agent or by development of an age related somatic mutation occurring 
somewhere on the PrP gene (Hsiao and Prusiner, 1990). In the absence of 
experimental data, however, the possibility of mutations occurring in exon 1 or, in 
the promoter region, and causing sporadic CJD, still exists. 
7.6 Is PrP a housekeeping gene ? 
Although there are exceptions, promoter regions of genes which do not contain either 
a TATA or CAAT box are generally associated with a housekeeping function. These 
housekeeping genes are expressed in many, if not all, cell types and often perform 
essential metabolic function e.g dihydrofolate reductase (Mitchell et al., 1986) and 
adenosine deaminase (Valerio et al., 1985). The promoter regions of housekeeping 
genes generally share common features which make them distinct from promoters of 
other genes. These include the absence of both TATA and CAAT boxes, highly 
G C rich, multiple transcription start sites, and multiple binding sites for the 
transcription factor Spi (see Dynan, 1986, for review). Data presented in chapters 
4 and 6 show that the mouse PrP promoter also shares these features. 
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Although the normal function of PrP is not known, despite the generation of PrP null 
mice (Bueler et al., 1992; Manson et at., 1994), its widespread expression has been 
well documented (Oesch et al., 1985; Caughey et al., 1988). PrP gene expression 
was shown in these studies to be high in the brain but expressed very poorly in the 
spleen. Intermediate levels of PrP mRNA were found in organs such as the heart and 
lung. These findings imply that PrP gene expression can be regulated. In chapter 
4 it was shown that a CpG island existed in the 5' region of the PrP gene. It may 
be that differential methylation of this CpG island controls the level of PrP gene 
expression in different tissues. Most other housekeeping genes have CpG islands 
associated at their 5' end (Gardiner-Garden and Frommer, 1987), and a similar degree 
of CpG island methylation may result in similar levels of gene expression in different 
tissues. 
Regulated gene expression of housekeeping genes such as dihydrofolate reductase 
(dhfr) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG coA reductase) 
has been shown to occur. For example, 1-1MG coA reductase is a housekeeping 
enzyme which is involved in cholesterol biosynthesis. A negative feedback 
mechanism exists whereby cholesterol can suppress HMG coA reductase at the level 
of transcription (Luskey et al., 1983). Dhfr, on the other hand, has been shown to 
have its rate of transcription increased four-fold during the proliferative growth phase 
of fibroblasts (Hendrickson et al., 1980; Santiago et al., 1983). 
It therefore seems likely that PrP is a housekeeping gene and, in common with other 
housekeeping genes, its expression may be regulated under certain conditions. 
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7.7 	Understanding PrP gene regulation: Implications for therapeutic 
intervention. 
Data now exists which show that the levels of normal PrP (PrV) are critical in 
controlling aspects of disease such as scrapie incubation period and progression of 
disease. 
Two main experiments have provided these data. Firstly, Scott et al (1989) generated 
mice which were transgenic for the Syrian hamster PrP gene (see section 1.6). 
Various lines had copy numbers for the transgene ranging from 2 to - 60 copies. 
After challenging these mice with hamster scrapie agent it was found that mice with 
high transgene copy number, and subsequently high PrP' and PrP mRNA expression 
(Prusiner et al., 1990), had much shorter incubation periods than mice with lower 
transgene copy numbers. The idea that PrP expression and scrapie incubation period 
inversely correlate was later reinforced by Bueler et a! (1992) who generated PrP 
homozygous null (PrP° ) and heterozygous null (PrP") mice. These mice were 
challenged with scrapie agent and their incubation periods ascertained (Bueler et al., 
1993). Homozygous null mice were found to be completely resistant to scrapie up 
to the age of 14 months. Wild-type mice all developed disease and died within 180 
days. Heterozygous null mice showed an enhanced resistance to scrapie, showing 
clinical symptoms after 253-337 days, but remaining alive after 380 days. In 
addition, the progression of disease (i.e clinical onset to death) is much slower in 
heterozygous null mice (50 - 130 days) than in wild type mice (- 13 days). 
A possible consequence of understanding PrP gene regulation is that development or 
progression of the transmissible degenerative encephalopathies may be controlled. 
Therapeutic intervention, by such means, would be less drastic than ablating PrP 
genes. This intervention may conceivably come about in several ways. If one, for 
example, had a thorough understanding of the factors which enhanced and repressed 
expression of PrP, especially in the central nervous system, then one may be able to 
control the expression of PrP in a given tissue. Consequently, the levels of expressed 
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PrP may be lowered beneath a critical level whereby disease could not be manifested 
within the life span of the animal. 
Another therapeutic approach has been suggested by Weissman et at (1993), whereby 
the levels of PrP expression could be controlled by antisense oligonucleotide therapy. 
Much progress has been made in the treatment of diseases with a genetic 
predisposition such as cystic fibrosis. For example, Hyde et al (1993) have 
introduced functional copies of the cystic fibrosis transmembrane conductance 
regulator (CTFR) gene into the airways of transgenic mice which carry defective 
copies of the gene. These functional copies of the gene were introduced by aerosol 
mediated lipofection and were found to induce correction of the ion conductance 
defect. This, in effect, caused transient alleviation of disease symptoms. 
However, in the TDEs the main focus of disease is in the central nervous system and 
therefore targeting of potential treatments may be more difficult. Despite this, it 
seems that if a therapeutic approach to the TDEs were to be developed then an 
understanding of PrP gene expression would be crucial. 
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Recipes for chapter 2 solutions. 
L-agar: 	10 g bactotryptone, 5 g bactoyeast extract, 10 g NaCl, 15 g bactoagar 
in 1 L H20 at pH 7. 
L-broth: 	10 g bactotryptone, 5 g bactoyeast extract, 10 g NaCl in 1 L H20 at 
PH 7. 
Solution I: 50 mM glucose, 25 mM Tris-HC1 pH 8, 10 mM EDTA pH 8. 
Solution II: 0.2 M NaOH, 1 % SDS. 
Solution III: 3 M Potassium acetate pH 5. 
T.E.: 	10 mM Tris-HC1 pH 8, 1 mM EDTA pH 8. 
Cell resuspension solution: 50 mM Tris-HC1 pH 7.5, 10 mM EDTA, 100 jig rn11 
RNase. 
Cell lysis solution: 	Same as solution II (above). 
Neutralisation solution: 	2.55 M Potassium acetate pH 4.8. 
Magic mini-prep 
purification resin: 	7 M guanidine HC1. 
Wash solution: 	 200 mM NaCl, 20 mM Tris-HCl pH 7.5, 5 mM EDTA: 
diluted 1:1 with 95 % ethanol. 
1 X TAE: 40 mM Tris-acetate, 1 mM EDTA pH 8. 
1 X TBE: 90 mM Tris-borate, 1 mM EDTA pH 8. 
Gel loading 
buffer: 	0.25 % (w/v) bromophenol blue, 0.25 % (w/v) xylene cyanol FF, 15 
% (w/v) Ficoll type 400 in dH20. 
179 
10 X CIP dephosphorylation 
buffer: 	 500 mM Tris-HC1, 1 mM EDTA pH 8.5. 
5 X T4 ligation buffer: 	0.25 M Tris-HCI pH 7.6, 50 mM MgC12, 5 mM ATP, 
5 mM DTT, 25 % (w/v) polyethylene glycol-8000. 
Solution A: 	470 il of solution 0, 9 p.! (3 mercaptoethanol, 12.5 p.! 2 mM 
dATP, drrP, dGTP. 
Solution 0: 	1.5 g Tris base, 0.25 g MgCl2  .6H20 added to 10 ml H20 at 
pH 8. 
Solution B: 	6.5g HEPES (N- 2-Hydroxyethyl piperazine-N'-2- 
ethanesulphonic acid) in 12.5 ml dH20 pH 6.6. 
Solution C: 	Random hexamer primers pdN6 (Pharmacia) at 50 p.g ml-1. 
10 X kinase buffer: 0.5 M Tris-HC1 pH 7.5, 0.1 M MgCl2, 50 mM DIT. 
20 X SSC: 	175.3 g NaCl, 88.2 g sodium citrate in 1 L dH20 at pH 7. 
Hybond-N transfer buffer: 
Hybond-N (pre) Hybridisation buffer 
- random labelled probes: 
oligonucleotide probes: 
0.4 M NaOH, 0.6 M NaCl. 
40 ml 1 M Na2PO4, 10 ml 1M NaHPO4, 
50 ml H20, 7 % SDS, 1 X Denhardts, 
5 mg boiled, sonicated and sheared 
herring sperm DNA. 
15 ml 6 X SSC, 0.1 % SDS, 1 X 
Denhardts, 5 mg boiled, sonicated and 
sheared herring sperm DNA, 32.5 nil 
H20- 
Genescreen transfer buffer: 	 2.3 M NaCl, 2.5 M NaOH. 
Eli 
Genescreen (pre) Hybridisation buffer: 	10 ml 50 % dextran sulphate, 15 ml 20 
X SSC, 5 ml 10 % SDS, 5 mg boiled, 
sonicated and sheared herring sperm 
DNA. 
Denaturing solution: 	1.5 M NaCl, 0.5 M NaOH 
Neutralising solution: 	1.5 M NaCl, 0.5 M Tris-HC1 pH 7.2, 1 mM EDTA. 
Sequenase reaction 
buffer: 	 200 mM Tris-HC1 pH 7.5, 100 mM MgC12, 250 mM 
NaCl. 
Labelling mix: 	 7.5 JIM dGTP, 7.5 JIM dCTP, 7.5 j.tM dTTP. 
Mn buffer: 	 0.15 M sodium isocitrate, 0.1 M MnC12. 
Stop solution: 	 95 % formamide, 20 mM EDTA, 0.05 % (w/v) 
brornophenol blue, 0.05 % (w/v) xylene cyanol FF. 
Freezing mix: 	 6 ml DMEM, 2 ml DMSO, 2 ml FCS. 
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APPENDIX 2. 
Recipes for chapter 3 solutions. 
TEN 9: 	 50 mM Tris-UCI pH 9, 100 mM EDTA, 200 mM NaCl. 
SM buffer: 	5.8 g NaCl, 2 g MgSO4, 50 ml 1 M Tris-HCl pH 7.5, 5 ml 2 
% gelatin. 
APPENDIX 3. 
Recipes for chapter 5 solutions. 
1 X exonuclease ifi buffer: 66 mM Tris-HC1 pH 8, 0.66 mM MgCl2 
7.4 X Si buffer: 	0.3 M potassium acetate pH 4.6, 2.5 M NaCl, 10 mM 
ZnSO4, 50 % glycerol. 
Si stop buffer: 	 0.3 M Tris base, 0.05 M EDTA. 
HEPES buffer 	 50 mM HEPES ( [4-(2-hydroxy ethyl)-1-piperazine 
ethanesuiphonic acid), 280 mM NaC121  1.5 mM 
Na2HPO4, pH 7.1. 
Mix A: 	 46 mM Tris-HCl pH 8, 2.3 jiCi D-threo-[dichloracetyl- 
1-14C] chioramphenicol, 231 jiM butryl co-A. 
100 X Mg buffer: 	0.1 M MgCl2.'  4.5 M 3-mercaptoethano1. 
12 
APPENDIX 4. 
Recipes for chapter 6 solutions. 
10 X RNA running buffer: 20.92 g MOPS (3-(N-morpholino) propanesuiphonic 
acid), 8.33 M sodium acetate, 10 ml 0.5 M EDTA in 
500 ml at pH 7. 
Formarnide sample buffer: 100111 lox RNA running buffer, 200 p.1 formarnide [99 
%], 120 41 formaldehyde [37 40 % w/v]. 
Ficoll-dye-EDTA: 	500 p.1 0.2 M EDTA pH 7, 0.3 g Ficoll type 400, trace 
bromophenol blue. 
Loading buffer: 	 95 % formarnide, 20 mM EDTA, 0.05 % (w/v) 
bromophenol blue, 0.05 % (w/v) xylene cyanol FF. 
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